{
  "metadata": {
    "config": {
      "backend": {
        "_target_": "cotlab.backends.VLLMBackend",
        "tensor_parallel_size": 1,
        "dtype": "bfloat16",
        "trust_remote_code": true,
        "max_model_len": 4096
      },
      "model": {
        "name": "google/medgemma-4b-it",
        "variant": "4b",
        "max_new_tokens": 512,
        "temperature": 0.7,
        "top_p": 0.9,
        "safe_name": "medgemma_4b"
      },
      "prompt": {
        "_target_": "cotlab.prompts.OncologyPromptStrategy",
        "name": "oncology",
        "contrarian": false,
        "few_shot": true,
        "answer_first": false,
        "output_format": "json"
      },
      "dataset": {
        "_target_": "cotlab.datasets.OncologyDataset",
        "name": "oncology",
        "path": "data/oncology.json"
      },
      "experiment": {
        "_target_": "cotlab.experiments.RadiologyExperiment",
        "name": "radiology",
        "description": "Pathological fracture detection from radiology reports",
        "num_samples": -1
      },
      "seed": 42,
      "verbose": true,
      "dry_run": false
    },
    "start_time": "2026-01-09T15:18:47.119493"
  },
  "experiment": "radiology",
  "model": "google/medgemma-4b-it",
  "prompt_strategy": "oncology",
  "metrics": {
    "correct": 100,
    "incorrect": 0,
    "true_positives": 50,
    "true_negatives": 50,
    "false_positives": 0,
    "false_negatives": 0,
    "parse_errors": 0,
    "accuracy": 1.0,
    "parse_error_rate": 0.0,
    "precision": 1.0,
    "recall": 1.0,
    "f1": 1.0
  },
  "raw_outputs": [
    {
      "sample_idx": 0,
      "input": "02/01/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Resolved febrile illness. Blood counts normalized. No organomegaly. Clinical improvement noted. No malignancy identified. Reassurance provided.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 02/01/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"resolved febrile illness\", \"blood counts normalized\", \"no organomegaly\", \"no malignancy identified\"],\n        \"rationale\": \"The report indicates a resolved febrile illness, normalized blood counts, absence of organomegaly, and no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Resolved febrile illness\", \"Blood counts normalized\", \"No organomegaly\", \"No malignancy identified\"],\n        \"rationale\": \"The report mentions the resolution of a febrile illness, normalized blood counts, absence of organomegaly, and the absence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Resolved febrile illness\", \"Blood counts normalized\", \"No organomegaly\", \"No malignancy identified\"],\n        \"rationale\": \"The report shows a resolved febrile illness, normalized blood counts, no organomegaly, and no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Resolved febrile illness\", \"Blood counts normalized\", \"No organomegaly\", \"No malignancy identified\"],\n        \"rationale\": \"The report shows a resolved febrile illness, normalized blood counts, no organomegaly, and no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Resolved febrile illness\", \"Blood counts normalized\", \"No organomegaly\", \"No malignancy identified\"],\n        \"rationale\": \"The report shows a resolved febrile illness, normalized blood counts, no organomegaly, and no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report indicates a resolved febrile illness, normalized blood counts, absence of organomegaly, and no evidence of malignancy.",
      "findings": [
        "resolved febrile illness",
        "blood counts normalized",
        "no organomegaly",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 0,
      "timestamp": "2026-01-09T15:19:56.111645"
    },
    {
      "sample_idx": 1,
      "input": "26/10/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Brain Tumor - Medulloblastoma.\n\nFrom clinical notes: Brain Tumor - Medulloblastoma. Paediatric oncology assessment.\n\nFindings: posterior fossa mass with enhancement and hydrocephalus. Restricted diffusion. High-grade medulloblastoma on histology. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 26/10/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"posterior fossa mass with enhancement and hydrocephalus\", \"Restricted diffusion\", \"High-grade medulloblastoma on histology\"],\n        \"rationale\": \"The report mentions a posterior fossa mass with enhancement and hydrocephalus, along with restricted diffusion, which are indicative of a brain tumor. Histology confirms a high-grade medulloblastoma, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"posterior fossa mass with enhancement and hydrocephalus\", \"Restricted diffusion\", \"High-grade medulloblastoma on histology\"],\n        \"rationale\": \"The report mentions a posterior fossa mass with enhancement and hydrocephalus, along with restricted diffusion, which are indicative of a brain tumor. Histology confirms a high-grade medulloblastoma, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"posterior fossa mass with enhancement and hydrocephalus\", \"Restricted diffusion\", \"High-grade medulloblastoma on histology\"],\n        \"rationale\": \"The report mentions a posterior fossa mass with enhancement and hydrocephalus, along with restricted diffusion, which are indicative of a brain tumor. Histology confirms a high-grade medulloblastoma, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"posterior fossa mass with enhancement and hydrocephalus\", \"Restricted diffusion\", \"High-grade medulloblastoma on histology\"],\n        \"rationale\": \"The report mentions a posterior fossa mass with enhancement and hydrocephalus, along with restricted diffusion, which are indicative of a brain tumor. Histology confirms a high-grade medulloblastoma, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"posterior fossa mass with enhancement and hydrocephalus\", \"Restricted diffusion\",",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report mentions a posterior fossa mass with enhancement and hydrocephalus, along with restricted diffusion, which are indicative of a brain tumor. Histology confirms a high-grade medulloblastoma, indicating malignancy.",
      "findings": [
        "posterior fossa mass with enhancement and hydrocephalus",
        "Restricted diffusion",
        "High-grade medulloblastoma on histology"
      ],
      "fracture_mentioned": null,
      "idx": 1,
      "timestamp": "2026-01-09T15:19:56.111669"
    },
    {
      "sample_idx": 2,
      "input": "03/07/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Follow-up post-treatment. No previous oncology history.\n\nFindings: Reactive lymphadenopathy secondary to viral infection. Node size decreasing on follow-up. No atypical features. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 03/07/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report mentions reactive lymphadenopathy, which is a benign finding. The report explicitly states that no atypical features or malignancy were identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\"],\n        \"rationale\": \"The report explicitly states reactive lymphadenopathy, which is a benign finding.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly mentions reactive lymphadenopathy, which is a benign finding. The report also states that no atypical features or malignancy were identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\"],\n        \"rationale\": \"The report explicitly mentions reactive lymphadenopathy, which is a benign finding.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly mentions reactive lymphadenopathy, which is a benign finding. The report also states that no atypical features or malignancy were identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\"],\n        \"rationale\": \"The report explicitly mentions reactive lymphadenopathy, which is a benign finding.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malign",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report mentions reactive lymphadenopathy, which is a benign finding. The report explicitly states that no atypical features or malignancy were identified.",
      "findings": [
        "reactive lymphadenopathy",
        "no atypical features",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 2,
      "timestamp": "2026-01-09T15:19:56.111683"
    },
    {
      "sample_idx": 3,
      "input": "27/02/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Non-Hodgkin Lymphoma.\n\nFrom clinical notes: Non-Hodgkin Lymphoma. Paediatric oncology assessment.\n\nFindings: abdominal lymphadenopathy with mesenteric and retroperitoneal nodes. Burkitt lymphoma confirmed on biopsy. High LDH levels. Recommend MDT discussion and treatment planning.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 27/02/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"abdominal lymphadenopathy\", \"Burkitt lymphoma confirmed on biopsy\", \"high LDH levels\"],\n        \"rationale\": \"The report mentions abdominal lymphadenopathy, confirms Burkitt lymphoma on biopsy, and reports elevated LDH levels, all of which are indicative of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"abdominal lymphadenopathy\", \"Burkitt lymphoma confirmed on biopsy\", \"high LDH levels\"],\n        \"rationale\": \"The report mentions abdominal lymphadenopathy, confirms Burkitt lymphoma on biopsy, and reports elevated LDH levels, all of which are indicative of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"abdominal lymphadenopathy\", \"Burkitt lymphoma confirmed on biopsy\", \"high LDH levels\"],\n        \"rationale\": \"The report mentions abdominal lymphadenopathy, confirms Burkitt lymphoma on biopsy, and reports elevated LDH levels, all of which are indicative of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"abdominal lymphadenopathy\", \"Burkitt lymphoma confirmed on biopsy\", \"high LDH levels\"],\n        \"rationale\": \"The report mentions abdominal lymphadenopathy, confirms Burkitt lymphoma on biopsy, and reports elevated LDH levels, all of which are indicative of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"abdominal lymphadenopathy\", \"Burkitt lymphoma confirmed on biopsy\", \"high LDH levels\"],\n        \"rationale\": \"The report mentions abdominal lymphadenopathy, confirms Burkitt lymphoma on biopsy, and reports elevated LDH levels, all of which are indicative of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\":",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report mentions abdominal lymphadenopathy, confirms Burkitt lymphoma on biopsy, and reports elevated LDH levels, all of which are indicative of malignancy.",
      "findings": [
        "abdominal lymphadenopathy",
        "Burkitt lymphoma confirmed on biopsy",
        "high LDH levels"
      ],
      "fracture_mentioned": null,
      "idx": 3,
      "timestamp": "2026-01-09T15:19:56.111695"
    },
    {
      "sample_idx": 4,
      "input": "04/05/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Acute Lymphoblastic Leukemia.\n\nFrom clinical notes: Acute Lymphoblastic Leukemia. Paediatric oncology assessment.\n\nFindings: bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells. Immunophenotyping consistent with B-cell ALL. CNS involvement negative. Recommend MDT discussion and treatment planning.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 04/05/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells\", \"Immunophenotyping consistent with B-cell ALL\"],\n        \"rationale\": \"The report explicitly states bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells and immunophenotyping consistent with B-cell ALL, confirming malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells\", \"Immunophenotyping consistent with B-cell ALL\"],\n        \"rationale\": \"The report explicitly states bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells and immunophenotyping consistent with B-cell ALL, confirming malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells\", \"Immunophenotyping consistent with B-cell ALL\"],\n        \"rationale\": \"The report explicitly states bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells and immunophenotyping consistent with B-cell ALL, confirming malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells\", \"Immunophenotyping consistent with B-cell ALL\"],\n        \"rationale\": \"The report explicitly states bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells and immunophenotyping consistent with B-cell ALL, confirming malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells\", \"Immunophenotyping consistent with B-cell ALL\"],\n        \"",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly states bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells and immunophenotyping consistent with B-cell ALL, confirming malignancy.",
      "findings": [
        "bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells",
        "Immunophenotyping consistent with B-cell ALL"
      ],
      "fracture_mentioned": null,
      "idx": 4,
      "timestamp": "2026-01-09T15:19:56.111707"
    },
    {
      "sample_idx": 5,
      "input": "17/09/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Reactive lymphadenopathy secondary to viral infection. Node size decreasing on follow-up. No atypical features. No malignancy identified. Reassurance provided.\n\nDr James Chen, Consultant Paediatric Oncologist 17/09/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly mentions reactive lymphadenopathy, indicating a benign process, and confirms the absence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly mentions reactive lymphadenopathy, indicating a benign process, and confirms the absence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly mentions reactive lymphadenopathy, indicating a benign process, and confirms the absence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly mentions reactive lymphadenopathy, indicating a benign process, and confirms the absence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly mentions reactive lymphadenopathy, indicating a benign process, and confirms the absence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly mentions reactive lymphadenopathy, indicating a benign process, and confirms the absence of",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly mentions reactive lymphadenopathy, indicating a benign process, and confirms the absence of malignancy.",
      "findings": [
        "reactive lymphadenopathy",
        "no atypical features",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 5,
      "timestamp": "2026-01-09T15:19:56.111718"
    },
    {
      "sample_idx": 6,
      "input": "11/07/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Lymphadenopathy. Suspected Neuroblastoma.\n\nFrom clinical notes: Neuroblastoma. Paediatric oncology assessment.\n\nFindings: large heterogeneous suprarenal mass with calcifications. MIBG avidity present. Elevated urinary catecholamines. Stage III disease. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 11/07/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"elevated urinary catecholamines\", \"Stage III disease\"],\n        \"rationale\": \"The report describes a suprarenal mass with calcifications, MIBG avidity, and elevated urinary catecholamines, suggestive of neuroblastoma. The stage III diagnosis further supports the presence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"elevated urinary catecholamines\", \"Stage III disease\"],\n        \"rationale\": \"The report describes a suprarenal mass with calcifications, MIBG avidity, and elevated urinary catecholamines, suggestive of neuroblastoma. The stage III diagnosis further supports the presence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"elevated urinary catecholamines\", \"Stage III disease\"],\n        \"rationale\": \"The report describes a suprarenal mass with calcifications, MIBG avidity, and elevated urinary catecholamines, suggestive of neuroblastoma. The stage III diagnosis further supports the presence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"elevated urinary catecholamines\", \"Stage III disease\"],\n        \"rationale\": \"The report describes a suprarenal mass with calcifications, MIBG avidity, and elevated urinary catecholamines, suggestive of neuroblastoma. The stage III diagnosis further supports the presence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes a suprarenal mass with calcifications, MIBG avidity, and elevated urinary catecholamines, suggestive of neuroblastoma. The stage III diagnosis further supports the presence of malignancy.",
      "findings": [
        "large heterogeneous suprarenal mass with calcifications",
        "MIBG avidity present",
        "elevated urinary catecholamines",
        "Stage III disease"
      ],
      "fracture_mentioned": null,
      "idx": 6,
      "timestamp": "2026-01-09T15:19:56.111731"
    },
    {
      "sample_idx": 7,
      "input": "21/03/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Normal chest radiograph. Clear lung fields. No mediastinal mass. Heart size normal. No malignancy identified. Reassurance provided.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 21/03/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no malignancy was identified, and the chest radiograph, lung fields, mediastinum, and heart size are all normal. Therefore, no malignancy is present.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no malignancy was identified, and the chest radiograph, lung fields, mediastinum, and heart size are all normal. Therefore, no malignancy is present.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no malignancy was identified, and the chest radiograph, lung fields, mediastinum, and heart size are all normal. Therefore, no malignancy is present.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no malignancy was identified, and the chest radiograph, lung fields, mediastinum, and heart size are all normal. Therefore, no malignancy is present.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states that no malignancy was identified, and the chest radiograph, lung fields, mediastinum, and heart size are all normal. Therefore, no malignancy is present.",
      "findings": [
        "normal chest radiograph",
        "clear lung fields",
        "no mediastinal mass",
        "heart size normal",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 7,
      "timestamp": "2026-01-09T15:19:56.111752"
    },
    {
      "sample_idx": 8,
      "input": "08/02/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Normal CBC with age-appropriate values. No blast cells. Platelets adequate. Hemoglobin within normal limits. No malignancy identified. Reassurance provided.\n\nDr James Chen, Consultant Paediatric Oncologist 08/02/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC\", \"age-appropriate values\", \"no blast cells\", \"platelets adequate\", \"hemoglobin within normal limits\", \"no malignancy identified\", \"reassurance provided\"],\n        \"rationale\": \"The report indicates normal blood counts, no blast cells, and no malignancy identified. The physician provides reassurance.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC\", \"age-appropriate values\", \"no blast cells\", \"platelets adequate\", \"hemoglobin within normal limits\", \"no malignancy identified\", \"reassurance provided\"],\n        \"rationale\": \"The report indicates normal blood counts, no blast cells, and no malignancy identified. The physician provides reassurance.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC\", \"age-appropriate values\", \"no blast cells\", \"platelets adequate\", \"hemoglobin within normal limits\", \"no malignancy identified\", \"reassurance provided\"],\n        \"rationale\": \"The report indicates normal blood counts, no blast cells, and no malignancy identified. The physician provides reassurance.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC\", \"age-appropriate values\", \"no blast cells\", \"platelets adequate\", \"hemoglobin within normal limits\", \"no malignancy identified\", \"reassurance provided\"],\n        \"rationale\": \"The report indicates normal blood counts, no blast cells, and no malignancy identified. The physician provides reassurance.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC\", \"age-appropriate values\", \"no blast cells\", \"platelets adequate\", \"hemoglobin within normal limits\", \"no malignancy identified\", \"reassurance provided\"],\n        \"rationale\": \"The",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report indicates normal blood counts, no blast cells, and no malignancy identified. The physician provides reassurance.",
      "findings": [
        "normal CBC",
        "age-appropriate values",
        "no blast cells",
        "platelets adequate",
        "hemoglobin within normal limits",
        "no malignancy identified",
        "reassurance provided"
      ],
      "fracture_mentioned": null,
      "idx": 8,
      "timestamp": "2026-01-09T15:19:56.111765"
    },
    {
      "sample_idx": 9,
      "input": "25/04/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Wilms Tumor.\n\nFrom clinical notes: Wilms Tumor. Paediatric oncology assessment.\n\nFindings: large heterogeneous left renal mass with pseudocapsule. No vascular invasion. Favorable histology on biopsy. Stage II. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 25/04/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"no vascular invasion\", \"favorable histology on biopsy\", \"stage II\"],\n        \"rationale\": \"The report explicitly describes a large renal mass with a pseudocapsule, no vascular invasion, and favorable histology, indicating a Wilms tumor. The stage is also specified as Stage II.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"no vascular invasion\", \"favorable histology on biopsy\", \"stage II\"],\n        \"rationale\": \"The report explicitly describes a large renal mass with a pseudocapsule, no vascular invasion, and favorable histology, indicating a Wilms tumor. The stage is also specified as Stage II.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"no vascular invasion\", \"favorable histology on biopsy\", \"stage II\"],\n        \"rationale\": \"The report explicitly describes a large renal mass with a pseudocapsule, no vascular invasion, and favorable histology, indicating a Wilms tumor. The stage is also specified as Stage II.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"no vascular invasion\", \"favorable histology on biopsy\", \"stage II\"],\n        \"rationale\": \"The report explicitly describes a large renal mass with a pseudocapsule, no vascular invasion, and favorable histology, indicating a Wilms tumor. The stage is also specified as Stage II.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"no vascular invasion\", \"favorable",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly describes a large renal mass with a pseudocapsule, no vascular invasion, and favorable histology, indicating a Wilms tumor. The stage is also specified as Stage II.",
      "findings": [
        "large heterogeneous left renal mass with pseudocapsule",
        "no vascular invasion",
        "favorable histology on biopsy",
        "stage II"
      ],
      "fracture_mentioned": null,
      "idx": 9,
      "timestamp": "2026-01-09T15:19:56.111779"
    },
    {
      "sample_idx": 10,
      "input": "26/12/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Hodgkin Lymphoma.\n\nFrom clinical notes: Hodgkin Lymphoma. Paediatric oncology assessment.\n\nFindings: mediastinal lymphadenopathy with bulky anterior mediastinal mass. PET-CT showing FDG-avid nodes. Classical Hodgkin, nodular sclerosing type. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 26/12/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"bulky anterior mediastinal mass\", \"FDG-avid nodes\", \"Classical Hodgkin, nodular sclerosing type\"],\n        \"rationale\": \"The report explicitly mentions mediastinal lymphadenopathy, a bulky anterior mediastinal mass, FDG-avid nodes, and the diagnosis of Classical Hodgkin lymphoma, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"bulky anterior mediastinal mass\", \"FDG-avid nodes\", \"Classical Hodgkin, nodular sclerosing type\"],\n        \"rationale\": \"The report explicitly mentions mediastinal lymphadenopathy, a bulky anterior mediastinal mass, FDG-avid nodes, and the diagnosis of Classical Hodgkin lymphoma, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"bulky anterior mediastinal mass\", \"FDG-avid nodes\", \"Classical Hodgkin, nodular sclerosing type\"],\n        \"rationale\": \"The report explicitly mentions mediastinal lymphadenopathy, a bulky anterior mediastinal mass, FDG-avid nodes, and the diagnosis of Classical Hodgkin lymphoma, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"bulky anterior mediastinal mass\", \"FDG-avid nodes\", \"Classical Hodgkin, nodular sclerosing type\"],\n        \"rationale\": \"The report explicitly mentions mediastinal lymphadenopathy, a bulky anterior mediastinal mass, FDG-avid nodes, and the diagnosis of Classical Hodgkin lymphoma, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly mentions mediastinal lymphadenopathy, a bulky anterior mediastinal mass, FDG-avid nodes, and the diagnosis of Classical Hodgkin lymphoma, indicating malignancy.",
      "findings": [
        "mediastinal lymphadenopathy",
        "bulky anterior mediastinal mass",
        "FDG-avid nodes",
        "Classical Hodgkin, nodular sclerosing type"
      ],
      "fracture_mentioned": null,
      "idx": 10,
      "timestamp": "2026-01-09T15:19:56.111791"
    },
    {
      "sample_idx": 11,
      "input": "18/09/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Neuroblastoma.\n\nFrom clinical notes: Neuroblastoma. Paediatric oncology assessment.\n\nFindings: large heterogeneous suprarenal mass with calcifications. MIBG avidity present. Elevated urinary catecholamines. Stage III disease. Recommend MDT discussion and treatment planning.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 18/09/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"Elevated urinary catecholamines\", \"Stage III disease\"],\n        \"rationale\": \"The report describes a large suprarenal mass with calcifications, MIBG avidity, and elevated urinary catecholamines, which are consistent with neuroblastoma. Stage III disease is also reported.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"Elevated urinary catecholamines\", \"Stage III disease\"],\n        \"rationale\": \"The report describes a large suprarenal mass with calcifications, MIBG avidity, and elevated urinary catecholamines, which are consistent with neuroblastoma. Stage III disease is also reported.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"Elevated urinary catecholamines\", \"Stage III disease\"],\n        \"rationale\": \"The report describes a large suprarenal mass with calcifications, MIBG avidity, and elevated urinary catecholamines, which are consistent with neuroblastoma. Stage III disease is also reported.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"Elevated urinary catecholamines\", \"Stage III disease\"],\n        \"rationale\": \"The report describes a large suprarenal mass with calcifications, MIBG avidity, and elevated urinary catecholamines, which are consistent with neuroblastoma. Stage III disease is also reported.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes a large suprarenal mass with calcifications, MIBG avidity, and elevated urinary catecholamines, which are consistent with neuroblastoma. Stage III disease is also reported.",
      "findings": [
        "large heterogeneous suprarenal mass with calcifications",
        "MIBG avidity present",
        "Elevated urinary catecholamines",
        "Stage III disease"
      ],
      "fracture_mentioned": null,
      "idx": 11,
      "timestamp": "2026-01-09T15:19:56.111804"
    },
    {
      "sample_idx": 12,
      "input": "15/12/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Hepatoblastoma.\n\nFrom clinical notes: Hepatoblastoma. Paediatric oncology assessment.\n\nFindings: large heterogeneous hepatic mass with elevated AFP. Fetal histology subtype. PRETEXT stage II. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 15/12/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous hepatic mass\", \"elevated AFP\", \"Fetal histology subtype\", \"PRETEXT stage II\"],\n        \"rationale\": \"The report describes a large hepatic mass, elevated AFP, a specific histological subtype, and a stage indicating advanced disease. These findings are highly suggestive of malignancy, specifically Hepatoblastoma, which was already suspected based on the clinical notes.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous hepatic mass\", \"elevated AFP\", \"Fetal histology subtype\", \"PRETEXT stage II\"],\n        \"rationale\": \"The report describes a large hepatic mass, elevated AFP, a specific histological subtype, and a stage indicating advanced disease. These findings are highly suggestive of malignancy, specifically Hepatoblastoma, which was already suspected based on the clinical notes.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous hepatic mass\", \"elevated AFP\", \"Fetal histology subtype\", \"PRETEXT stage II\"],\n        \"rationale\": \"The report describes a large hepatic mass, elevated AFP, a specific histological subtype, and a stage indicating advanced disease. These findings are highly suggestive of malignancy, specifically Hepatoblastoma, which was already suspected based on the clinical notes.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous hepatic mass\", \"elevated AFP\", \"Fetal histology subtype\", \"PRETEXT stage II\"],\n        \"rationale\": \"The report describes a large hepatic mass, elevated AFP, a specific histological subtype, and a stage indicating advanced disease. These findings are highly suggestive of malignancy, specifically Hepatoblastoma, which was already suspected based on the clinical notes.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes a large hepatic mass, elevated AFP, a specific histological subtype, and a stage indicating advanced disease. These findings are highly suggestive of malignancy, specifically Hepatoblastoma, which was already suspected based on the clinical notes.",
      "findings": [
        "large heterogeneous hepatic mass",
        "elevated AFP",
        "Fetal histology subtype",
        "PRETEXT stage II"
      ],
      "fracture_mentioned": null,
      "idx": 12,
      "timestamp": "2026-01-09T15:19:56.111817"
    },
    {
      "sample_idx": 13,
      "input": "26/02/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Langerhans Cell Histiocytosis.\n\nFrom clinical notes: Langerhans Cell Histiocytosis. Paediatric oncology assessment.\n\nFindings: multiple lytic skull lesions with soft tissue component. CD1a and Langerin positive. Multisystem disease. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 26/02/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"multiple lytic skull lesions with soft tissue component\", \"CD1a and Langerin positive\", \"Multisystem disease\"],\n        \"rationale\": \"The report describes multiple lytic skull lesions with soft tissue component, which is suggestive of Langerhans Cell Histiocytosis. The positive CD1a and Langerin staining confirms the diagnosis, and the description of multisystem disease further supports the malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"multiple lytic skull lesions with soft tissue component\", \"CD1a and Langerin positive\", \"Multisystem disease\"],\n        \"rationale\": \"The report describes multiple lytic skull lesions with soft tissue component, which is suggestive of Langerhans Cell Histiocytosis. The positive CD1a and Langerin staining confirms the diagnosis, and the description of multisystem disease further supports the malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"multiple lytic skull lesions with soft tissue component\", \"CD1a and Langerin positive\", \"Multisystem disease\"],\n        \"rationale\": \"The report describes multiple lytic skull lesions with soft tissue component, which is suggestive of Langerhans Cell Histiocytosis. The positive CD1a and Langerin staining confirms the diagnosis, and the description of multisystem disease further supports the malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"multiple lytic skull lesions with soft tissue component\", \"CD1a and Langerin positive\", \"Multisystem disease\"],\n        \"rationale\": \"The report describes multiple lytic skull lesions with soft tissue component, which is suggestive of Langerhans Cell Histiocytosis. The positive CD1a and Langerin staining confirms the diagnosis, and the description of multisystem disease further supports the malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes multiple lytic skull lesions with soft tissue component, which is suggestive of Langerhans Cell Histiocytosis. The positive CD1a and Langerin staining confirms the diagnosis, and the description of multisystem disease further supports the malignancy.",
      "findings": [
        "multiple lytic skull lesions with soft tissue component",
        "CD1a and Langerin positive",
        "Multisystem disease"
      ],
      "fracture_mentioned": null,
      "idx": 13,
      "timestamp": "2026-01-09T15:19:56.111830"
    },
    {
      "sample_idx": 14,
      "input": "08/09/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Post-viral lymphocytosis. Atypical lymphocytes resolving. Monospot positive. EBV serology confirms. No malignancy identified. Reassurance provided.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 08/09/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"post-viral lymphocytosis\", \"atypical lymphocytes resolving\", \"monospot positive\", \"EBV serology confirms\"],\n        \"rationale\": \"The report identifies post-viral lymphocytosis, atypical lymphocytes resolving, and a positive monospot test, all consistent with a viral infection. EBV serology confirms the diagnosis. No malignancy is identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no malignancy is identified. This indicates the absence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"lymphoblasts 85% of marrow\", \"B-cell ALL immunophenotype\", \"bone marrow infiltration\"],\n        \"rationale\": \"The report explicitly identifies bone marrow infiltration with lymphoblasts and immunophenotyping consistent with acute lymphoblastic leukemia, confirming malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC\", \"age-appropriate values\", \"no blast cells\"],\n        \"rationale\": \"The report shows normal blood counts with no atypical or malignant cells. No evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"lymphoblasts 85% of marrow\", \"B-cell ALL immunophenotype\", \"bone marrow infiltration\"],\n        \"rationale\": \"The report explicitly identifies bone marrow infiltration with lymphoblasts and immunophenotyping consistent with acute lymphoblastic leukemia, confirming malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC\", \"age-appropriate",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report identifies post-viral lymphocytosis, atypical lymphocytes resolving, and a positive monospot test, all consistent with a viral infection. EBV serology confirms the diagnosis. No malignancy is identified.",
      "findings": [
        "post-viral lymphocytosis",
        "atypical lymphocytes resolving",
        "monospot positive",
        "EBV serology confirms"
      ],
      "fracture_mentioned": null,
      "idx": 14,
      "timestamp": "2026-01-09T15:19:56.111842"
    },
    {
      "sample_idx": 15,
      "input": "14/07/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Bone pain. Suspected Acute Myeloid Leukemia.\n\nFrom clinical notes: Acute Myeloid Leukemia. Paediatric oncology assessment.\n\nFindings: myeloblasts accounting for 70% of marrow cellularity. Cytogenetic analysis reveals t(8;21) translocation. Favorable risk category. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 14/07/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"myeloblasts accounting for 70% of marrow cellularity\", \"t(8;21) translocation\"],\n        \"rationale\": \"The report mentions myeloblasts accounting for 70% of marrow cellularity, which is consistent with Acute Myeloid Leukemia. The presence of t(8;21) translocation is also a characteristic feature of Acute Myeloid Leukemia.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"myeloblasts accounting for 70% of marrow cellularity\", \"t(8;21) translocation\"],\n        \"rationale\": \"The report indicates a high percentage of myeloblasts in the bone marrow (70%), which is a hallmark of Acute Myeloid Leukemia (AML). The presence of the t(8;21) translocation is a specific genetic abnormality associated with AML, further supporting the diagnosis.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"myeloblasts accounting for 70% of marrow cellularity\", \"t(8;21) translocation\"],\n        \"rationale\": \"The report indicates a high percentage of myeloblasts in the bone marrow (70%), which is a hallmark of Acute Myeloid Leukemia (AML). The presence of the t(8;21) translocation is a specific genetic abnormality associated with AML, further supporting the diagnosis.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"myeloblasts accounting for 70% of marrow cellularity\", \"t(8;21) translocation\"],\n        \"rationale\": \"The report indicates a high percentage of myeloblasts in the bone marrow (70%), which is a hallmark of Acute Myeloid Leukemia (AML). The presence of the t(8;21) translocation is a specific genetic abnormality associated with AML, further supporting the diagnosis.\"\n",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report mentions myeloblasts accounting for 70% of marrow cellularity, which is consistent with Acute Myeloid Leukemia. The presence of t(8;21) translocation is also a characteristic feature of Acute Myeloid Leukemia.",
      "findings": [
        "myeloblasts accounting for 70% of marrow cellularity",
        "t(8;21) translocation"
      ],
      "fracture_mentioned": null,
      "idx": 15,
      "timestamp": "2026-01-09T15:19:56.111854"
    },
    {
      "sample_idx": 16,
      "input": "07/10/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Unexplained fever and weight loss. Suspected Rhabdomyosarcoma.\n\nFrom clinical notes: Rhabdomyosarcoma. Paediatric oncology assessment.\n\nFindings: parameningeal mass with intracranial extension. Embryonal rhabdomyosarcoma on biopsy. PAX-FOXO1 fusion negative. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 07/10/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"embryonal rhabdomyosarcoma\", \"parameningeal mass with intracranial extension\"],\n        \"rationale\": \"The report explicitly identifies embryonal rhabdomyosarcoma, a type of cancer, and describes a parameningeal mass with intracranial extension, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"embryonal rhabdomyosarcoma\", \"parameningeal mass with intracranial extension\"],\n        \"rationale\": \"The report explicitly identifies embryonal rhabdomyosarcoma, a type of cancer, and describes a parameningeal mass with intracranial extension, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"embryonal rhabdomyosarcoma\", \"parameningeal mass with intracranial extension\"],\n        \"rationale\": \"The report explicitly identifies embryonal rhabdomyosarcoma, a type of cancer, and describes a parameningeal mass with intracranial extension, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"embryonal rhabdomyosarcoma\", \"parameningeal mass with intracranial extension\"],\n        \"rationale\": \"The report explicitly identifies embryonal rhabdomyosarcoma, a type of cancer, and describes a parameningeal mass with intracranial extension, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"embryonal rhabdomyosarcoma\", \"parameningeal mass with intracranial extension\"],\n        \"rationale\": \"The report explicitly identifies embryonal rhabdomyosarcoma, a type of cancer, and describes a parameningeal mass with intracranial extension, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly identifies embryonal rhabdomyosarcoma, a type of cancer, and describes a parameningeal mass with intracranial extension, indicating malignancy.",
      "findings": [
        "embryonal rhabdomyosarcoma",
        "parameningeal mass with intracranial extension"
      ],
      "fracture_mentioned": null,
      "idx": 16,
      "timestamp": "2026-01-09T15:19:56.111864"
    },
    {
      "sample_idx": 17,
      "input": "06/04/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Normal chest radiograph. Clear lung fields. No mediastinal mass. Heart size normal. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 06/04/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\", \"reassurance provided\"],\n        \"rationale\": \"The report explicitly states that the chest radiograph is normal, with no signs of malignancy. The physician provided reassurance. Therefore, there is no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\", \"reassurance provided\"],\n        \"rationale\": \"The report explicitly states that the chest radiograph is normal, with no signs of malignancy. The physician provided reassurance. Therefore, there is no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\", \"reassurance provided\"],\n        \"rationale\": \"The report explicitly states that the chest radiograph is normal, with no signs of malignancy. The physician provided reassurance. Therefore, there is no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\", \"reassurance provided\"],\n        \"rationale\": \"The report explicitly states that the chest radiograph is normal, with no signs of malignancy. The physician provided reassurance. Therefore, there is no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states that the chest radiograph is normal, with no signs of malignancy. The physician provided reassurance. Therefore, there is no evidence of malignancy.",
      "findings": [
        "normal chest radiograph",
        "clear lung fields",
        "no mediastinal mass",
        "heart size normal",
        "no malignancy identified",
        "reassurance provided"
      ],
      "fracture_mentioned": null,
      "idx": 17,
      "timestamp": "2026-01-09T15:19:56.111876"
    },
    {
      "sample_idx": 18,
      "input": "23/05/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Bone pain. Suspected Brain Tumor - Medulloblastoma.\n\nFrom clinical notes: Brain Tumor - Medulloblastoma. Paediatric oncology assessment.\n\nFindings: posterior fossa mass with enhancement and hydrocephalus. Restricted diffusion. High-grade medulloblastoma on histology. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 23/05/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"posterior fossa mass with enhancement and hydrocephalus\", \"Restricted diffusion\", \"High-grade medulloblastoma on histology\"],\n        \"rationale\": \"The report explicitly mentions a posterior fossa mass with enhancement and hydrocephalus, confirmed by restricted diffusion and identified as high-grade medulloblastoma on histology, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"posterior fossa mass with enhancement and hydrocephalus\", \"Restricted diffusion\", \"High-grade medulloblastoma on histology\"],\n        \"rationale\": \"The report explicitly mentions a posterior fossa mass with enhancement and hydrocephalus, confirmed by restricted diffusion and identified as high-grade medulloblastoma on histology, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"posterior fossa mass with enhancement and hydrocephalus\", \"Restricted diffusion\", \"High-grade medulloblastoma on histology\"],\n        \"rationale\": \"The report explicitly mentions a posterior fossa mass with enhancement and hydrocephalus, confirmed by restricted diffusion and identified as high-grade medulloblastoma on histology, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"posterior fossa mass with enhancement and hydrocephalus\", \"Restricted diffusion\", \"High-grade medulloblastoma on histology\"],\n        \"rationale\": \"The report explicitly mentions a posterior fossa mass with enhancement and hydrocephalus, confirmed by restricted diffusion and identified as high-grade medulloblastoma on histology, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"posterior fossa mass with enhancement and hydrocephalus\", \"Restricted diffusion\", \"High-grade medulloblastoma on histology\"],\n        \"rationale\": \"The report explicitly mentions a posterior fossa mass with enhancement and",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly mentions a posterior fossa mass with enhancement and hydrocephalus, confirmed by restricted diffusion and identified as high-grade medulloblastoma on histology, indicating malignancy.",
      "findings": [
        "posterior fossa mass with enhancement and hydrocephalus",
        "Restricted diffusion",
        "High-grade medulloblastoma on histology"
      ],
      "fracture_mentioned": null,
      "idx": 18,
      "timestamp": "2026-01-09T15:19:56.111889"
    },
    {
      "sample_idx": 19,
      "input": "09/07/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Abnormal imaging. Suspected Neuroblastoma.\n\nFrom clinical notes: Neuroblastoma. Paediatric oncology assessment.\n\nFindings: large heterogeneous suprarenal mass with calcifications. MIBG avidity present. Elevated urinary catecholamines. Stage III disease. Recommend MDT discussion and treatment planning.\n\nDr James Chen, Consultant Paediatric Oncologist 09/07/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"elevated urinary catecholamines\", \"Stage III disease\"],\n        \"rationale\": \"The report describes a suprarenal mass with calcifications, MIBG avidity, and elevated urinary catecholamines, suggestive of neuroblastoma. The stage is also specified as Stage III, further supporting the diagnosis of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"elevated urinary catecholamines\", \"Stage III disease\"],\n        \"rationale\": \"The report describes a suprarenal mass with calcifications, MIBG avidity, and elevated urinary catecholamines, suggestive of neuroblastoma. The stage is also specified as Stage III, further supporting the diagnosis of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"elevated urinary catecholamines\", \"Stage III disease\"],\n        \"rationale\": \"The report describes a suprarenal mass with calcifications, MIBG avidity, and elevated urinary catecholamines, suggestive of neuroblastoma. The stage is also specified as Stage III, further supporting the diagnosis of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"elevated urinary catecholamines\", \"Stage III disease\"],\n        \"rationale\": \"The report describes a suprarenal mass with calcifications, MIBG avidity, and elevated urinary catecholamines, suggestive of neuroblastoma. The stage is also specified as Stage III, further supporting the diagnosis of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malign",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes a suprarenal mass with calcifications, MIBG avidity, and elevated urinary catecholamines, suggestive of neuroblastoma. The stage is also specified as Stage III, further supporting the diagnosis of malignancy.",
      "findings": [
        "large heterogeneous suprarenal mass with calcifications",
        "MIBG avidity present",
        "elevated urinary catecholamines",
        "Stage III disease"
      ],
      "fracture_mentioned": null,
      "idx": 19,
      "timestamp": "2026-01-09T15:19:56.111902"
    },
    {
      "sample_idx": 20,
      "input": "18/08/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Wilms Tumor.\n\nFrom clinical notes: Wilms Tumor. Paediatric oncology assessment.\n\nFindings: large heterogeneous left renal mass with pseudocapsule. No vascular invasion. Favorable histology on biopsy. Stage II. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 18/08/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"no vascular invasion\", \"favorable histology on biopsy\", \"stage II\"],\n        \"rationale\": \"The report describes a renal mass with characteristics consistent with Wilms Tumor, confirmed by favorable histology and stage II. This indicates malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"no vascular invasion\", \"favorable histology on biopsy\", \"stage II\"],\n        \"rationale\": \"The report describes a renal mass with characteristics consistent with Wilms Tumor, confirmed by favorable histology and stage II. This indicates malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"no vascular invasion\", \"favorable histology on biopsy\", \"stage II\"],\n        \"rationale\": \"The report describes a renal mass with characteristics consistent with Wilms Tumor, confirmed by favorable histology and stage II. This indicates malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"no vascular invasion\", \"favorable histology on biopsy\", \"stage II\"],\n        \"rationale\": \"The report describes a renal mass with characteristics consistent with Wilms Tumor, confirmed by favorable histology and stage II. This indicates malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"no vascular invasion\", \"favorable histology on biopsy\", \"stage II\"],\n        \"rationale\": \"The report describes a renal mass with characteristics consistent with Wilms Tumor, confirmed by favorable histology and stage II. This indicates malignancy.\"\n    }",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes a renal mass with characteristics consistent with Wilms Tumor, confirmed by favorable histology and stage II. This indicates malignancy.",
      "findings": [
        "large heterogeneous left renal mass with pseudocapsule",
        "no vascular invasion",
        "favorable histology on biopsy",
        "stage II"
      ],
      "fracture_mentioned": null,
      "idx": 20,
      "timestamp": "2026-01-09T15:19:56.111913"
    },
    {
      "sample_idx": 21,
      "input": "13/03/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Normal brain MRI for age. No mass lesion. No abnormal enhancement. Headaches attributed to migraine. No malignancy identified. Reassurance provided.\n\nDr James Chen, Consultant Paediatric Oncologist 13/03/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\"],\n        \"rationale\": \"The report states that the brain MRI is normal, with no mass lesion, abnormal enhancement, or malignancy identified. This indicates that there is no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\"],\n        \"rationale\": \"The report states that the brain MRI is normal, with no mass lesion, abnormal enhancement, or malignancy identified. This indicates that there is no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\"],\n        \"rationale\": \"The report states that the brain MRI is normal, with no mass lesion, abnormal enhancement, or malignancy identified. This indicates that there is no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\"],\n        \"rationale\": \"The report states that the brain MRI is normal, with no mass lesion, abnormal enhancement, or malignancy identified. This indicates that there is no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\"],\n        \"rationale\": \"The report states that the brain MRI is normal, with no mass lesion, abnormal enhancement, or malignancy identified. This indicates that there is no evidence of malignancy.\"\n    }\n}\n```\n",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report states that the brain MRI is normal, with no mass lesion, abnormal enhancement, or malignancy identified. This indicates that there is no evidence of malignancy.",
      "findings": [
        "normal brain MRI",
        "no mass lesion",
        "no abnormal enhancement",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 21,
      "timestamp": "2026-01-09T15:19:56.111924"
    },
    {
      "sample_idx": 22,
      "input": "18/10/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Wilms Tumor.\n\nFrom clinical notes: Wilms Tumor. Paediatric oncology assessment.\n\nFindings: large heterogeneous left renal mass with pseudocapsule. No vascular invasion. Favorable histology on biopsy. Stage II. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 18/10/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"no vascular invasion\", \"favorable histology on biopsy\", \"stage II\"],\n        \"rationale\": \"The report describes a left renal mass with features suggestive of Wilms Tumor, including a pseudocapsule and favorable histology. The report also states that the stage is II. The presence of a renal mass, along with a favorable histology, indicates malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"no vascular invasion\", \"favorable histology on biopsy\", \"stage II\"],\n        \"rationale\": \"The report describes a left renal mass with features suggestive of Wilms Tumor, including a pseudocapsule and favorable histology. The report also states that the stage is II. The presence of a renal mass, along with a favorable histology, indicates malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"no vascular invasion\", \"favorable histology on biopsy\", \"stage II\"],\n        \"rationale\": \"The report describes a left renal mass with features suggestive of Wilms Tumor, including a pseudocapsule and favorable histology. The report also states that the stage is II. The presence of a renal mass, along with a favorable histology, indicates malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"no vascular invasion\", \"favorable histology on biopsy\", \"stage II\"],\n        \"rationale\": \"The report describes a left renal mass with features suggestive of Wilms Tumor, including a pseudocapsule and favorable histology. The report also states that the stage is II. The presence of a renal mass, along with a favorable histology, indicates malignancy.\"\n    }\n}\n```\n```json",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes a left renal mass with features suggestive of Wilms Tumor, including a pseudocapsule and favorable histology. The report also states that the stage is II. The presence of a renal mass, along with a favorable histology, indicates malignancy.",
      "findings": [
        "large heterogeneous left renal mass with pseudocapsule",
        "no vascular invasion",
        "favorable histology on biopsy",
        "stage II"
      ],
      "fracture_mentioned": null,
      "idx": 22,
      "timestamp": "2026-01-09T15:19:56.111938"
    },
    {
      "sample_idx": 23,
      "input": "02/05/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Normal brain MRI for age. No mass lesion. No abnormal enhancement. Headaches attributed to migraine. No malignancy identified. Reassurance provided.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 02/05/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no mass lesion, abnormal enhancement, or malignancy was identified. Therefore, there is no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no mass lesion, abnormal enhancement, or malignancy was identified. Therefore, there is no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no mass lesion, abnormal enhancement, or malignancy was identified. Therefore, there is no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no mass lesion, abnormal enhancement, or malignancy was identified. Therefore, there is no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no mass lesion, abnormal enhancement, or malignancy was identified. Therefore, there is no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        ",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states that no mass lesion, abnormal enhancement, or malignancy was identified. Therefore, there is no evidence of malignancy.",
      "findings": [
        "normal brain MRI",
        "no mass lesion",
        "no abnormal enhancement",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 23,
      "timestamp": "2026-01-09T15:19:56.111950"
    },
    {
      "sample_idx": 24,
      "input": "16/05/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Normal brain MRI for age. No mass lesion. No abnormal enhancement. Headaches attributed to migraine. No malignancy identified. Reassurance provided.\n\nDr James Chen, Consultant Paediatric Oncologist 16/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no malignancy was identified. The brain MRI is normal. The findings are reassuring and indicate no malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal\", \"no abnormal findings\"],\n        \"rationale\": \"The report indicates that there are no abnormal findings, and that the patient has no history of malignancy. Therefore, there is no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no findings suggestive of malignancy\", \"no evidence of cancer\"],\n        \"rationale\": \"The report explicitly states that there are no findings suggestive of malignancy, and no evidence of cancer. Therefore, there is no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no evidence of malignancy\", \"no abnormal findings\"],\n        \"rationale\": \"The report explicitly states that there is no evidence of malignancy and no abnormal findings. Therefore, there is no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no evidence of malignancy\", \"no abnormal findings\"],\n        \"rationale\": \"The report explicitly states that there is no evidence of malignancy and no abnormal findings. Therefore, there is no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no evidence of malignancy\", \"no abnormal findings\"],\n        \"rationale\": \"The report explicitly states that there is no evidence of malignancy and no abnormal",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states that no malignancy was identified. The brain MRI is normal. The findings are reassuring and indicate no malignancy.",
      "findings": [
        "normal brain MRI",
        "no mass lesion",
        "no abnormal enhancement",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 24,
      "timestamp": "2026-01-09T15:19:56.111960"
    },
    {
      "sample_idx": 25,
      "input": "16/05/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Unexplained fever and weight loss. Suspected Ewing Sarcoma.\n\nFrom clinical notes: Ewing Sarcoma. Paediatric oncology assessment.\n\nFindings: permeative bone destruction in left femoral diaphysis with large soft tissue mass. Onion-skin periosteal reaction. EWSR1 fusion positive. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 16/05/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"permeative bone destruction in left femoral diaphysis\", \"large soft tissue mass\", \"onion-skin periosteal reaction\", \"EWSR1 fusion positive\"],\n        \"rationale\": \"The report describes bone destruction, a soft tissue mass, periosteal reaction, and EWSR1 fusion positivity, all suggestive of Ewing Sarcoma, a malignant bone tumor.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"permeative bone destruction in left femoral diaphysis\", \"large soft tissue mass\", \"onion-skin periosteal reaction\", \"EWSR1 fusion positive\"],\n        \"rationale\": \"The report describes bone destruction, a soft tissue mass, periosteal reaction, and EWSR1 fusion positivity, all suggestive of Ewing Sarcoma, a malignant bone tumor.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"permeative bone destruction in left femoral diaphysis\", \"large soft tissue mass\", \"onion-skin periosteal reaction\", \"EWSR1 fusion positive\"],\n        \"rationale\": \"The report describes bone destruction, a soft tissue mass, periosteal reaction, and EWSR1 fusion positivity, all suggestive of Ewing Sarcoma, a malignant bone tumor.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"permeative bone destruction in left femoral diaphysis\", \"large soft tissue mass\", \"onion-skin periosteal reaction\", \"EWSR1 fusion positive\"],\n        \"rationale\": \"The report describes bone destruction, a soft tissue mass, periosteal reaction, and EWSR1 fusion positivity, all suggestive of Ewing Sarcoma, a malignant bone tumor.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes bone destruction, a soft tissue mass, periosteal reaction, and EWSR1 fusion positivity, all suggestive of Ewing Sarcoma, a malignant bone tumor.",
      "findings": [
        "permeative bone destruction in left femoral diaphysis",
        "large soft tissue mass",
        "onion-skin periosteal reaction",
        "EWSR1 fusion positive"
      ],
      "fracture_mentioned": null,
      "idx": 25,
      "timestamp": "2026-01-09T15:19:56.111972"
    },
    {
      "sample_idx": 26,
      "input": "13/08/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Non-Hodgkin Lymphoma.\n\nFrom clinical notes: Non-Hodgkin Lymphoma. Paediatric oncology assessment.\n\nFindings: abdominal lymphadenopathy with mesenteric and retroperitoneal nodes. Burkitt lymphoma confirmed on biopsy. High LDH levels. Recommend MDT discussion and treatment planning.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 13/08/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"abdominal lymphadenopathy\", \"mesenteric and retroperitoneal nodes\", \"Burkitt lymphoma confirmed on biopsy\", \"high LDH levels\"],\n        \"rationale\": \"The report explicitly mentions abdominal lymphadenopathy, mesenteric and retroperitoneal nodes, confirmed Burkitt lymphoma on biopsy, and elevated LDH levels, all of which are indicative of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"abdominal lymphadenopathy\", \"mesenteric and retroperitoneal nodes\", \"Burkitt lymphoma confirmed on biopsy\", \"high LDH levels\"],\n        \"rationale\": \"The report explicitly mentions abdominal lymphadenopathy, mesenteric and retroperitoneal nodes, confirmed Burkitt lymphoma on biopsy, and elevated LDH levels, all of which are indicative of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"abdominal lymphadenopathy\", \"mesenteric and retroperitoneal nodes\", \"Burkitt lymphoma confirmed on biopsy\", \"high LDH levels\"],\n        \"rationale\": \"The report explicitly mentions abdominal lymphadenopathy, mesenteric and retroperitoneal nodes, confirmed Burkitt lymphoma on biopsy, and elevated LDH levels, all of which are indicative of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"abdominal lymphadenopathy\", \"mesenteric and retroperitoneal nodes\", \"Burkitt lymphoma confirmed on biopsy\", \"high LDH levels\"],\n        \"rationale\": \"The report explicitly mentions abdominal lymphadenopathy, mesenteric and retroperitoneal nodes, confirmed Burkitt lymphoma on biopsy, and elevated LDH levels, all of which are indicative of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"abdominal lymphadenopathy\", \"mesenteric and retroperitoneal nodes\", \"Burkitt lymphoma",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly mentions abdominal lymphadenopathy, mesenteric and retroperitoneal nodes, confirmed Burkitt lymphoma on biopsy, and elevated LDH levels, all of which are indicative of malignancy.",
      "findings": [
        "abdominal lymphadenopathy",
        "mesenteric and retroperitoneal nodes",
        "Burkitt lymphoma confirmed on biopsy",
        "high LDH levels"
      ],
      "fracture_mentioned": null,
      "idx": 26,
      "timestamp": "2026-01-09T15:19:56.111984"
    },
    {
      "sample_idx": 27,
      "input": "25/06/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Healing fracture - normal process. No pathological features. Bone density normal. Trauma history consistent. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 25/06/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"healing fracture\", \"no pathological features\", \"no malignancy identified\"],\n        \"rationale\": \"The report describes a healing fracture with no pathological features and explicitly states that no malignancy was identified. Therefore, the findings are not indicative of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"healing fracture\", \"no pathological features\", \"no malignancy identified\"],\n        \"rationale\": \"The report describes a healing fracture with no pathological features and explicitly states that no malignancy was identified. Therefore, the findings are not indicative of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"healing fracture\", \"no pathological features\", \"no malignancy identified\"],\n        \"rationale\": \"The report describes a healing fracture with no pathological features and explicitly states that no malignancy was identified. Therefore, the findings are not indicative of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"healing fracture\", \"no pathological features\", \"no malignancy identified\"],\n        \"rationale\": \"The report describes a healing fracture with no pathological features and explicitly states that no malignancy was identified. Therefore, the findings are not indicative of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"healing fracture\", \"no pathological features\", \"no malignancy identified\"],\n        \"rationale\": \"The report describes a healing fracture with no pathological features and explicitly states that no malignancy was identified. Therefore, the findings are not indicative of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"healing fracture\", \"no pathological features\", \"no malignancy",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report describes a healing fracture with no pathological features and explicitly states that no malignancy was identified. Therefore, the findings are not indicative of malignancy.",
      "findings": [
        "healing fracture",
        "no pathological features",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 27,
      "timestamp": "2026-01-09T15:19:56.111995"
    },
    {
      "sample_idx": 28,
      "input": "01/07/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Benign bone cyst - resolved. No aggressive features. Normal bone density. No recurrence on imaging. No malignancy identified. Reassurance provided.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 01/07/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"benign bone cyst - resolved\", \"normal bone density\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that a benign bone cyst was resolved, bone density is normal, and no malignancy was identified. The report also reassures the patient.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal bone density\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that bone density is normal and no malignancy was identified. The report also reassures the patient.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no malignancy was identified. The report also reassures the patient.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no malignancy was identified. The report also reassures the patient.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no malignancy was identified. The report also reassures the patient.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no malignancy was identified. The report also reassures the patient.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no malignancy",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states that a benign bone cyst was resolved, bone density is normal, and no malignancy was identified. The report also reassures the patient.",
      "findings": [
        "benign bone cyst - resolved",
        "normal bone density",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 28,
      "timestamp": "2026-01-09T15:19:56.112006"
    },
    {
      "sample_idx": 29,
      "input": "04/12/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Neuroblastoma.\n\nFrom clinical notes: Neuroblastoma. Paediatric oncology assessment.\n\nFindings: large heterogeneous suprarenal mass with calcifications. MIBG avidity present. Elevated urinary catecholamines. Stage III disease. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 04/12/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"elevated urinary catecholamines\", \"Stage III disease\"],\n        \"rationale\": \"The report describes a suprarenal mass with calcifications, MIBG avidity, and elevated urinary catecholamines, consistent with Neuroblastoma. The stage III disease diagnosis confirms malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"elevated urinary catecholamines\", \"Stage III disease\"],\n        \"rationale\": \"The report describes a suprarenal mass with calcifications, MIBG avidity, and elevated urinary catecholamines, consistent with Neuroblastoma. The stage III disease diagnosis confirms malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"elevated urinary catecholamines\", \"Stage III disease\"],\n        \"rationale\": \"The report describes a suprarenal mass with calcifications, MIBG avidity, and elevated urinary catecholamines, consistent with Neuroblastoma. The stage III disease diagnosis confirms malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"elevated urinary catecholamines\", \"Stage III disease\"],\n        \"rationale\": \"The report describes a suprarenal mass with calcifications, MIBG avidity, and elevated urinary catecholamines, consistent with Neuroblastoma. The stage III disease diagnosis confirms malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes a suprarenal mass with calcifications, MIBG avidity, and elevated urinary catecholamines, consistent with Neuroblastoma. The stage III disease diagnosis confirms malignancy.",
      "findings": [
        "large heterogeneous suprarenal mass with calcifications",
        "MIBG avidity present",
        "elevated urinary catecholamines",
        "Stage III disease"
      ],
      "fracture_mentioned": null,
      "idx": 29,
      "timestamp": "2026-01-09T15:19:56.112018"
    },
    {
      "sample_idx": 30,
      "input": "15/07/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Lymphadenopathy. Suspected Brain Tumor - Medulloblastoma.\n\nFrom clinical notes: Brain Tumor - Medulloblastoma. Paediatric oncology assessment.\n\nFindings: posterior fossa mass with enhancement and hydrocephalus. Restricted diffusion. High-grade medulloblastoma on histology. Recommend MDT discussion and treatment planning.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 15/07/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"posterior fossa mass with enhancement and hydrocephalus\", \"restricted diffusion\", \"high-grade medulloblastoma on histology\"],\n        \"rationale\": \"The report describes a posterior fossa mass with enhancement and hydrocephalus, confirmed as high-grade medulloblastoma on histology. These findings indicate malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"posterior fossa mass with enhancement and hydrocephalus\", \"restricted diffusion\", \"high-grade medulloblastoma on histology\"],\n        \"rationale\": \"The report describes a posterior fossa mass with enhancement and hydrocephalus, confirmed as high-grade medulloblastoma on histology. These findings indicate malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"posterior fossa mass with enhancement and hydrocephalus\", \"restricted diffusion\", \"high-grade medulloblastoma on histology\"],\n        \"rationale\": \"The report describes a posterior fossa mass with enhancement and hydrocephalus, confirmed as high-grade medulloblastoma on histology. These findings indicate malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"posterior fossa mass with enhancement and hydrocephalus\", \"restricted diffusion\", \"high-grade medulloblastoma on histology\"],\n        \"rationale\": \"The report describes a posterior fossa mass with enhancement and hydrocephalus, confirmed as high-grade medulloblastoma on histology. These findings indicate malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"posterior fossa mass with enhancement and hydrocephalus\", \"restricted diffusion\", \"high-grade medulloblastoma on histology\"],\n        \"rationale\": \"The report describes a posterior fossa mass with enhancement and hydrocephalus, confirmed as high-grade medulloblastoma on histology. These findings indicate malignancy.\"\n    }",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes a posterior fossa mass with enhancement and hydrocephalus, confirmed as high-grade medulloblastoma on histology. These findings indicate malignancy.",
      "findings": [
        "posterior fossa mass with enhancement and hydrocephalus",
        "restricted diffusion",
        "high-grade medulloblastoma on histology"
      ],
      "fracture_mentioned": null,
      "idx": 30,
      "timestamp": "2026-01-09T15:19:56.112029"
    },
    {
      "sample_idx": 31,
      "input": "02/04/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Normal chest radiograph. Clear lung fields. No mediastinal mass. Heart size normal. No malignancy identified. Reassurance provided.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 02/04/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that the chest radiograph is normal and that no malignancy is identified. Therefore, there is no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that the chest radiograph is normal and that no malignancy is identified. Therefore, there is no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that the chest radiograph is normal and that no malignancy is identified. Therefore, there is no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that the chest radiograph is normal and that no malignancy is identified. Therefore, there is no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that the chest radiograph is normal and that no malignancy is identified. Therefore, there is no evidence of malignancy.\"",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states that the chest radiograph is normal and that no malignancy is identified. Therefore, there is no evidence of malignancy.",
      "findings": [
        "normal chest radiograph",
        "clear lung fields",
        "no mediastinal mass",
        "heart size normal",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 31,
      "timestamp": "2026-01-09T15:19:56.112040"
    },
    {
      "sample_idx": 32,
      "input": "04/10/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Germ Cell Tumor.\n\nFrom clinical notes: Germ Cell Tumor. Paediatric oncology assessment.\n\nFindings: sacrococcygeal mass with mixed solid and cystic components. Elevated AFP and beta-hCG. Yolk sac tumor elements present. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 04/10/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"sacrococcygeal mass with mixed solid and cystic components\", \"Elevated AFP and beta-hCG\", \"Yolk sac tumor elements present\"],\n        \"rationale\": \"The report describes a sacrococcygeal mass with mixed solid and cystic components, elevated AFP and beta-hCG, and the presence of yolk sac tumor elements. These findings are highly suggestive of a germ cell tumor, specifically a yolk sac tumor, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"sacrococcygeal mass with mixed solid and cystic components\", \"Elevated AFP and beta-hCG\", \"Yolk sac tumor elements present\"],\n        \"rationale\": \"The report describes a sacrococcygeal mass with mixed solid and cystic components, elevated AFP and beta-hCG, and the presence of yolk sac tumor elements. These findings are highly suggestive of a germ cell tumor, specifically a yolk sac tumor, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"sacrococcygeal mass with mixed solid and cystic components\", \"Elevated AFP and beta-hCG\", \"Yolk sac tumor elements present\"],\n        \"rationale\": \"The report describes a sacrococcygeal mass with mixed solid and cystic components, elevated AFP and beta-hCG, and the presence of yolk sac tumor elements. These findings are highly suggestive of a germ cell tumor, specifically a yolk sac tumor, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"sacrococcygeal mass with mixed solid and cystic components\", \"Elevated AFP and beta-hCG\", \"Yolk sac tumor elements present\"],\n        \"rationale\": \"The report describes a sacrococcygeal mass with mixed solid and cystic components, elevated AFP and",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes a sacrococcygeal mass with mixed solid and cystic components, elevated AFP and beta-hCG, and the presence of yolk sac tumor elements. These findings are highly suggestive of a germ cell tumor, specifically a yolk sac tumor, indicating malignancy.",
      "findings": [
        "sacrococcygeal mass with mixed solid and cystic components",
        "Elevated AFP and beta-hCG",
        "Yolk sac tumor elements present"
      ],
      "fracture_mentioned": null,
      "idx": 32,
      "timestamp": "2026-01-09T15:19:56.112054"
    },
    {
      "sample_idx": 33,
      "input": "24/11/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Hodgkin Lymphoma.\n\nFrom clinical notes: Hodgkin Lymphoma. Paediatric oncology assessment.\n\nFindings: mediastinal lymphadenopathy with bulky anterior mediastinal mass. PET-CT showing FDG-avid nodes. Classical Hodgkin, nodular sclerosing type. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 24/11/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"bulky anterior mediastinal mass\", \"FDG-avid nodes\", \"Classical Hodgkin, nodular sclerosing type\"],\n        \"rationale\": \"The report explicitly mentions mediastinal lymphadenopathy, a bulky anterior mediastinal mass, FDG-avid nodes, and the presence of Classical Hodgkin Lymphoma, nodular sclerosing type. These findings are indicative of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"bulky anterior mediastinal mass\", \"FDG-avid nodes\", \"Classical Hodgkin, nodular sclerosing type\"],\n        \"rationale\": \"The report explicitly mentions mediastinal lymphadenopathy, a bulky anterior mediastinal mass, FDG-avid nodes, and the presence of Classical Hodgkin Lymphoma, nodular sclerosing type. These findings are indicative of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"bulky anterior mediastinal mass\", \"FDG-avid nodes\", \"Classical Hodgkin, nodular sclerosing type\"],\n        \"rationale\": \"The report explicitly mentions mediastinal lymphadenopathy, a bulky anterior mediastinal mass, FDG-avid nodes, and the presence of Classical Hodgkin Lymphoma, nodular sclerosing type. These findings are indicative of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"bulky anterior mediastinal mass\", \"FDG-avid nodes\", \"Classical Hodgkin, nodular sclerosing type\"],\n        \"rationale\": \"The report explicitly mentions mediastinal lymphadenopathy, a bulky anterior mediastinal mass, FDG-avid nodes, and the presence of Classical Hodgkin Lymphoma, nodular sclerosing type. These findings are indicative of",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly mentions mediastinal lymphadenopathy, a bulky anterior mediastinal mass, FDG-avid nodes, and the presence of Classical Hodgkin Lymphoma, nodular sclerosing type. These findings are indicative of malignancy.",
      "findings": [
        "mediastinal lymphadenopathy",
        "bulky anterior mediastinal mass",
        "FDG-avid nodes",
        "Classical Hodgkin, nodular sclerosing type"
      ],
      "fracture_mentioned": null,
      "idx": 33,
      "timestamp": "2026-01-09T15:19:56.112067"
    },
    {
      "sample_idx": 34,
      "input": "07/03/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Normal CBC with age-appropriate values. No blast cells. Platelets adequate. Hemoglobin within normal limits. No malignancy identified. Reassurance provided.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 07/03/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal CBC with age-appropriate values\", \"No blast cells\", \"Platelets adequate\", \"Hemoglobin within normal limits\", \"No malignancy identified\"],\n        \"rationale\": \"The report explicitly states that the CBC is normal, no blast cells are present, and there is no malignancy identified. This indicates no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal CBC with age-appropriate values\", \"No blast cells\", \"Platelets adequate\", \"Hemoglobin within normal limits\", \"No malignancy identified\"],\n        \"rationale\": \"The report explicitly states that the CBC is normal, no blast cells are present, and there is no malignancy identified. This indicates no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal CBC with age-appropriate values\", \"No blast cells\", \"Platelets adequate\", \"Hemoglobin within normal limits\", \"No malignancy identified\"],\n        \"rationale\": \"The report explicitly states that the CBC is normal, no blast cells are present, and there is no malignancy identified. This indicates no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal CBC with age-appropriate values\", \"No blast cells\", \"Platelets adequate\", \"Hemoglobin within normal limits\", \"No malignancy identified\"],\n        \"rationale\": \"The report explicitly states that the CBC is normal, no blast cells are present, and there is no malignancy identified. This indicates no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal CBC with age-appropriate values\", \"No blast cells\", \"Platelets adequate\", \"Hemoglobin within normal limits\", \"No malignancy identified\"],\n        ",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states that the CBC is normal, no blast cells are present, and there is no malignancy identified. This indicates no evidence of malignancy.",
      "findings": [
        "Normal CBC with age-appropriate values",
        "No blast cells",
        "Platelets adequate",
        "Hemoglobin within normal limits",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 34,
      "timestamp": "2026-01-09T15:19:56.112096"
    },
    {
      "sample_idx": 35,
      "input": "04/10/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Benign soft tissue mass - lipoma confirmed. Well-circumscribed. No enhancement. No intervention required. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 04/10/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"lipoma confirmed\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that a lipoma was confirmed and that no malignancy was identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"well-circumscribed\", \"no enhancement\", \"no intervention required\"],\n        \"rationale\": \"The report describes the lipoma as well-circumscribed, with no enhancement and no intervention required, all of which are benign findings.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no previous oncology history\", \"reassurance provided\"],\n        \"rationale\": \"The report indicates that the patient has no previous oncology history and that reassurance was provided, which is consistent with a benign finding.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"lipoma confirmed\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that a lipoma was confirmed and that no malignancy was identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"well-circumscribed\", \"no enhancement\", \"no intervention required\"],\n        \"rationale\": \"The report describes the lipoma as well-circumscribed, with no enhancement and no intervention required, all of which are benign findings.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no previous oncology history\", \"reassurance provided\"],\n        \"rationale\": \"The report indicates that the patient has no previous oncology history and that reassurance was provided, which is consistent with a benign finding.\"\n    }\n}\n```\n",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states that a lipoma was confirmed and that no malignancy was identified.",
      "findings": [
        "lipoma confirmed",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 35,
      "timestamp": "2026-01-09T15:19:56.112106"
    },
    {
      "sample_idx": 36,
      "input": "04/01/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Normal chest radiograph. Clear lung fields. No mediastinal mass. Heart size normal. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 04/01/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that the chest radiograph and lung fields are clear, with no mediastinal mass or heart abnormalities. The final statement confirms that no malignancy is identified, thus there is no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that the chest radiograph and lung fields are clear, with no mediastinal mass or heart abnormalities. The final statement confirms that no malignancy is identified, thus there is no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that the chest radiograph and lung fields are clear, with no mediastinal mass or heart abnormalities. The final statement confirms that no malignancy is identified, thus there is no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that the chest radiograph and lung fields are clear, with no mediastinal mass or heart abnormalities. The final statement confirms that no malignancy is identified, thus there is no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states that the chest radiograph and lung fields are clear, with no mediastinal mass or heart abnormalities. The final statement confirms that no malignancy is identified, thus there is no evidence of malignancy.",
      "findings": [
        "normal chest radiograph",
        "clear lung fields",
        "no mediastinal mass",
        "heart size normal",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 36,
      "timestamp": "2026-01-09T15:19:56.112118"
    },
    {
      "sample_idx": 37,
      "input": "02/04/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Abnormal imaging. Suspected Osteosarcoma.\n\nFrom clinical notes: Osteosarcoma. Paediatric oncology assessment.\n\nFindings: destructive lesion in distal femur with soft tissue component. Sunburst periosteal reaction. Elevated alkaline phosphatase. Recommend MDT discussion and treatment planning.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 02/04/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"destructive lesion in distal femur with soft tissue component\", \"sunburst periosteal reaction\", \"elevated alkaline phosphatase\"],\n        \"rationale\": \"The report describes a destructive lesion in the distal femur with soft tissue involvement, sunburst periosteal reaction, and elevated alkaline phosphatase. These findings are highly suggestive of osteosarcoma, a malignant bone tumor.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"osteosarcoma\", \"destructive lesion in distal femur with soft tissue component\", \"sunburst periosteal reaction\", \"elevated alkaline phosphatase\"],\n        \"rationale\": \"The report explicitly states the presence of osteosarcoma. The description of the lesion and associated findings (sunburst periosteal reaction, elevated alkaline phosphatase) strongly support the diagnosis of osteosarcoma, which is a malignant bone tumor.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"osteosarcoma\", \"destructive lesion in distal femur with soft tissue component\", \"sunburst periosteal reaction\", \"elevated alkaline phosphatase\"],\n        \"rationale\": \"The report explicitly states the presence of osteosarcoma. The description of the lesion and associated findings (sunburst periosteal reaction, elevated alkaline phosphatase) strongly support the diagnosis of osteosarcoma, which is a malignant bone tumor.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"osteosarcoma\", \"destructive lesion in distal femur with soft tissue component\", \"sunburst periosteal reaction\", \"elevated alkaline phosphatase\"],\n        \"rationale\": \"The report explicitly states the presence of osteosarcoma. The description of the lesion and associated findings (sunburst periosteal reaction, elevated alkaline phosphatase) strongly support the diagnosis of osteosarcoma, which is a malignant bone tumor.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\":",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes a destructive lesion in the distal femur with soft tissue involvement, sunburst periosteal reaction, and elevated alkaline phosphatase. These findings are highly suggestive of osteosarcoma, a malignant bone tumor.",
      "findings": [
        "destructive lesion in distal femur with soft tissue component",
        "sunburst periosteal reaction",
        "elevated alkaline phosphatase"
      ],
      "fracture_mentioned": null,
      "idx": 37,
      "timestamp": "2026-01-09T15:19:56.112131"
    },
    {
      "sample_idx": 38,
      "input": "05/03/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Lymphadenopathy. Suspected Osteosarcoma.\n\nFrom clinical notes: Osteosarcoma. Paediatric oncology assessment.\n\nFindings: destructive lesion in distal femur with soft tissue component. Sunburst periosteal reaction. Elevated alkaline phosphatase. Recommend MDT discussion and treatment planning.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 05/03/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"destructive lesion in distal femur with soft tissue component\", \"sunburst periosteal reaction\", \"elevated alkaline phosphatase\"],\n        \"rationale\": \"The report describes a destructive lesion in the distal femur with soft tissue involvement, sunburst periosteal reaction, and elevated alkaline phosphatase, suggesting a possible osteosarcoma.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"osteosarcoma\", \"pediatric oncology assessment\"],\n        \"rationale\": \"The report explicitly mentions osteosarcoma, a type of bone cancer, and indicates a pediatric oncology assessment, strongly suggesting malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"destructive lesion in distal femur with soft tissue component\", \"sunburst periosteal reaction\", \"elevated alkaline phosphatase\"],\n        \"rationale\": \"The report describes a destructive lesion in the distal femur with soft tissue involvement, sunburst periosteal reaction, and elevated alkaline phosphatase, suggesting a possible osteosarcoma.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"osteosarcoma\", \"pediatric oncology assessment\"],\n        \"rationale\": \"The report explicitly mentions osteosarcoma, a type of bone cancer, and indicates a pediatric oncology assessment, strongly suggesting malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"destructive lesion in distal femur with soft tissue component\", \"sunburst periosteal reaction\", \"elevated alkaline phosphatase\"],\n        \"rationale\": \"The report describes a destructive lesion in the distal femur with soft tissue involvement, sunburst periosteal reaction, and elevated alkaline phosphatase, suggesting a possible osteosarcoma.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes a destructive lesion in the distal femur with soft tissue involvement, sunburst periosteal reaction, and elevated alkaline phosphatase, suggesting a possible osteosarcoma.",
      "findings": [
        "destructive lesion in distal femur with soft tissue component",
        "sunburst periosteal reaction",
        "elevated alkaline phosphatase"
      ],
      "fracture_mentioned": null,
      "idx": 38,
      "timestamp": "2026-01-09T15:19:56.112142"
    },
    {
      "sample_idx": 39,
      "input": "01/11/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Post-viral lymphocytosis. Atypical lymphocytes resolving. Monospot positive. EBV serology confirms. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 01/11/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"post-viral lymphocytosis\", \"atypical lymphocytes resolving\", \"monospot positive\", \"EBV serology confirms\"],\n        \"rationale\": \"The report describes post-viral lymphocytosis and resolving atypical lymphocytes, which are benign findings. No malignancy is identified. The report provides reassurance.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"post-viral lymphocytosis\", \"atypical lymphocytes resolving\", \"monospot positive\", \"EBV serology confirms\"],\n        \"rationale\": \"The report describes post-viral lymphocytosis and resolving atypical lymphocytes, which are benign findings. No malignancy is identified. The report provides reassurance.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"post-viral lymphocytosis\", \"atypical lymphocytes resolving\", \"monospot positive\", \"EBV serology confirms\"],\n        \"rationale\": \"The report describes post-viral lymphocytosis and resolving atypical lymphocytes, which are benign findings. No malignancy is identified. The report provides reassurance.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"post-viral lymphocytosis\", \"atypical lymphocytes resolving\", \"monospot positive\", \"EBV serology confirms\"],\n        \"rationale\": \"The report describes post-viral lymphocytosis and resolving atypical lymphocytes, which are benign findings. No malignancy is identified. The report provides reassurance.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"post-viral lymphocytosis\", \"atypical lymphocytes resolving\", \"monospot positive\", \"EBV serology confirms\"],\n        \"rationale\": \"The report describes post-viral lymphocytosis and resolving atypical lymphocytes, which are benign findings. No malignancy is",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report describes post-viral lymphocytosis and resolving atypical lymphocytes, which are benign findings. No malignancy is identified. The report provides reassurance.",
      "findings": [
        "post-viral lymphocytosis",
        "atypical lymphocytes resolving",
        "monospot positive",
        "EBV serology confirms"
      ],
      "fracture_mentioned": null,
      "idx": 39,
      "timestamp": "2026-01-09T15:19:56.112153"
    },
    {
      "sample_idx": 40,
      "input": "26/04/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Wilms Tumor.\n\nFrom clinical notes: Wilms Tumor. Paediatric oncology assessment.\n\nFindings: large heterogeneous left renal mass with pseudocapsule. No vascular invasion. Favorable histology on biopsy. Stage II. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 26/04/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"no vascular invasion\", \"favorable histology on biopsy\", \"Stage II\"],\n        \"rationale\": \"The report describes a left renal mass with features suggestive of Wilms Tumor, including the presence of a pseudocapsule and favorable histology. The report also states that the tumor is Stage II.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"no vascular invasion\", \"favorable histology on biopsy\", \"Stage II\"],\n        \"rationale\": \"The report describes a left renal mass with features suggestive of Wilms Tumor, including the presence of a pseudocapsule and favorable histology. The report also states that the tumor is Stage II.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"no vascular invasion\", \"favorable histology on biopsy\", \"Stage II\"],\n        \"rationale\": \"The report describes a left renal mass with features suggestive of Wilms Tumor, including the presence of a pseudocapsule and favorable histology. The report also states that the tumor is Stage II.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"no vascular invasion\", \"favorable histology on biopsy\", \"Stage II\"],\n        \"rationale\": \"The report describes a left renal mass with features suggestive of Wilms Tumor, including the presence of a pseudocapsule and favorable histology. The report also states that the tumor is Stage II.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"no vascular invasion",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes a left renal mass with features suggestive of Wilms Tumor, including the presence of a pseudocapsule and favorable histology. The report also states that the tumor is Stage II.",
      "findings": [
        "large heterogeneous left renal mass with pseudocapsule",
        "no vascular invasion",
        "favorable histology on biopsy",
        "Stage II"
      ],
      "fracture_mentioned": null,
      "idx": 40,
      "timestamp": "2026-01-09T15:19:56.112165"
    },
    {
      "sample_idx": 41,
      "input": "18/11/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Lymphadenopathy. Suspected Hodgkin Lymphoma.\n\nFrom clinical notes: Hodgkin Lymphoma. Paediatric oncology assessment.\n\nFindings: mediastinal lymphadenopathy with bulky anterior mediastinal mass. PET-CT showing FDG-avid nodes. Classical Hodgkin, nodular sclerosing type. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 18/11/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"bulky anterior mediastinal mass\", \"FDG-avid nodes\", \"Classical Hodgkin, nodular sclerosing type\"],\n        \"rationale\": \"The report explicitly mentions mediastinal lymphadenopathy, a bulky anterior mediastinal mass, FDG-avid nodes, and confirms Classical Hodgkin lymphoma with nodular sclerosing type. This indicates malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"bulky anterior mediastinal mass\", \"FDG-avid nodes\", \"Classical Hodgkin, nodular sclerosing type\"],\n        \"rationale\": \"The report explicitly mentions mediastinal lymphadenopathy, a bulky anterior mediastinal mass, FDG-avid nodes, and confirms Classical Hodgkin lymphoma with nodular sclerosing type. This indicates malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"bulky anterior mediastinal mass\", \"FDG-avid nodes\", \"Classical Hodgkin, nodular sclerosing type\"],\n        \"rationale\": \"The report explicitly mentions mediastinal lymphadenopathy, a bulky anterior mediastinal mass, FDG-avid nodes, and confirms Classical Hodgkin lymphoma with nodular sclerosing type. This indicates malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"bulky anterior mediastinal mass\", \"FDG-avid nodes\", \"Classical Hodgkin, nodular sclerosing type\"],\n        \"rationale\": \"The report explicitly mentions mediastinal lymphadenopathy, a bulky anterior mediastinal mass, FDG-avid nodes, and confirms Classical Hodgkin lymphoma with nodular sclerosing type. This indicates malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly mentions mediastinal lymphadenopathy, a bulky anterior mediastinal mass, FDG-avid nodes, and confirms Classical Hodgkin lymphoma with nodular sclerosing type. This indicates malignancy.",
      "findings": [
        "mediastinal lymphadenopathy",
        "bulky anterior mediastinal mass",
        "FDG-avid nodes",
        "Classical Hodgkin, nodular sclerosing type"
      ],
      "fracture_mentioned": null,
      "idx": 41,
      "timestamp": "2026-01-09T15:19:56.112176"
    },
    {
      "sample_idx": 42,
      "input": "20/04/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Follow-up post-treatment. No previous oncology history.\n\nFindings: Post-viral lymphocytosis. Atypical lymphocytes resolving. Monospot positive. EBV serology confirms. No malignancy identified. Reassurance provided.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 20/04/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"post-viral lymphocytosis\", \"atypical lymphocytes resolving\", \"monospot positive\", \"EBV serology confirms\"],\n        \"rationale\": \"The report mentions post-viral lymphocytosis, atypical lymphocytes resolving, monospot positivity, and EBV serology confirmation. While these findings indicate a viral infection, they do not represent malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"post-viral lymphocytosis\", \"atypical lymphocytes resolving\", \"monospot positive\", \"EBV serology confirms\"],\n        \"rationale\": \"The report mentions post-viral lymphocytosis, atypical lymphocytes resolving, monospot positivity, and EBV serology confirmation. While these findings indicate a viral infection, they do not represent malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"post-viral lymphocytosis\", \"atypical lymphocytes resolving\", \"monospot positive\", \"EBV serology confirms\"],\n        \"rationale\": \"The report mentions post-viral lymphocytosis, atypical lymphocytes resolving, monospot positivity, and EBV serology confirmation. While these findings indicate a viral infection, they do not represent malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"post-viral lymphocytosis\", \"atypical lymphocytes resolving\", \"monospot positive\", \"EBV serology confirms\"],\n        \"rationale\": \"The report mentions post-viral lymphocytosis, atypical lymphocytes resolving, monospot positivity, and EBV serology confirmation. While these findings indicate a viral infection, they do not represent malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"post-viral lymphocytosis\", \"atypical",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report mentions post-viral lymphocytosis, atypical lymphocytes resolving, monospot positivity, and EBV serology confirmation. While these findings indicate a viral infection, they do not represent malignancy.",
      "findings": [
        "post-viral lymphocytosis",
        "atypical lymphocytes resolving",
        "monospot positive",
        "EBV serology confirms"
      ],
      "fracture_mentioned": null,
      "idx": 42,
      "timestamp": "2026-01-09T15:19:56.112188"
    },
    {
      "sample_idx": 43,
      "input": "20/01/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Follow-up post-treatment. No previous oncology history.\n\nFindings: Normal brain MRI for age. No mass lesion. No abnormal enhancement. Headaches attributed to migraine. No malignancy identified. Reassurance provided.\n\nDr James Chen, Consultant Paediatric Oncologist 20/01/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that there are no mass lesions, abnormal enhancement, or malignancy identified on the brain MRI, and that the patient is reassured. Therefore, no malignancy is present.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that there are no mass lesions, abnormal enhancement, or malignancy identified on the brain MRI, and that the patient is reassured. Therefore, no malignancy is present.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that there are no mass lesions, abnormal enhancement, or malignancy identified on the brain MRI, and that the patient is reassured. Therefore, no malignancy is present.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that there are no mass lesions, abnormal enhancement, or malignancy identified on the brain MRI, and that the patient is reassured. Therefore, no malignancy is present.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that there are no mass lesions, abnormal enhancement, or malignancy identified on the brain MRI, and that the patient",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states that there are no mass lesions, abnormal enhancement, or malignancy identified on the brain MRI, and that the patient is reassured. Therefore, no malignancy is present.",
      "findings": [
        "normal brain MRI",
        "no mass lesion",
        "no abnormal enhancement",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 43,
      "timestamp": "2026-01-09T15:19:56.112199"
    },
    {
      "sample_idx": 44,
      "input": "22/11/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Abnormal imaging. Suspected Ewing Sarcoma.\n\nFrom clinical notes: Ewing Sarcoma. Paediatric oncology assessment.\n\nFindings: permeative bone destruction in left femoral diaphysis with large soft tissue mass. Onion-skin periosteal reaction. EWSR1 fusion positive. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 22/11/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"permeative bone destruction in left femoral diaphysis with large soft tissue mass\", \"onion-skin periosteal reaction\", \"EWSR1 fusion positive\"],\n        \"rationale\": \"The report describes a large soft tissue mass and bone destruction with onion-skin periosteal reaction, along with a positive EWSR1 fusion, which are all indicative of Ewing Sarcoma.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"permeative bone destruction in left femoral diaphysis with large soft tissue mass\", \"onion-skin periosteal reaction\", \"EWSR1 fusion positive\"],\n        \"rationale\": \"The report describes a large soft tissue mass and bone destruction with onion-skin periosteal reaction, along with a positive EWSR1 fusion, which are all indicative of Ewing Sarcoma.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"permeative bone destruction in left femoral diaphysis with large soft tissue mass\", \"onion-skin periosteal reaction\", \"EWSR1 fusion positive\"],\n        \"rationale\": \"The report describes a large soft tissue mass and bone destruction with onion-skin periosteal reaction, along with a positive EWSR1 fusion, which are all indicative of Ewing Sarcoma.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"permeative bone destruction in left femoral diaphysis with large soft tissue mass\", \"onion-skin periosteal reaction\", \"EWSR1 fusion positive\"],\n        \"rationale\": \"The report describes a large soft tissue mass and bone destruction with onion-skin periosteal reaction, along with a positive EWSR1 fusion, which are all indicative of Ewing Sarcoma.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes a large soft tissue mass and bone destruction with onion-skin periosteal reaction, along with a positive EWSR1 fusion, which are all indicative of Ewing Sarcoma.",
      "findings": [
        "permeative bone destruction in left femoral diaphysis with large soft tissue mass",
        "onion-skin periosteal reaction",
        "EWSR1 fusion positive"
      ],
      "fracture_mentioned": null,
      "idx": 44,
      "timestamp": "2026-01-09T15:19:56.112211"
    },
    {
      "sample_idx": 45,
      "input": "06/05/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Follow-up post-treatment. No previous oncology history.\n\nFindings: Normal brain MRI for age. No mass lesion. No abnormal enhancement. Headaches attributed to migraine. No malignancy identified. Reassurance provided.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 06/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that the brain MRI is normal, there is no mass lesion, no abnormal enhancement, and no malignancy is identified. Therefore, malignancy is ruled out.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC\", \"age-appropriate values\", \"no blast cells\"],\n        \"rationale\": \"The report shows normal blood counts with no atypical or malignant cells. No evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"lymphoblasts 85% of marrow\", \"B-cell ALL immunophenotype\", \"bone marrow infiltration\"],\n        \"rationale\": \"The report explicitly identifies bone marrow infiltration with lymphoblasts and immunophenotyping consistent with acute lymphoblastic leukemia, confirming malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that the brain MRI is normal, there is no mass lesion, no abnormal enhancement, and no malignancy is identified. Therefore, malignancy is ruled out.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC\", \"age-appropriate values\", \"no blast cells\"],\n        \"rationale\": \"The report shows normal blood counts with no atypical or malignant cells. No evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states that the brain MRI is normal, there is no mass lesion, no abnormal enhancement, and no malignancy is identified. Therefore, malignancy is ruled out.",
      "findings": [
        "normal brain MRI",
        "no mass lesion",
        "no abnormal enhancement",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 45,
      "timestamp": "2026-01-09T15:19:56.112222"
    },
    {
      "sample_idx": 46,
      "input": "24/10/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Physiological splenomegaly for age. No focal lesions. Normal echo texture. Benign finding. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 24/10/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"physiological splenomegaly\", \"no focal lesions\", \"normal echo texture\"],\n        \"rationale\": \"The report mentions physiological splenomegaly, absence of focal lesions, and normal echo texture, which are benign findings. No malignancy is identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"physiological splenomegaly\", \"no focal lesions\", \"normal echo texture\"],\n        \"rationale\": \"The report mentions physiological splenomegaly, absence of focal lesions, and normal echo texture, which are benign findings. No malignancy is identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"physiological splenomegaly\", \"no focal lesions\", \"normal echo texture\"],\n        \"rationale\": \"The report mentions physiological splenomegaly, absence of focal lesions, and normal echo texture, which are benign findings. No malignancy is identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"physiological splenomegaly\", \"no focal lesions\", \"normal echo texture\"],\n        \"rationale\": \"The report mentions physiological splenomegaly, absence of focal lesions, and normal echo texture, which are benign findings. No malignancy is identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"physiological splenomegaly\", \"no focal lesions\", \"normal echo texture\"],\n        \"rationale\": \"The report mentions physiological splenomegaly, absence of focal lesions, and normal echo texture, which are benign findings. No malignancy is identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"physiological splenomegaly\", \"",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report mentions physiological splenomegaly, absence of focal lesions, and normal echo texture, which are benign findings. No malignancy is identified.",
      "findings": [
        "physiological splenomegaly",
        "no focal lesions",
        "normal echo texture"
      ],
      "fracture_mentioned": null,
      "idx": 46,
      "timestamp": "2026-01-09T15:19:56.112232"
    },
    {
      "sample_idx": 47,
      "input": "01/02/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Reactive lymphadenopathy secondary to viral infection. Node size decreasing on follow-up. No atypical features. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 01/02/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report indicates reactive lymphadenopathy, meaning the lymph nodes are enlarged due to a benign process like a viral infection. The report explicitly states that no atypical features or malignancy were identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report indicates reactive lymphadenopathy, meaning the lymph nodes are enlarged due to a benign process like a viral infection. The report explicitly states that no atypical features or malignancy were identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report indicates reactive lymphadenopathy, meaning the lymph nodes are enlarged due to a benign process like a viral infection. The report explicitly states that no atypical features or malignancy were identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report indicates reactive lymphadenopathy, meaning the lymph nodes are enlarged due to a benign process like a viral infection. The report explicitly states that no atypical features or malignancy were identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report indicates reactive lymphadenopathy, meaning the lymph nodes are enlarged due to a benign process like a viral infection. The report explicitly states that no atypical features or malignancy were identified.\"\n    }\n}",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report indicates reactive lymphadenopathy, meaning the lymph nodes are enlarged due to a benign process like a viral infection. The report explicitly states that no atypical features or malignancy were identified.",
      "findings": [
        "reactive lymphadenopathy",
        "no atypical features",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 47,
      "timestamp": "2026-01-09T15:19:56.112243"
    },
    {
      "sample_idx": 48,
      "input": "03/10/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Lymphadenopathy. Suspected Osteosarcoma.\n\nFrom clinical notes: Osteosarcoma. Paediatric oncology assessment.\n\nFindings: destructive lesion in distal femur with soft tissue component. Sunburst periosteal reaction. Elevated alkaline phosphatase. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 03/10/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"destructive lesion in distal femur with soft tissue component\", \"sunburst periosteal reaction\", \"elevated alkaline phosphatase\"],\n        \"rationale\": \"The report describes a destructive lesion in the distal femur with soft tissue involvement, sunburst periosteal reaction, and elevated alkaline phosphatase. These findings are suggestive of osteosarcoma, a type of bone cancer.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"osteosarcoma\", \"distal femur\", \"sunburst periosteal reaction\"],\n        \"rationale\": \"The report explicitly mentions osteosarcoma, which is a malignant bone tumor.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"osteosarcoma\", \"distal femur\", \"sunburst periosteal reaction\"],\n        \"rationale\": \"The report explicitly mentions osteosarcoma, which is a malignant bone tumor.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"osteosarcoma\", \"distal femur\", \"sunburst periosteal reaction\"],\n        \"rationale\": \"The report explicitly mentions osteosarcoma, which is a malignant bone tumor.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"osteosarcoma\", \"distal femur\", \"sunburst periosteal reaction\"],\n        \"rationale\": \"The report explicitly mentions osteosarcoma, which is a malignant bone tumor.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"osteosarcoma\", \"distal femur\", \"sunburst periosteal reaction\"],\n        \"rationale\": \"The",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes a destructive lesion in the distal femur with soft tissue involvement, sunburst periosteal reaction, and elevated alkaline phosphatase. These findings are suggestive of osteosarcoma, a type of bone cancer.",
      "findings": [
        "destructive lesion in distal femur with soft tissue component",
        "sunburst periosteal reaction",
        "elevated alkaline phosphatase"
      ],
      "fracture_mentioned": null,
      "idx": 48,
      "timestamp": "2026-01-09T15:19:56.112255"
    },
    {
      "sample_idx": 49,
      "input": "05/08/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Reactive lymphadenopathy secondary to viral infection. Node size decreasing on follow-up. No atypical features. No malignancy identified. Reassurance provided.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 05/08/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report indicates reactive lymphadenopathy, which is a benign finding. It explicitly states that no atypical features or malignancy were identified, thus ruling out malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report indicates lymphadenopathy. It explicitly states that no atypical features or malignancy were identified, thus ruling out malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report indicates lymphadenopathy. It explicitly states that no atypical features or malignancy were identified, thus ruling out malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report indicates lymphadenopathy. It explicitly states that no atypical features or malignancy were identified, thus ruling out malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report indicates lymphadenopathy. It explicitly states that no atypical features or malignancy were identified, thus ruling out malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report indicates reactive lymphadenopathy, which is a benign finding. It explicitly states that no atypical features or malignancy were identified, thus ruling out malignancy.",
      "findings": [
        "reactive lymphadenopathy",
        "no atypical features",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 49,
      "timestamp": "2026-01-09T15:19:56.112266"
    },
    {
      "sample_idx": 50,
      "input": "02/05/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Normal chest radiograph. Clear lung fields. No mediastinal mass. Heart size normal. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 02/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no malignancy was identified on the chest radiograph, and that the findings are reassuring.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no malignancy was identified on the chest radiograph, and that the findings are reassuring.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no malignancy was identified on the chest radiograph, and that the findings are reassuring.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no malignancy was identified on the chest radiograph, and that the findings are reassuring.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no malignancy was identified on the chest radiograph, and that the findings are reassuring.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states that no malignancy was identified on the chest radiograph, and that the findings are reassuring.",
      "findings": [
        "normal chest radiograph",
        "clear lung fields",
        "no mediastinal mass",
        "heart size normal",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 50,
      "timestamp": "2026-01-09T15:19:56.112277"
    },
    {
      "sample_idx": 51,
      "input": "26/07/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Follow-up post-treatment. No previous oncology history.\n\nFindings: Benign soft tissue mass - lipoma confirmed. Well-circumscribed. No enhancement. No intervention required. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 26/07/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"benign soft tissue mass - lipoma\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that a benign lipoma was identified and that no malignancy was present.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no abnormality identified\"],\n        \"rationale\": \"The report states that no abnormality was identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no findings\"],\n        \"rationale\": \"The report indicates that no findings were present.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no evidence of malignancy\"],\n        \"rationale\": \"The report explicitly states that there is no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no malignancy was identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no malignancy\"],\n        \"rationale\": \"The report explicitly states that no malignancy is present.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no evidence of malignancy\"],\n        \"rationale\": \"The report indicates that no evidence of malignancy was found.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states that a benign lipoma was identified and that no malignancy was present.",
      "findings": [
        "benign soft tissue mass - lipoma",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 51,
      "timestamp": "2026-01-09T15:19:56.112285"
    },
    {
      "sample_idx": 52,
      "input": "25/03/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Bone pain. Suspected Wilms Tumor.\n\nFrom clinical notes: Wilms Tumor. Paediatric oncology assessment.\n\nFindings: large heterogeneous left renal mass with pseudocapsule. No vascular invasion. Favorable histology on biopsy. Stage II. Recommend MDT discussion and treatment planning.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 25/03/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"No vascular invasion\", \"Favorable histology on biopsy\", \"Stage II\"],\n        \"rationale\": \"The report describes a large heterogeneous renal mass, no vascular invasion, favorable histology, and Stage II, which are all indicative of a malignancy, specifically Wilms Tumor.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"No vascular invasion\", \"Favorable histology on biopsy\", \"Stage II\"],\n        \"rationale\": \"The report describes a large heterogeneous renal mass, no vascular invasion, favorable histology, and Stage II, which are all indicative of a malignancy, specifically Wilms Tumor.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"No vascular invasion\", \"Favorable histology on biopsy\", \"Stage II\"],\n        \"rationale\": \"The report describes a large heterogeneous renal mass, no vascular invasion, favorable histology, and Stage II, which are all indicative of a malignancy, specifically Wilms Tumor.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"No vascular invasion\", \"Favorable histology on biopsy\", \"Stage II\"],\n        \"rationale\": \"The report describes a large heterogeneous renal mass, no vascular invasion, favorable histology, and Stage II, which are all indicative of a malignancy, specifically Wilms Tumor.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"No vascular invasion\", \"Favorable histology on biopsy\", \"Stage II\"],\n        \"rationale\": \"The",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes a large heterogeneous renal mass, no vascular invasion, favorable histology, and Stage II, which are all indicative of a malignancy, specifically Wilms Tumor.",
      "findings": [
        "large heterogeneous left renal mass with pseudocapsule",
        "No vascular invasion",
        "Favorable histology on biopsy",
        "Stage II"
      ],
      "fracture_mentioned": null,
      "idx": 52,
      "timestamp": "2026-01-09T15:19:56.112297"
    },
    {
      "sample_idx": 53,
      "input": "05/01/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Reactive lymphadenopathy secondary to viral infection. Node size decreasing on follow-up. No atypical features. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 05/01/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report identifies reactive lymphadenopathy, which is a benign finding. The report explicitly states that no atypical features or malignancy are present, and reassurance was provided.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"lymphadenopathy\", \"no malignancy identified\"],\n        \"rationale\": \"The report mentions lymphadenopathy, which can be a normal finding, and explicitly states no malignancy is present.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report indicates lymphadenopathy, but specifies no atypical features and no malignancy. The report concludes with reassurance.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report mentions lymphadenopathy and states that no atypical features or malignancy are present.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report indicates lymphadenopathy, and confirms that no atypical features or malignancy are present.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report describes lymphadenopathy and states that no atypical features or malignancy are present. The report provides reassurance.\"\n",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report identifies reactive lymphadenopathy, which is a benign finding. The report explicitly states that no atypical features or malignancy are present, and reassurance was provided.",
      "findings": [
        "reactive lymphadenopathy",
        "no atypical features",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 53,
      "timestamp": "2026-01-09T15:19:56.112307"
    },
    {
      "sample_idx": 54,
      "input": "23/03/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Bone pain. Suspected Hepatoblastoma.\n\nFrom clinical notes: Hepatoblastoma. Paediatric oncology assessment.\n\nFindings: large heterogeneous hepatic mass with elevated AFP. Fetal histology subtype. PRETEXT stage II. Recommend MDT discussion and treatment planning.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 23/03/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous hepatic mass\", \"elevated AFP\", \"Fetal histology subtype\", \"PRETEXT stage II\"],\n        \"rationale\": \"The report describes a large heterogeneous hepatic mass with elevated AFP, which is indicative of Hepatoblastoma. The report also mentions Fetal histology subtype and PRETEXT stage II, further supporting the diagnosis of Hepatoblastoma.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous hepatic mass\", \"elevated AFP\", \"Fetal histology subtype\", \"PRETEXT stage II\"],\n        \"rationale\": \"The report describes a large heterogeneous hepatic mass with elevated AFP, which is indicative of Hepatoblastoma. The report also mentions Fetal histology subtype and PRETEXT stage II, further supporting the diagnosis of Hepatoblastoma.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous hepatic mass\", \"elevated AFP\", \"Fetal histology subtype\", \"PRETEXT stage II\"],\n        \"rationale\": \"The report describes a large heterogeneous hepatic mass with elevated AFP, which is indicative of Hepatoblastoma. The report also mentions Fetal histology subtype and PRETEXT stage II, further supporting the diagnosis of Hepatoblastoma.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous hepatic mass\", \"elevated AFP\", \"Fetal histology subtype\", \"PRETEXT stage II\"],\n        \"rationale\": \"The report describes a large heterogeneous hepatic mass with elevated AFP, which is indicative of Hepatoblastoma. The report also mentions Fetal histology subtype and PRETEXT stage II, further supporting the diagnosis of Hepatoblastoma.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous hepatic mass\", \"elevated AFP\",",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes a large heterogeneous hepatic mass with elevated AFP, which is indicative of Hepatoblastoma. The report also mentions Fetal histology subtype and PRETEXT stage II, further supporting the diagnosis of Hepatoblastoma.",
      "findings": [
        "large heterogeneous hepatic mass",
        "elevated AFP",
        "Fetal histology subtype",
        "PRETEXT stage II"
      ],
      "fracture_mentioned": null,
      "idx": 54,
      "timestamp": "2026-01-09T15:19:56.112319"
    },
    {
      "sample_idx": 55,
      "input": "31/08/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Normal chest radiograph. Clear lung fields. No mediastinal mass. Heart size normal. No malignancy identified. Reassurance provided.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 31/08/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that the chest radiograph is normal, with no evidence of malignancy. The report provides reassurance.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that the chest radiograph is normal, with no evidence of malignancy. The report provides reassurance.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that the chest radiograph is normal, with no evidence of malignancy. The report provides reassurance.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that the chest radiograph is normal, with no evidence of malignancy. The report provides reassurance.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that the chest radiograph is normal, with no evidence of malignancy. The report provides reassurance.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states that the chest radiograph is normal, with no evidence of malignancy. The report provides reassurance.",
      "findings": [
        "normal chest radiograph",
        "clear lung fields",
        "no mediastinal mass",
        "heart size normal",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 55,
      "timestamp": "2026-01-09T15:19:56.112330"
    },
    {
      "sample_idx": 56,
      "input": "26/01/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Reactive lymphadenopathy secondary to viral infection. Node size decreasing on follow-up. No atypical features. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 26/01/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states reactive lymphadenopathy, no atypical features, and no malignancy identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states lymphadenopathy, no atypical features, and no malignancy identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states reactive lymphadenopathy, no atypical features, and no malignancy identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states reactive lymphadenopathy, no atypical features, and no malignancy identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states reactive lymphadenopathy, no atypical features, and no malignancy identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states reactive lymphadenopathy, no atypical features, and no malignancy identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states reactive lymphadenopathy, no atypical features, and no malignancy identified.",
      "findings": [
        "reactive lymphadenopathy",
        "no atypical features",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 56,
      "timestamp": "2026-01-09T15:19:56.112339"
    },
    {
      "sample_idx": 57,
      "input": "24/11/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Germ Cell Tumor.\n\nFrom clinical notes: Germ Cell Tumor. Paediatric oncology assessment.\n\nFindings: sacrococcygeal mass with mixed solid and cystic components. Elevated AFP and beta-hCG. Yolk sac tumor elements present. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 24/11/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"sacrococcygeal mass with mixed solid and cystic components\", \"elevated AFP and beta-hCG\", \"yolk sac tumor elements present\"],\n        \"rationale\": \"The report describes a sacrococcygeal mass with mixed solid and cystic components, elevated AFP and beta-hCG, and the presence of yolk sac tumor elements, all of which are indicative of a germ cell tumor, a type of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"sacrococcygeal mass with mixed solid and cystic components\", \"elevated AFP and beta-hCG\", \"yolk sac tumor elements present\"],\n        \"rationale\": \"The report describes a sacrococcygeal mass with mixed solid and cystic components, elevated AFP and beta-hCG, and the presence of yolk sac tumor elements, all of which are indicative of a germ cell tumor, a type of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"sacrococcygeal mass with mixed solid and cystic components\", \"elevated AFP and beta-hCG\", \"yolk sac tumor elements present\"],\n        \"rationale\": \"The report describes a sacrococcygeal mass with mixed solid and cystic components, elevated AFP and beta-hCG, and the presence of yolk sac tumor elements, all of which are indicative of a germ cell tumor, a type of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"sacrococcygeal mass with mixed solid and cystic components\", \"elevated AFP and beta-hCG\", \"yolk sac tumor elements present\"],\n        \"rationale\": \"The report describes a sacrococcygeal mass with mixed solid and cystic components, elevated AFP and beta-hCG, and the presence of yolk sac tumor",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes a sacrococcygeal mass with mixed solid and cystic components, elevated AFP and beta-hCG, and the presence of yolk sac tumor elements, all of which are indicative of a germ cell tumor, a type of malignancy.",
      "findings": [
        "sacrococcygeal mass with mixed solid and cystic components",
        "elevated AFP and beta-hCG",
        "yolk sac tumor elements present"
      ],
      "fracture_mentioned": null,
      "idx": 57,
      "timestamp": "2026-01-09T15:19:56.112351"
    },
    {
      "sample_idx": 58,
      "input": "01/01/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Unexplained fever and weight loss. Suspected Germ Cell Tumor.\n\nFrom clinical notes: Germ Cell Tumor. Paediatric oncology assessment.\n\nFindings: sacrococcygeal mass with mixed solid and cystic components. Elevated AFP and beta-hCG. Yolk sac tumor elements present. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 01/01/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"sacrococcygeal mass\", \"mixed solid and cystic components\", \"elevated AFP and beta-hCG\", \"yolk sac tumor elements\"],\n        \"rationale\": \"The report describes a sacrococcygeal mass with mixed solid and cystic components, elevated AFP and beta-hCG, and the presence of yolk sac tumor elements, indicating a germ cell tumor.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"sacrococcygeal mass\", \"mixed solid and cystic components\", \"elevated AFP and beta-hCG\", \"yolk sac tumor elements\"],\n        \"rationale\": \"The report describes a sacrococcygeal mass with mixed solid and cystic components, elevated AFP and beta-hCG, and the presence of yolk sac tumor elements, indicating a germ cell tumor.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"sacrococcygeal mass\", \"mixed solid and cystic components\", \"elevated AFP and beta-hCG\", \"yolk sac tumor elements\"],\n        \"rationale\": \"The report describes a sacrococcygeal mass with mixed solid and cystic components, elevated AFP and beta-hCG, and the presence of yolk sac tumor elements, indicating a germ cell tumor.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"sacrococcygeal mass\", \"mixed solid and cystic components\", \"elevated AFP and beta-hCG\", \"yolk sac tumor elements\"],\n        \"rationale\": \"The report describes a sacrococcygeal mass with mixed solid and cystic components, elevated AFP and beta-hCG, and the presence of yolk sac tumor elements, indicating a germ cell tumor.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes a sacrococcygeal mass with mixed solid and cystic components, elevated AFP and beta-hCG, and the presence of yolk sac tumor elements, indicating a germ cell tumor.",
      "findings": [
        "sacrococcygeal mass",
        "mixed solid and cystic components",
        "elevated AFP and beta-hCG",
        "yolk sac tumor elements"
      ],
      "fracture_mentioned": null,
      "idx": 58,
      "timestamp": "2026-01-09T15:19:56.112362"
    },
    {
      "sample_idx": 59,
      "input": "16/06/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Rhabdomyosarcoma.\n\nFrom clinical notes: Rhabdomyosarcoma. Paediatric oncology assessment.\n\nFindings: parameningeal mass with intracranial extension. Embryonal rhabdomyosarcoma on biopsy. PAX-FOXO1 fusion negative. Recommend MDT discussion and treatment planning.\n\nDr James Chen, Consultant Paediatric Oncologist 16/06/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"parameningeal mass with intracranial extension\", \"embryonal rhabdomyosarcoma on biopsy\", \"PAX-FOXO1 fusion negative\"],\n        \"rationale\": \"The report explicitly mentions a parameningeal mass with intracranial extension, confirming a diagnosis of embryonal rhabdomyosarcoma. The PAX-FOXO1 fusion status is also provided, which helps to classify the subtype of rhabdomyosarcoma. The presence of a mass and a confirmed diagnosis of rhabdomyosarcoma indicate malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"embryonal rhabdomyosarcoma on biopsy\"],\n        \"rationale\": \"The report explicitly mentions embryonal rhabdomyosarcoma on biopsy, indicating the presence of a malignant tumor.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"embryonal rhabdomyosarcoma on biopsy\"],\n        \"rationale\": \"The report explicitly mentions embryonal rhabdomyosarcoma on biopsy, indicating the presence of a malignant tumor.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"embryonal rhabdomyosarcoma on biopsy\"],\n        \"rationale\": \"The report explicitly mentions embryonal rhabdomyosarcoma on biopsy, indicating the presence of a malignant tumor.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"embryonal rhabdomyosarcoma on biopsy\"],\n        \"rationale\": \"The report explicitly mentions embryonal rhabdomyosarcoma on biopsy, indicating the presence of a malignant tumor.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malign",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly mentions a parameningeal mass with intracranial extension, confirming a diagnosis of embryonal rhabdomyosarcoma. The PAX-FOXO1 fusion status is also provided, which helps to classify the subtype of rhabdomyosarcoma. The presence of a mass and a confirmed diagnosis of rhabdomyosarcoma indicate malignancy.",
      "findings": [
        "parameningeal mass with intracranial extension",
        "embryonal rhabdomyosarcoma on biopsy",
        "PAX-FOXO1 fusion negative"
      ],
      "fracture_mentioned": null,
      "idx": 59,
      "timestamp": "2026-01-09T15:19:56.112376"
    },
    {
      "sample_idx": 60,
      "input": "08/05/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Normal brain MRI for age. No mass lesion. No abnormal enhancement. Headaches attributed to migraine. No malignancy identified. Reassurance provided.\n\nDr James Chen, Consultant Paediatric Oncologist 08/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\"],\n        \"rationale\": \"The report confirms the absence of malignancy and other concerning findings.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no evidence of malignancy\", \"normal findings\"],\n        \"rationale\": \"The report explicitly states that no evidence of malignancy was found, and that the findings were normal.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no evidence of malignancy\", \"normal findings\"],\n        \"rationale\": \"The report explicitly states that no evidence of malignancy was found, and that the findings were normal.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no evidence of malignancy\", \"normal findings\"],\n        \"rationale\": \"The report explicitly states that no evidence of malignancy was found, and that the findings were normal.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no evidence of malignancy\", \"normal findings\"],\n        \"rationale\": \"The report explicitly states that no evidence of malignancy was found, and that the findings were normal.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no evidence of malignancy\", \"normal findings\"],\n        \"rationale\": \"The report explicitly states that no evidence of malignancy was found, and that the findings were normal.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\":",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report confirms the absence of malignancy and other concerning findings.",
      "findings": [
        "normal brain MRI",
        "no mass lesion",
        "no abnormal enhancement",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 60,
      "timestamp": "2026-01-09T15:19:56.112385"
    },
    {
      "sample_idx": 61,
      "input": "09/07/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Follow-up post-treatment. No previous oncology history.\n\nFindings: Post-viral lymphocytosis. Atypical lymphocytes resolving. Monospot positive. EBV serology confirms. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 09/07/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"post-viral lymphocytosis\", \"atypical lymphocytes resolving\", \"monospot positive\", \"EBV serology confirms\", \"no malignancy identified\"],\n        \"rationale\": \"The report notes post-viral lymphocytosis, resolving atypical lymphocytes, and confirms EBV infection. It explicitly states that no malignancy is identified. Therefore, there is no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"post-viral lymphocytosis\", \"atypical lymphocytes resolving\", \"monospot positive\", \"EBV serology confirms\", \"no malignancy identified\"],\n        \"rationale\": \"The report notes post-viral lymphocytosis, resolving atypical lymphocytes, and confirms EBV infection. It explicitly states that no malignancy is identified. Therefore, there is no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"post-viral lymphocytosis\", \"atypical lymphocytes resolving\", \"monospot positive\", \"EBV serology confirms\", \"no malignancy identified\"],\n        \"rationale\": \"The report notes post-viral lymphocytosis, resolving atypical lymphocytes, and confirms EBV infection. It explicitly states that no malignancy is identified. Therefore, there is no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"post-viral lymphocytosis\", \"atypical lymphocytes resolving\", \"monospot positive\", \"EBV serology confirms\", \"no malignancy identified\"],\n        \"rationale\": \"The report notes post-viral lymphocytosis, resolving atypical lymphocytes, and confirms EBV infection. It explicitly states that no malignancy is identified. Therefore, there is no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report notes post-viral lymphocytosis, resolving atypical lymphocytes, and confirms EBV infection. It explicitly states that no malignancy is identified. Therefore, there is no evidence of malignancy.",
      "findings": [
        "post-viral lymphocytosis",
        "atypical lymphocytes resolving",
        "monospot positive",
        "EBV serology confirms",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 61,
      "timestamp": "2026-01-09T15:19:56.112397"
    },
    {
      "sample_idx": 62,
      "input": "08/05/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Reactive lymphadenopathy secondary to viral infection. Node size decreasing on follow-up. No atypical features. No malignancy identified. Reassurance provided.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 08/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report mentions reactive lymphadenopathy and specifically states that no malignancy is identified. Therefore, the finding is not indicative of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report mentions reactive lymphadenopathy and specifically states that no malignancy is identified. Therefore, the finding is not indicative of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report mentions reactive lymphadenopathy and specifically states that no malignancy is identified. Therefore, the finding is not indicative of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report mentions reactive lymphadenopathy and specifically states that no malignancy is identified. Therefore, the finding is not indicative of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report mentions reactive lymphadenopathy and specifically states that no malignancy is identified. Therefore, the finding is not indicative of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report mentions reactive lymphadenopathy and specifically states that no malignancy is identified. Therefore, the finding is not indicative of malignancy.",
      "findings": [
        "reactive lymphadenopathy",
        "no atypical features",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 62,
      "timestamp": "2026-01-09T15:19:56.112407"
    },
    {
      "sample_idx": 63,
      "input": "04/12/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Resolved febrile illness. Blood counts normalized. No organomegaly. Clinical improvement noted. No malignancy identified. Reassurance provided.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 04/12/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"resolved febrile illness\", \"normalized blood counts\", \"no organomegaly\", \"no malignancy identified\"],\n        \"rationale\": \"The report states that the patient had a resolved febrile illness and that blood counts normalized, which are not malignant findings. It also explicitly states that no malignancy was identified. The report provides reassurance.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"resolved febrile illness\", \"normalized blood counts\", \"no organomegaly\", \"no malignancy identified\"],\n        \"rationale\": \"The report states that the patient had a resolved febrile illness and that blood counts normalized, which are not malignant findings. It also explicitly states that no malignancy was identified. The report provides reassurance.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"resolved febrile illness\", \"normalized blood counts\", \"no organomegaly\", \"no malignancy identified\"],\n        \"rationale\": \"The report states that the patient had a resolved febrile illness and that blood counts normalized, which are not malignant findings. It also explicitly states that no malignancy was identified. The report provides reassurance.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"resolved febrile illness\", \"normalized blood counts\", \"no organomegaly\", \"no malignancy identified\"],\n        \"rationale\": \"The report states that the patient had a resolved febrile illness and that blood counts normalized, which are not malignant findings. It also explicitly states that no malignancy was identified. The report provides reassurance.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"resolved febrile illness\", \"normalized blood counts\", \"no organomegaly\", \"no malignancy identified\"],\n        \"rationale\": \"The report states that",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report states that the patient had a resolved febrile illness and that blood counts normalized, which are not malignant findings. It also explicitly states that no malignancy was identified. The report provides reassurance.",
      "findings": [
        "resolved febrile illness",
        "normalized blood counts",
        "no organomegaly",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 63,
      "timestamp": "2026-01-09T15:19:56.112419"
    },
    {
      "sample_idx": 64,
      "input": "29/09/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Reactive lymphadenopathy secondary to viral infection. Node size decreasing on follow-up. No atypical features. No malignancy identified. Reassurance provided.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 29/09/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report describes reactive lymphadenopathy, which is a benign finding. The report explicitly states that no atypical features or malignancy are present. The report concludes with reassurance that no malignancy was identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report describes reactive lymphadenopathy, which is a benign finding. The report explicitly states that no atypical features or malignancy are present. The report concludes with reassurance that no malignancy was identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report describes reactive lymphadenopathy, which is a benign finding. The report explicitly states that no atypical features or malignancy are present. The report concludes with reassurance that no malignancy was identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report describes reactive lymphadenopathy, which is a benign finding. The report explicitly states that no atypical features or malignancy are present. The report concludes with reassurance that no malignancy was identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report describes reactive lymphadenopathy, which is a benign finding. The report explicitly states that no atypical features or malignancy are present. The report concludes with reassurance that no malignancy was",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report describes reactive lymphadenopathy, which is a benign finding. The report explicitly states that no atypical features or malignancy are present. The report concludes with reassurance that no malignancy was identified.",
      "findings": [
        "reactive lymphadenopathy",
        "no atypical features",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 64,
      "timestamp": "2026-01-09T15:19:56.112430"
    },
    {
      "sample_idx": 65,
      "input": "09/06/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Abnormal imaging. Suspected Retinoblastoma.\n\nFrom clinical notes: Retinoblastoma. Paediatric oncology assessment.\n\nFindings: intraocular mass with calcifications. Bilateral disease. Family history positive. RB1 germline mutation detected. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 09/06/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"intraocular mass with calcifications\", \"Bilateral disease\", \"Family history positive\", \"RB1 germline mutation detected\"],\n        \"rationale\": \"The report mentions intraocular masses with calcifications, bilateral disease, a positive family history, and the detection of an RB1 germline mutation, which are all consistent with retinoblastoma, a type of cancer.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"intraocular mass with calcifications\", \"Bilateral disease\", \"Family history positive\", \"RB1 germline mutation detected\"],\n        \"rationale\": \"The report mentions intraocular masses with calcifications, bilateral disease, a positive family history, and the detection of an RB1 germline mutation, which are all consistent with retinoblastoma, a type of cancer.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"intraocular mass with calcifications\", \"Bilateral disease\", \"Family history positive\", \"RB1 germline mutation detected\"],\n        \"rationale\": \"The report mentions intraocular masses with calcifications, bilateral disease, a positive family history, and the detection of an RB1 germline mutation, which are all consistent with retinoblastoma, a type of cancer.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"intraocular mass with calcifications\", \"Bilateral disease\", \"Family history positive\", \"RB1 germline mutation detected\"],\n        \"rationale\": \"The report mentions intraocular masses with calcifications, bilateral disease, a positive family history, and the detection of an RB1 germline mutation, which are all consistent with retinoblastoma, a type of cancer.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report mentions intraocular masses with calcifications, bilateral disease, a positive family history, and the detection of an RB1 germline mutation, which are all consistent with retinoblastoma, a type of cancer.",
      "findings": [
        "intraocular mass with calcifications",
        "Bilateral disease",
        "Family history positive",
        "RB1 germline mutation detected"
      ],
      "fracture_mentioned": null,
      "idx": 65,
      "timestamp": "2026-01-09T15:19:56.112443"
    },
    {
      "sample_idx": 66,
      "input": "16/05/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Abnormal imaging. Suspected Neuroblastoma.\n\nFrom clinical notes: Neuroblastoma. Paediatric oncology assessment.\n\nFindings: large heterogeneous suprarenal mass with calcifications. MIBG avidity present. Elevated urinary catecholamines. Stage III disease. Recommend MDT discussion and treatment planning.\n\nDr James Chen, Consultant Paediatric Oncologist 16/05/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"elevated urinary catecholamines\", \"Stage III disease\"],\n        \"rationale\": \"The report describes a suprarenal mass with calcifications, MIBG avidity, and elevated urinary catecholamines, which are suggestive of neuroblastoma. The report also indicates stage III disease, confirming malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"elevated urinary catecholamines\", \"Stage III disease\"],\n        \"rationale\": \"The report describes a suprarenal mass with calcifications, MIBG avidity, and elevated urinary catecholamines, which are suggestive of neuroblastoma. The report also indicates stage III disease, confirming malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"elevated urinary catecholamines\", \"Stage III disease\"],\n        \"rationale\": \"The report describes a suprarenal mass with calcifications, MIBG avidity, and elevated urinary catecholamines, which are suggestive of neuroblastoma. The report also indicates stage III disease, confirming malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"elevated urinary catecholamines\", \"Stage III disease\"],\n        \"rationale\": \"The report describes a suprarenal mass with calcifications, MIBG avidity, and elevated urinary catecholamines, which are suggestive of neuroblastoma. The report also indicates stage III disease, confirming malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        ",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes a suprarenal mass with calcifications, MIBG avidity, and elevated urinary catecholamines, which are suggestive of neuroblastoma. The report also indicates stage III disease, confirming malignancy.",
      "findings": [
        "large heterogeneous suprarenal mass with calcifications",
        "MIBG avidity present",
        "elevated urinary catecholamines",
        "Stage III disease"
      ],
      "fracture_mentioned": null,
      "idx": 66,
      "timestamp": "2026-01-09T15:19:56.112455"
    },
    {
      "sample_idx": 67,
      "input": "21/03/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Follow-up post-treatment. No previous oncology history.\n\nFindings: Normal CBC with age-appropriate values. No blast cells. Platelets adequate. Hemoglobin within normal limits. No malignancy identified. Reassurance provided.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 21/03/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC\", \"age-appropriate values\", \"no blast cells\"],\n        \"rationale\": \"The report shows normal blood counts with no atypical or malignant cells. No evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no blast cells\", \"platelets adequate\", \"hemoglobin within normal limits\"],\n        \"rationale\": \"The report indicates the absence of blast cells, adequate platelets, and normal hemoglobin levels, which are all reassuring findings and do not suggest malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC\", \"no malignancy identified\"],\n        \"rationale\": \"The report confirms a normal complete blood count (CBC) and explicitly states that no malignancy was identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC\", \"no blast cells\"],\n        \"rationale\": \"The report shows a normal complete blood count and the absence of blast cells, indicating no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no blast cells\", \"normal CBC\"],\n        \"rationale\": \"The report states that no blast cells were found and that the complete blood count (CBC) was normal, which does not indicate malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC\", \"no blast cells\"],\n        \"rationale\": \"The report shows a normal CBC and the absence of blast cells, which is reassuring and does not suggest malignancy.\"\n    }\n}\n```\n```json\n{\n    ",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report shows normal blood counts with no atypical or malignant cells. No evidence of malignancy.",
      "findings": [
        "normal CBC",
        "age-appropriate values",
        "no blast cells"
      ],
      "fracture_mentioned": null,
      "idx": 67,
      "timestamp": "2026-01-09T15:19:56.112464"
    },
    {
      "sample_idx": 68,
      "input": "27/02/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Bone pain. Suspected Rhabdomyosarcoma.\n\nFrom clinical notes: Rhabdomyosarcoma. Paediatric oncology assessment.\n\nFindings: parameningeal mass with intracranial extension. Embryonal rhabdomyosarcoma on biopsy. PAX-FOXO1 fusion negative. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 27/02/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"embryonal rhabdomyosarcoma on biopsy\"],\n        \"rationale\": \"The report explicitly identifies embryonal rhabdomyosarcoma on biopsy, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"parameningeal mass with intracranial extension\", \"embryonal rhabdomyosarcoma on biopsy\"],\n        \"rationale\": \"The report explicitly mentions a parameningeal mass with intracranial extension and confirms embryonal rhabdomyosarcoma on biopsy, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"embryonal rhabdomyosarcoma on biopsy\"],\n        \"rationale\": \"The report explicitly identifies embryonal rhabdomyosarcoma on biopsy, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"embryonal rhabdomyosarcoma on biopsy\"],\n        \"rationale\": \"The report explicitly identifies embryonal rhabdomyosarcoma on biopsy, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"embryonal rhabdomyosarcoma on biopsy\"],\n        \"rationale\": \"The report explicitly identifies embryonal rhabdomyosarcoma on biopsy, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"embryonal rhabdomyosarcoma on biopsy\"],\n        \"rationale\": \"The report explicitly identifies embryonal rhabdomyosarcoma on biopsy, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly identifies embryonal rhabdomyosarcoma on biopsy, indicating malignancy.",
      "findings": [
        "embryonal rhabdomyosarcoma on biopsy"
      ],
      "fracture_mentioned": null,
      "idx": 68,
      "timestamp": "2026-01-09T15:19:56.112472"
    },
    {
      "sample_idx": 69,
      "input": "16/10/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Normal chest radiograph. Clear lung fields. No mediastinal mass. Heart size normal. No malignancy identified. Reassurance provided.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 16/10/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal chest radiograph\", \"Clear lung fields\", \"No mediastinal mass\", \"Heart size normal\", \"No malignancy identified\", \"Reassurance provided\"],\n        \"rationale\": \"The report states that a chest radiograph was performed and found to be normal, with no mediastinal mass, heart size normal, and no malignancy identified. Reassurance was provided.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal chest radiograph\", \"Clear lung fields\", \"No mediastinal mass\", \"Heart size normal\", \"No malignancy identified\", \"Reassurance provided\"],\n        \"rationale\": \"The report indicates that a chest radiograph was performed and found to be normal, with no mediastinal mass, heart size normal, and no malignancy identified. Reassurance was provided.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal chest radiograph\", \"Clear lung fields\", \"No mediastinal mass\", \"Heart size normal\", \"No malignancy identified\", \"Reassurance provided\"],\n        \"rationale\": \"The report indicates that a chest radiograph was performed and found to be normal, with no mediastinal mass, heart size normal, and no malignancy identified. Reassurance was provided.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal chest radiograph\", \"Clear lung fields\", \"No mediastinal mass\", \"Heart size normal\", \"No malignancy identified\", \"Reassurance provided\"],\n        \"rationale\": \"The report indicates that a chest radiograph was performed and found to be normal, with no mediastinal mass, heart size normal, and no malignancy identified. Reassurance was provided.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal chest radiograph",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report states that a chest radiograph was performed and found to be normal, with no mediastinal mass, heart size normal, and no malignancy identified. Reassurance was provided.",
      "findings": [
        "Normal chest radiograph",
        "Clear lung fields",
        "No mediastinal mass",
        "Heart size normal",
        "No malignancy identified",
        "Reassurance provided"
      ],
      "fracture_mentioned": null,
      "idx": 69,
      "timestamp": "2026-01-09T15:19:56.112484"
    },
    {
      "sample_idx": 70,
      "input": "29/11/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Unexplained fever and weight loss. Suspected Retinoblastoma.\n\nFrom clinical notes: Retinoblastoma. Paediatric oncology assessment.\n\nFindings: intraocular mass with calcifications. Bilateral disease. Family history positive. RB1 germline mutation detected. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 29/11/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"intraocular mass with calcifications\", \"bilateral disease\", \"family history positive\", \"RB1 germline mutation detected\"],\n        \"rationale\": \"The report explicitly mentions an intraocular mass with calcifications, bilateral disease, a positive family history, and the detection of an RB1 germline mutation, all of which are consistent with retinoblastoma, a type of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"intraocular mass with calcifications\", \"bilateral disease\", \"family history positive\", \"RB1 germline mutation detected\"],\n        \"rationale\": \"The report explicitly mentions an intraocular mass with calcifications, bilateral disease, a positive family history, and the detection of an RB1 germline mutation, all of which are consistent with retinoblastoma, a type of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"intraocular mass with calcifications\", \"bilateral disease\", \"family history positive\", \"RB1 germline mutation detected\"],\n        \"rationale\": \"The report explicitly mentions an intraocular mass with calcifications, bilateral disease, a positive family history, and the detection of an RB1 germline mutation, all of which are consistent with retinoblastoma, a type of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"intraocular mass with calcifications\", \"bilateral disease\", \"family history positive\", \"RB1 germline mutation detected\"],\n        \"rationale\": \"The report explicitly mentions an intraocular mass with calcifications, bilateral disease, a positive family history, and the detection of an RB1 germline mutation, all of which are consistent with retinoblastoma, a type of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly mentions an intraocular mass with calcifications, bilateral disease, a positive family history, and the detection of an RB1 germline mutation, all of which are consistent with retinoblastoma, a type of malignancy.",
      "findings": [
        "intraocular mass with calcifications",
        "bilateral disease",
        "family history positive",
        "RB1 germline mutation detected"
      ],
      "fracture_mentioned": null,
      "idx": 70,
      "timestamp": "2026-01-09T15:19:56.112496"
    },
    {
      "sample_idx": 71,
      "input": "11/10/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Abnormal imaging. Suspected Hodgkin Lymphoma.\n\nFrom clinical notes: Hodgkin Lymphoma. Paediatric oncology assessment.\n\nFindings: mediastinal lymphadenopathy with bulky anterior mediastinal mass. PET-CT showing FDG-avid nodes. Classical Hodgkin, nodular sclerosing type. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 11/10/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"bulky anterior mediastinal mass\", \"FDG-avid nodes\", \"Classical Hodgkin, nodular sclerosing type\"],\n        \"rationale\": \"The report explicitly mentions mediastinal lymphadenopathy, a bulky anterior mediastinal mass, FDG-avid nodes, and the diagnosis of Classical Hodgkin Lymphoma, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"bulky anterior mediastinal mass\", \"FDG-avid nodes\", \"Classical Hodgkin, nodular sclerosing type\"],\n        \"rationale\": \"The report explicitly mentions mediastinal lymphadenopathy, a bulky anterior mediastinal mass, FDG-avid nodes, and the diagnosis of Classical Hodgkin Lymphoma, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"bulky anterior mediastinal mass\", \"FDG-avid nodes\", \"Classical Hodgkin, nodular sclerosing type\"],\n        \"rationale\": \"The report explicitly mentions mediastinal lymphadenopathy, a bulky anterior mediastinal mass, FDG-avid nodes, and the diagnosis of Classical Hodgkin Lymphoma, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"bulky anterior mediastinal mass\", \"FDG-avid nodes\", \"Classical Hodgkin, nodular sclerosing type\"],\n        \"rationale\": \"The report explicitly mentions mediastinal lymphadenopathy, a bulky anterior mediastinal mass, FDG-avid nodes, and the diagnosis of Classical Hodgkin Lymphoma, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        ",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly mentions mediastinal lymphadenopathy, a bulky anterior mediastinal mass, FDG-avid nodes, and the diagnosis of Classical Hodgkin Lymphoma, indicating malignancy.",
      "findings": [
        "mediastinal lymphadenopathy",
        "bulky anterior mediastinal mass",
        "FDG-avid nodes",
        "Classical Hodgkin, nodular sclerosing type"
      ],
      "fracture_mentioned": null,
      "idx": 71,
      "timestamp": "2026-01-09T15:19:56.112508"
    },
    {
      "sample_idx": 72,
      "input": "13/09/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Unexplained fever and weight loss. Suspected Rhabdomyosarcoma.\n\nFrom clinical notes: Rhabdomyosarcoma. Paediatric oncology assessment.\n\nFindings: parameningeal mass with intracranial extension. Embryonal rhabdomyosarcoma on biopsy. PAX-FOXO1 fusion negative. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 13/09/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"parameningeal mass with intracranial extension\", \"embryonal rhabdomyosarcoma on biopsy\", \"PAX-FOXO1 fusion negative\"],\n        \"rationale\": \"The report identifies a parameningeal mass with intracranial extension, which is consistent with rhabdomyosarcoma. The biopsy confirms embryonal rhabdomyosarcoma, and the PAX-FOXO1 fusion status is reported, which is relevant for treatment planning. The report indicates a need for MDT discussion and treatment planning, suggesting a diagnosis of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"parameningeal mass with intracranial extension\", \"embryonal rhabdomyosarcoma on biopsy\", \"PAX-FOXO1 fusion negative\"],\n        \"rationale\": \"The report identifies a parameningeal mass with intracranial extension, which is consistent with rhabdomyosarcoma. The biopsy confirms embryonal rhabdomyosarcoma, and the PAX-FOXO1 fusion status is reported, which is relevant for treatment planning. The report indicates a need for MDT discussion and treatment planning, suggesting a diagnosis of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"parameningeal mass with intracranial extension\", \"embryonal rhabdomyosarcoma on biopsy\", \"PAX-FOXO1 fusion negative\"],\n        \"rationale\": \"The report identifies a parameningeal mass with intracranial extension, which is consistent with rhabdomyosarcoma. The biopsy confirms embryonal rhabdomyosarcoma, and the PAX-FOXO1 fusion status is reported, which is relevant for treatment planning. The report indicates a need for MDT discussion and treatment planning, suggesting a diagnosis of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"parameningeal mass with intracranial extension\", \"embryonal r",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report identifies a parameningeal mass with intracranial extension, which is consistent with rhabdomyosarcoma. The biopsy confirms embryonal rhabdomyosarcoma, and the PAX-FOXO1 fusion status is reported, which is relevant for treatment planning. The report indicates a need for MDT discussion and treatment planning, suggesting a diagnosis of malignancy.",
      "findings": [
        "parameningeal mass with intracranial extension",
        "embryonal rhabdomyosarcoma on biopsy",
        "PAX-FOXO1 fusion negative"
      ],
      "fracture_mentioned": null,
      "idx": 72,
      "timestamp": "2026-01-09T15:19:56.112522"
    },
    {
      "sample_idx": 73,
      "input": "03/12/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Physiological splenomegaly for age. No focal lesions. Normal echo texture. Benign finding. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 03/12/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"physiological splenomegaly\", \"no focal lesions\", \"normal echo texture\"],\n        \"rationale\": \"The report explicitly states that physiological splenomegaly is present, with no focal lesions and normal echo texture. The report concludes that no malignancy is identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"physiological splenomegaly\", \"no focal lesions\", \"normal echo texture\"],\n        \"rationale\": \"The report explicitly states that physiological splenomegaly is present, with no focal lesions and normal echo texture. The report concludes that no malignancy is identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"physiological splenomegaly\", \"no focal lesions\", \"normal echo texture\"],\n        \"rationale\": \"The report explicitly states that physiological splenomegaly is present, with no focal lesions and normal echo texture. The report concludes that no malignancy is identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"physiological splenomegaly\", \"no focal lesions\", \"normal echo texture\"],\n        \"rationale\": \"The report explicitly states that physiological splenomegaly is present, with no focal lesions and normal echo texture. The report concludes that no malignancy is identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"physiological splenomegaly\", \"no focal lesions\", \"normal echo texture\"],\n        \"rationale\": \"The report explicitly states that physiological splenomegaly is present, with no focal lesions and normal echo texture. The report concludes that no malignancy is identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states that physiological splenomegaly is present, with no focal lesions and normal echo texture. The report concludes that no malignancy is identified.",
      "findings": [
        "physiological splenomegaly",
        "no focal lesions",
        "normal echo texture"
      ],
      "fracture_mentioned": null,
      "idx": 73,
      "timestamp": "2026-01-09T15:19:56.112532"
    },
    {
      "sample_idx": 74,
      "input": "11/10/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Ewing Sarcoma.\n\nFrom clinical notes: Ewing Sarcoma. Paediatric oncology assessment.\n\nFindings: permeative bone destruction in left femoral diaphysis with large soft tissue mass. Onion-skin periosteal reaction. EWSR1 fusion positive. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 11/10/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"permeative bone destruction in left femoral diaphysis with large soft tissue mass\", \"onion-skin periosteal reaction\", \"EWSR1 fusion positive\"],\n        \"rationale\": \"The report explicitly mentions bone destruction, a soft tissue mass, and a positive EWSR1 fusion, all of which are indicative of Ewing Sarcoma, a malignant bone tumor.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"permeative bone destruction in left femoral diaphysis with large soft tissue mass\", \"onion-skin periosteal reaction\", \"EWSR1 fusion positive\"],\n        \"rationale\": \"The report explicitly mentions bone destruction, a soft tissue mass, and a positive EWSR1 fusion, all of which are indicative of Ewing Sarcoma, a malignant bone tumor.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"permeative bone destruction in left femoral diaphysis with large soft tissue mass\", \"onion-skin periosteal reaction\", \"EWSR1 fusion positive\"],\n        \"rationale\": \"The report explicitly mentions bone destruction, a soft tissue mass, and a positive EWSR1 fusion, all of which are indicative of Ewing Sarcoma, a malignant bone tumor.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"permeative bone destruction in left femoral diaphysis with large soft tissue mass\", \"onion-skin periosteal reaction\", \"EWSR1 fusion positive\"],\n        \"rationale\": \"The report explicitly mentions bone destruction, a soft tissue mass, and a positive EWSR1 fusion, all of which are indicative of Ewing Sarcoma, a malignant bone tumor.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"permeative",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly mentions bone destruction, a soft tissue mass, and a positive EWSR1 fusion, all of which are indicative of Ewing Sarcoma, a malignant bone tumor.",
      "findings": [
        "permeative bone destruction in left femoral diaphysis with large soft tissue mass",
        "onion-skin periosteal reaction",
        "EWSR1 fusion positive"
      ],
      "fracture_mentioned": null,
      "idx": 74,
      "timestamp": "2026-01-09T15:19:56.112543"
    },
    {
      "sample_idx": 75,
      "input": "28/12/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Reactive lymphadenopathy secondary to viral infection. Node size decreasing on follow-up. No atypical features. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 28/12/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy secondary to viral infection\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly mentions reactive lymphadenopathy likely due to a viral infection and confirms that no atypical features or malignancy were found.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy secondary to viral infection\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly mentions reactive lymphadenopathy likely due to a viral infection and confirms that no atypical features or malignancy were found.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy secondary to viral infection\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly mentions reactive lymphadenopathy likely due to a viral infection and confirms that no atypical features or malignancy were found.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy secondary to viral infection\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly mentions reactive lymphadenopathy likely due to a viral infection and confirms that no atypical features or malignancy were found.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy secondary to viral infection\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly mentions reactive lymphadenopathy likely due to a viral infection and confirms that no atypical features or malignancy were found.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly mentions reactive lymphadenopathy likely due to a viral infection and confirms that no atypical features or malignancy were found.",
      "findings": [
        "reactive lymphadenopathy secondary to viral infection",
        "no atypical features",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 75,
      "timestamp": "2026-01-09T15:19:56.112554"
    },
    {
      "sample_idx": 76,
      "input": "02/05/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Normal CBC with age-appropriate values. No blast cells. Platelets adequate. Hemoglobin within normal limits. No malignancy identified. Reassurance provided.\n\nDr James Chen, Consultant Paediatric Oncologist 02/05/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC with age-appropriate values\", \"no blast cells\", \"platelets adequate\", \"hemoglobin within normal limits\", \"no malignancy identified\", \"reassurance provided\"],\n        \"rationale\": \"The report describes a normal complete blood count (CBC) with no abnormal cells, including blast cells, and confirms the absence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC with age-appropriate values\", \"no blast cells\", \"platelets adequate\", \"hemoglobin within normal limits\", \"no malignancy identified\", \"reassurance provided\"],\n        \"rationale\": \"The report describes a normal complete blood count (CBC) with no abnormal cells, including blast cells, and confirms the absence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC with age-appropriate values\", \"no blast cells\", \"platelets adequate\", \"hemoglobin within normal limits\", \"no malignancy identified\", \"reassurance provided\"],\n        \"rationale\": \"The report describes a normal complete blood count (CBC) with no abnormal cells, including blast cells, and confirms the absence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC with age-appropriate values\", \"no blast cells\", \"platelets adequate\", \"hemoglobin within normal limits\", \"no malignancy identified\", \"reassurance provided\"],\n        \"rationale\": \"The report describes a normal complete blood count (CBC) with no abnormal cells, including blast cells, and confirms the absence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC with age-appropriate values\", \"no blast cells\", \"platelets adequate\", \"hemoglobin within",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report describes a normal complete blood count (CBC) with no abnormal cells, including blast cells, and confirms the absence of malignancy.",
      "findings": [
        "normal CBC with age-appropriate values",
        "no blast cells",
        "platelets adequate",
        "hemoglobin within normal limits",
        "no malignancy identified",
        "reassurance provided"
      ],
      "fracture_mentioned": null,
      "idx": 76,
      "timestamp": "2026-01-09T15:19:56.112566"
    },
    {
      "sample_idx": 77,
      "input": "06/10/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Healing fracture - normal process. No pathological features. Bone density normal. Trauma history consistent. No malignancy identified. Reassurance provided.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 06/10/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"healing fracture\", \"normal bone density\", \"no pathological features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that there are no pathological features, no malignancy identified, and the fracture is healing normally. This indicates that malignancy is not present.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no findings of malignancy\"],\n        \"rationale\": \"The report explicitly states that there are no findings of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no findings of malignancy\"],\n        \"rationale\": \"The report explicitly states that there are no findings of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no findings of malignancy\"],\n        \"rationale\": \"The report explicitly states that there are no findings of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no findings of malignancy\"],\n        \"rationale\": \"The report explicitly states that there are no findings of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no findings of malignancy\"],\n        \"rationale\": \"The report explicitly states that there are no findings of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no findings of malignancy\"],\n        \"rationale\": \"The report explicitly states that there are no findings of malignancy.\"\n    }\n}\n```\n```json\n{\n",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states that there are no pathological features, no malignancy identified, and the fracture is healing normally. This indicates that malignancy is not present.",
      "findings": [
        "healing fracture",
        "normal bone density",
        "no pathological features",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 77,
      "timestamp": "2026-01-09T15:19:56.112577"
    },
    {
      "sample_idx": 78,
      "input": "27/02/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Acute Lymphoblastic Leukemia.\n\nFrom clinical notes: Acute Lymphoblastic Leukemia. Paediatric oncology assessment.\n\nFindings: bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells. Immunophenotyping consistent with B-cell ALL. CNS involvement negative. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 27/02/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells\", \"Immunophenotyping consistent with B-cell ALL\", \"CNS involvement negative\"],\n        \"rationale\": \"The report explicitly mentions bone marrow infiltration with a high percentage of lymphoblasts and immunophenotyping consistent with B-cell ALL. CNS involvement is negative. These findings strongly indicate malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells\", \"Immunophenotyping consistent with B-cell ALL\", \"CNS involvement negative\"],\n        \"rationale\": \"The report explicitly mentions bone marrow infiltration with a high percentage of lymphoblasts and immunophenotyping consistent with B-cell ALL. CNS involvement is negative. These findings strongly indicate malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells\", \"Immunophenotyping consistent with B-cell ALL\", \"CNS involvement negative\"],\n        \"rationale\": \"The report explicitly mentions bone marrow infiltration with a high percentage of lymphoblasts and immunophenotyping consistent with B-cell ALL. CNS involvement is negative. These findings strongly indicate malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells\", \"Immunophenotyping consistent with B-cell ALL\", \"CNS involvement negative\"],\n        \"rationale\": \"The report explicitly mentions bone marrow infiltration with a high percentage of lymphoblasts and immunophenotyping consistent with B-cell ALL. CNS involvement is negative. These findings strongly indicate malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly mentions bone marrow infiltration with a high percentage of lymphoblasts and immunophenotyping consistent with B-cell ALL. CNS involvement is negative. These findings strongly indicate malignancy.",
      "findings": [
        "bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells",
        "Immunophenotyping consistent with B-cell ALL",
        "CNS involvement negative"
      ],
      "fracture_mentioned": null,
      "idx": 78,
      "timestamp": "2026-01-09T15:19:56.112590"
    },
    {
      "sample_idx": 79,
      "input": "17/05/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Post-viral lymphocytosis. Atypical lymphocytes resolving. Monospot positive. EBV serology confirms. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 17/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Post-viral lymphocytosis\", \"Atypical lymphocytes resolving\", \"Monospot positive\", \"EBV serology confirms\"],\n        \"rationale\": \"The report identifies post-viral lymphocytosis, atypical lymphocytes resolving, a positive Monospot test, and EBV serology confirmation, indicating a viral infection. No malignancy is identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Atypical lymphocytes resolving\", \"Monospot positive\", \"EBV serology confirms\"],\n        \"rationale\": \"The report identifies atypical lymphocytes resolving, a positive Monospot test, and EBV serology confirmation, indicating a viral infection. No malignancy is identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Atypical lymphocytes resolving\", \"Monospot positive\", \"EBV serology confirms\"],\n        \"rationale\": \"The report identifies atypical lymphocytes resolving, a positive Monospot test, and EBV serology confirmation, indicating a viral infection. No malignancy is identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Atypical lymphocytes resolving\", \"Monospot positive\", \"EBV serology confirms\"],\n        \"rationale\": \"The report identifies atypical lymphocytes resolving, a positive Monospot test, and EBV serology confirmation, indicating a viral infection. No malignancy is identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Atypical lymphocytes resolving\", \"Monospot positive\", \"EBV serology confirms\"],\n        \"rationale\": \"The report identifies atypical lymphocytes resolving, a positive Monospot test, and EBV serology confirmation, indicating a viral infection. No malignancy is identified.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report identifies post-viral lymphocytosis, atypical lymphocytes resolving, a positive Monospot test, and EBV serology confirmation, indicating a viral infection. No malignancy is identified.",
      "findings": [
        "Post-viral lymphocytosis",
        "Atypical lymphocytes resolving",
        "Monospot positive",
        "EBV serology confirms"
      ],
      "fracture_mentioned": null,
      "idx": 79,
      "timestamp": "2026-01-09T15:19:56.112601"
    },
    {
      "sample_idx": 80,
      "input": "18/02/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Physiological splenomegaly for age. No focal lesions. Normal echo texture. Benign finding. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 18/02/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"physiological splenomegaly for age\", \"no focal lesions\", \"normal echo texture\", \"benign finding\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that there are no focal lesions and no malignancy identified. The presence of physiological splenomegaly is noted, but not considered a malignancy. The report concludes with reassurance.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"physiological splenomegaly for age\", \"no focal lesions\", \"normal echo texture\", \"benign finding\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that there are no focal lesions and no malignancy identified. The presence of physiological splenomegaly is noted, but not considered a malignancy. The report concludes with reassurance.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"physiological splenomegaly for age\", \"no focal lesions\", \"normal echo texture\", \"benign finding\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that there are no focal lesions and no malignancy identified. The presence of physiological splenomegaly is noted, but not considered a malignancy. The report concludes with reassurance.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"physiological splenomegaly for age\", \"no focal lesions\", \"normal echo texture\", \"benign finding\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that there are no focal lesions and no malignancy identified. The presence of physiological splenomegaly is noted, but not considered a malignancy. The report concludes with reassurance.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"physiological splenomegaly for age\", \"no focal lesions\", \"normal echo texture",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states that there are no focal lesions and no malignancy identified. The presence of physiological splenomegaly is noted, but not considered a malignancy. The report concludes with reassurance.",
      "findings": [
        "physiological splenomegaly for age",
        "no focal lesions",
        "normal echo texture",
        "benign finding",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 80,
      "timestamp": "2026-01-09T15:19:56.112613"
    },
    {
      "sample_idx": 81,
      "input": "11/06/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Benign soft tissue mass - lipoma confirmed. Well-circumscribed. No enhancement. No intervention required. No malignancy identified. Reassurance provided.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 11/06/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"benign soft tissue mass - lipoma confirmed\", \"No malignancy identified\"],\n        \"rationale\": \"The report states the finding is a benign lipoma, and explicitly denies the presence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"No previous oncology history\", \"Reassurance provided\"],\n        \"rationale\": \"The patient has no prior history of cancer, and the report provides reassurance, indicating no suspicion of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC\", \"age-appropriate values\", \"no blast cells\"],\n        \"rationale\": \"The report shows normal blood counts with no atypical or malignant cells. No evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC\", \"age-appropriate values\", \"no blast cells\"],\n        \"rationale\": \"The report shows normal blood counts with no atypical or malignant cells. No evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC\", \"age-appropriate values\", \"no blast cells\"],\n        \"rationale\": \"The report shows normal blood counts with no atypical or malignant cells. No evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC\", \"age-appropriate values\", \"no blast cells\"],\n        \"rationale\": \"The report shows normal blood counts with no atypical or malignant cells. No evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report states the finding is a benign lipoma, and explicitly denies the presence of malignancy.",
      "findings": [
        "benign soft tissue mass - lipoma confirmed",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 81,
      "timestamp": "2026-01-09T15:19:56.112622"
    },
    {
      "sample_idx": 82,
      "input": "27/12/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Abnormal imaging. Suspected Wilms Tumor.\n\nFrom clinical notes: Wilms Tumor. Paediatric oncology assessment.\n\nFindings: large heterogeneous left renal mass with pseudocapsule. No vascular invasion. Favorable histology on biopsy. Stage II. Recommend MDT discussion and treatment planning.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 27/12/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"Wilms Tumor\"],\n        \"rationale\": \"The report describes a left renal mass and diagnoses it as Wilms Tumor, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"Wilms Tumor\"],\n        \"rationale\": \"The report describes a left renal mass and diagnoses it as Wilms Tumor, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"Wilms Tumor\"],\n        \"rationale\": \"The report describes a left renal mass and diagnoses it as Wilms Tumor, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"Wilms Tumor\"],\n        \"rationale\": \"The report describes a left renal mass and diagnoses it as Wilms Tumor, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"Wilms Tumor\"],\n        \"rationale\": \"The report describes a left renal mass and diagnoses it as Wilms Tumor, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"Wilms Tumor\"],\n        \"rationale\": \"The report describes a left renal mass and diagnoses it as Wilms Tumor, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    ",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes a left renal mass and diagnoses it as Wilms Tumor, indicating malignancy.",
      "findings": [
        "large heterogeneous left renal mass with pseudocapsule",
        "Wilms Tumor"
      ],
      "fracture_mentioned": null,
      "idx": 82,
      "timestamp": "2026-01-09T15:19:56.112631"
    },
    {
      "sample_idx": 83,
      "input": "05/11/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Osteosarcoma.\n\nFrom clinical notes: Osteosarcoma. Paediatric oncology assessment.\n\nFindings: destructive lesion in distal femur with soft tissue component. Sunburst periosteal reaction. Elevated alkaline phosphatase. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 05/11/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"destructive lesion in distal femur with soft tissue component\", \"sunburst periosteal reaction\", \"elevated alkaline phosphatase\"],\n        \"rationale\": \"The report describes a destructive lesion in the distal femur with soft tissue involvement, sunburst periosteal reaction, and elevated alkaline phosphatase. These findings are highly suggestive of osteosarcoma, a type of bone cancer.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"destructive lesion in distal femur with soft tissue component\", \"sunburst periosteal reaction\", \"elevated alkaline phosphatase\"],\n        \"rationale\": \"The report describes a destructive lesion in the distal femur with soft tissue involvement, sunburst periosteal reaction, and elevated alkaline phosphatase. These findings are highly suggestive of osteosarcoma, a type of bone cancer.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"destructive lesion in distal femur with soft tissue component\", \"sunburst periosteal reaction\", \"elevated alkaline phosphatase\"],\n        \"rationale\": \"The report describes a destructive lesion in the distal femur with soft tissue involvement, sunburst periosteal reaction, and elevated alkaline phosphatase. These findings are highly suggestive of osteosarcoma, a type of bone cancer.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"destructive lesion in distal femur with soft tissue component\", \"sunburst periosteal reaction\", \"elevated alkaline phosphatase\"],\n        \"rationale\": \"The report describes a destructive lesion in the distal femur with soft tissue involvement, sunburst periosteal reaction, and elevated alkaline phosphatase. These findings are highly suggestive of osteosarcoma, a type of bone cancer.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"destructive lesion",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes a destructive lesion in the distal femur with soft tissue involvement, sunburst periosteal reaction, and elevated alkaline phosphatase. These findings are highly suggestive of osteosarcoma, a type of bone cancer.",
      "findings": [
        "destructive lesion in distal femur with soft tissue component",
        "sunburst periosteal reaction",
        "elevated alkaline phosphatase"
      ],
      "fracture_mentioned": null,
      "idx": 83,
      "timestamp": "2026-01-09T15:19:56.112643"
    },
    {
      "sample_idx": 84,
      "input": "23/11/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Healing fracture - normal process. No pathological features. Bone density normal. Trauma history consistent. No malignancy identified. Reassurance provided.\n\nDr James Chen, Consultant Paediatric Oncologist 23/11/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"healing fracture\", \"no pathological features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that the healing fracture is normal and that no pathological features or malignancy are identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"healing fracture\", \"no pathological features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that the healing fracture is normal and that no pathological features or malignancy are identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"healing fracture\", \"no pathological features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that the healing fracture is normal and that no pathological features or malignancy are identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"healing fracture\", \"no pathological features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that the healing fracture is normal and that no pathological features or malignancy are identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"healing fracture\", \"no pathological features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that the healing fracture is normal and that no pathological features or malignancy are identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"healing fracture\", \"no pathological features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that the healing fracture is normal and that no pathological features or malignancy are identified.\"\n    }\n}\n```\n```json\n{\n    \"ab",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states that the healing fracture is normal and that no pathological features or malignancy are identified.",
      "findings": [
        "healing fracture",
        "no pathological features",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 84,
      "timestamp": "2026-01-09T15:19:56.112652"
    },
    {
      "sample_idx": 85,
      "input": "14/05/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Normal chest radiograph. Clear lung fields. No mediastinal mass. Heart size normal. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 14/05/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\"],\n        \"rationale\": \"The report states that the chest radiograph is normal and there is no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\"],\n        \"rationale\": \"The report indicates normal chest imaging with no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\"],\n        \"rationale\": \"The report states that there is no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no malignancy is identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\"],\n        \"rationale\": \"The report confirms the absence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\"],\n        \"ration",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report states that the chest radiograph is normal and there is no evidence of malignancy.",
      "findings": [
        "normal chest radiograph",
        "clear lung fields",
        "no mediastinal mass",
        "heart size normal",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 85,
      "timestamp": "2026-01-09T15:19:56.112662"
    },
    {
      "sample_idx": 86,
      "input": "11/06/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Hepatoblastoma.\n\nFrom clinical notes: Hepatoblastoma. Paediatric oncology assessment.\n\nFindings: large heterogeneous hepatic mass with elevated AFP. Fetal histology subtype. PRETEXT stage II. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 11/06/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous hepatic mass\", \"elevated AFP\", \"Fetal histology subtype\", \"PRETEXT stage II\"],\n        \"rationale\": \"The report describes a large heterogeneous hepatic mass, elevated AFP, and a fetal histology subtype, all suggestive of hepatoblastoma. The PRETEXT stage also indicates a certain stage of the cancer. The report concludes with a recommendation for MDT discussion and treatment planning, further supporting the suspicion of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous hepatic mass\", \"elevated AFP\", \"Fetal histology subtype\", \"PRETEXT stage II\"],\n        \"rationale\": \"The report describes a large heterogeneous hepatic mass, elevated AFP, and a fetal histology subtype, all suggestive of hepatoblastoma. The PRETEXT stage also indicates a certain stage of the cancer. The report concludes with a recommendation for MDT discussion and treatment planning, further supporting the suspicion of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous hepatic mass\", \"elevated AFP\", \"Fetal histology subtype\", \"PRETEXT stage II\"],\n        \"rationale\": \"The report describes a large heterogeneous hepatic mass, elevated AFP, and a fetal histology subtype, all suggestive of hepatoblastoma. The PRETEXT stage also indicates a certain stage of the cancer. The report concludes with a recommendation for MDT discussion and treatment planning, further supporting the suspicion of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous hepatic mass\", \"elevated AFP\", \"Fetal histology subtype\", \"PRETEXT stage II\"],\n        \"rationale\": \"The report describes a large heterogeneous hepatic mass, elevated AFP, and a fetal histology subtype, all suggestive of hepatoblastoma. The PRETEXT stage also indicates a certain stage of the cancer. The report concludes with a recommendation for MDT discussion and",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes a large heterogeneous hepatic mass, elevated AFP, and a fetal histology subtype, all suggestive of hepatoblastoma. The PRETEXT stage also indicates a certain stage of the cancer. The report concludes with a recommendation for MDT discussion and treatment planning, further supporting the suspicion of malignancy.",
      "findings": [
        "large heterogeneous hepatic mass",
        "elevated AFP",
        "Fetal histology subtype",
        "PRETEXT stage II"
      ],
      "fracture_mentioned": null,
      "idx": 86,
      "timestamp": "2026-01-09T15:19:56.112676"
    },
    {
      "sample_idx": 87,
      "input": "16/12/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Abnormal imaging. Suspected Acute Myeloid Leukemia.\n\nFrom clinical notes: Acute Myeloid Leukemia. Paediatric oncology assessment.\n\nFindings: myeloblasts accounting for 70% of marrow cellularity. Cytogenetic analysis reveals t(8;21) translocation. Favorable risk category. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 16/12/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"myeloblasts accounting for 70% of marrow cellularity\", \"t(8;21) translocation\"],\n        \"rationale\": \"The report states that myeloblasts account for 70% of marrow cellularity, indicating a diagnosis of acute myeloid leukemia. The presence of t(8;21) translocation is also consistent with AML. Therefore, malignancy is confirmed.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"myeloblasts accounting for 70% of marrow cellularity\", \"t(8;21) translocation\"],\n        \"rationale\": \"The report indicates a high percentage of myeloblasts in the bone marrow (70%), which is a hallmark of acute myeloid leukemia (AML). The presence of t(8;21) translocation is a specific cytogenetic abnormality commonly associated with AML. Therefore, the findings strongly suggest malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"myeloblasts accounting for 70% of marrow cellularity\", \"t(8;21) translocation\"],\n        \"rationale\": \"The report details a high percentage of myeloblasts in the bone marrow (70%), which is indicative of acute myeloid leukemia (AML). The presence of the t(8;21) translocation is a specific genetic abnormality strongly associated with AML. These findings together confirm the presence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"myeloblasts accounting for 70% of marrow cellularity\", \"t(8;21) translocation\"],\n        \"rationale\": \"The report states that myeloblasts account for 70% of marrow cellularity, which is diagnostic for acute myeloid leukemia (AML). The t(8;21) translocation is a specific genetic abnormality commonly found in AML. The presence of both findings indicates malignancy.\"",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report states that myeloblasts account for 70% of marrow cellularity, indicating a diagnosis of acute myeloid leukemia. The presence of t(8;21) translocation is also consistent with AML. Therefore, malignancy is confirmed.",
      "findings": [
        "myeloblasts accounting for 70% of marrow cellularity",
        "t(8;21) translocation"
      ],
      "fracture_mentioned": null,
      "idx": 87,
      "timestamp": "2026-01-09T15:19:56.112687"
    },
    {
      "sample_idx": 88,
      "input": "29/05/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Wilms Tumor.\n\nFrom clinical notes: Wilms Tumor. Paediatric oncology assessment.\n\nFindings: large heterogeneous left renal mass with pseudocapsule. No vascular invasion. Favorable histology on biopsy. Stage II. Recommend MDT discussion and treatment planning.\n\nDr James Chen, Consultant Paediatric Oncologist 29/05/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"no vascular invasion\", \"favorable histology on biopsy\", \"stage II\"],\n        \"rationale\": \"The report describes a left renal mass with a pseudocapsule, no vascular invasion, favorable histology, and stage II. This indicates the presence of a renal tumor, likely Wilms Tumor, which is a type of kidney cancer. The presence of a renal mass with the described characteristics is considered malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal renal function\", \"no evidence of metastatic disease\", \"normal blood counts\"],\n        \"rationale\": \"The report shows normal renal function, no evidence of metastatic disease, and normal blood counts. This indicates that there is no malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"lymphoblasts 85% of marrow\", \"B-cell ALL immunophenotype\", \"bone marrow infiltration\"],\n        \"rationale\": \"The report explicitly identifies bone marrow infiltration with lymphoblasts and immunophenotyping consistent with acute lymphoblastic leukemia, confirming malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC\", \"age-appropriate values\", \"no blast cells\"],\n        \"rationale\": \"The report shows normal blood counts with no atypical or malignant cells. No evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"no vascular invasion\", \"favorable histology on biopsy\", \"stage II\"],\n        \"rationale\": \"The report describes a left renal mass with a pseudocapsule, no vascular invasion, favorable histology, and stage II. This indicates the presence of a renal",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes a left renal mass with a pseudocapsule, no vascular invasion, favorable histology, and stage II. This indicates the presence of a renal tumor, likely Wilms Tumor, which is a type of kidney cancer. The presence of a renal mass with the described characteristics is considered malignancy.",
      "findings": [
        "large heterogeneous left renal mass with pseudocapsule",
        "no vascular invasion",
        "favorable histology on biopsy",
        "stage II"
      ],
      "fracture_mentioned": null,
      "idx": 88,
      "timestamp": "2026-01-09T15:19:56.112700"
    },
    {
      "sample_idx": 89,
      "input": "16/01/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Acute Lymphoblastic Leukemia.\n\nFrom clinical notes: Acute Lymphoblastic Leukemia. Paediatric oncology assessment.\n\nFindings: bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells. Immunophenotyping consistent with B-cell ALL. CNS involvement negative. Recommend MDT discussion and treatment planning.\n\nDr James Chen, Consultant Paediatric Oncologist 16/01/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells\", \"Immunophenotyping consistent with B-cell ALL\"],\n        \"rationale\": \"The report explicitly states bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells and confirms the presence of B-cell ALL based on immunophenotyping, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells\", \"Immunophenotyping consistent with B-cell ALL\"],\n        \"rationale\": \"The report explicitly states bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells and confirms the presence of B-cell ALL based on immunophenotyping, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells\", \"Immunophenotyping consistent with B-cell ALL\"],\n        \"rationale\": \"The report explicitly states bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells and confirms the presence of B-cell ALL based on immunophenotyping, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells\", \"Immunophenotyping consistent with B-cell ALL\"],\n        \"rationale\": \"The report explicitly states bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells and confirms the presence of B-cell ALL based on immunophenotyping, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"bone marrow infiltration with lymphoblasts comprising 85% of nucleated",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly states bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells and confirms the presence of B-cell ALL based on immunophenotyping, indicating malignancy.",
      "findings": [
        "bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells",
        "Immunophenotyping consistent with B-cell ALL"
      ],
      "fracture_mentioned": null,
      "idx": 89,
      "timestamp": "2026-01-09T15:19:56.112712"
    },
    {
      "sample_idx": 90,
      "input": "06/09/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Retinoblastoma.\n\nFrom clinical notes: Retinoblastoma. Paediatric oncology assessment.\n\nFindings: intraocular mass with calcifications. Bilateral disease. Family history positive. RB1 germline mutation detected. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 06/09/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"intraocular mass with calcifications\", \"bilateral disease\", \"family history positive\", \"RB1 germline mutation detected\"],\n        \"rationale\": \"The report describes an intraocular mass with calcifications, bilateral disease, a positive family history, and the detection of an RB1 germline mutation, all strongly suggestive of retinoblastoma, a malignant tumor.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"intraocular mass with calcifications\", \"bilateral disease\", \"family history positive\", \"RB1 germline mutation detected\"],\n        \"rationale\": \"The report describes an intraocular mass with calcifications, bilateral disease, a positive family history, and the detection of an RB1 germline mutation, all strongly suggestive of retinoblastoma, a malignant tumor.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"intraocular mass with calcifications\", \"bilateral disease\", \"family history positive\", \"RB1 germline mutation detected\"],\n        \"rationale\": \"The report describes an intraocular mass with calcifications, bilateral disease, a positive family history, and the detection of an RB1 germline mutation, all strongly suggestive of retinoblastoma, a malignant tumor.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"intraocular mass with calcifications\", \"bilateral disease\", \"family history positive\", \"RB1 germline mutation detected\"],\n        \"rationale\": \"The report describes an intraocular mass with calcifications, bilateral disease, a positive family history, and the detection of an RB1 germline mutation, all strongly suggestive of retinoblastoma, a malignant tumor.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"intraocular",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes an intraocular mass with calcifications, bilateral disease, a positive family history, and the detection of an RB1 germline mutation, all strongly suggestive of retinoblastoma, a malignant tumor.",
      "findings": [
        "intraocular mass with calcifications",
        "bilateral disease",
        "family history positive",
        "RB1 germline mutation detected"
      ],
      "fracture_mentioned": null,
      "idx": 90,
      "timestamp": "2026-01-09T15:19:56.112723"
    },
    {
      "sample_idx": 91,
      "input": "30/01/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Healing fracture - normal process. No pathological features. Bone density normal. Trauma history consistent. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 30/01/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"healing fracture\", \"normal bone density\", \"no pathological features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no pathological features or malignancy were identified. The healing fracture and normal bone density further support this conclusion.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"healing fracture\", \"normal bone density\", \"no pathological features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no pathological features or malignancy were identified. The healing fracture and normal bone density further support this conclusion.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"healing fracture\", \"normal bone density\", \"no pathological features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no pathological features or malignancy were identified. The healing fracture and normal bone density further support this conclusion.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"healing fracture\", \"normal bone density\", \"no pathological features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no pathological features or malignancy were identified. The healing fracture and normal bone density further support this conclusion.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"healing fracture\", \"normal bone density\", \"no pathological features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no pathological features or malignancy were identified. The healing fracture and normal bone density further support this conclusion.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"healing fracture\", \"normal bone",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states that no pathological features or malignancy were identified. The healing fracture and normal bone density further support this conclusion.",
      "findings": [
        "healing fracture",
        "normal bone density",
        "no pathological features",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 91,
      "timestamp": "2026-01-09T15:19:56.112734"
    },
    {
      "sample_idx": 92,
      "input": "22/05/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Benign bone cyst - resolved. No aggressive features. Normal bone density. No recurrence on imaging. No malignancy identified. Reassurance provided.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 22/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Benign bone cyst - resolved\", \"No aggressive features\", \"Normal bone density\", \"No recurrence on imaging\", \"No malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no malignancy is identified and that the bone cyst has resolved. This indicates no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Benign bone cyst - resolved\", \"No aggressive features\", \"Normal bone density\", \"No recurrence on imaging\", \"No malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no malignancy is identified and that the bone cyst has resolved. This indicates no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Benign bone cyst - resolved\", \"No aggressive features\", \"Normal bone density\", \"No recurrence on imaging\", \"No malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no malignancy is identified and that the bone cyst has resolved. This indicates no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Benign bone cyst - resolved\", \"No aggressive features\", \"Normal bone density\", \"No recurrence on imaging\", \"No malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no malignancy is identified and that the bone cyst has resolved. This indicates no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Benign bone cyst - resolved\", \"No aggressive features\", \"Normal bone density\", \"No recurrence on imaging\", \"No malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no malignancy is identified and that the bone cyst has resolved. This indicates no evidence of malignancy.\"\n    }\n}",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states that no malignancy is identified and that the bone cyst has resolved. This indicates no evidence of malignancy.",
      "findings": [
        "Benign bone cyst - resolved",
        "No aggressive features",
        "Normal bone density",
        "No recurrence on imaging",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 92,
      "timestamp": "2026-01-09T15:19:56.112745"
    },
    {
      "sample_idx": 93,
      "input": "04/02/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Healing fracture - normal process. No pathological features. Bone density normal. Trauma history consistent. No malignancy identified. Reassurance provided.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 04/02/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"healing fracture\", \"normal bone density\", \"no pathological features\", \"no malignancy identified\"],\n        \"rationale\": \"The report describes a healing fracture with normal bone density and no pathological features. It explicitly states that no malignancy was identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no abnormal findings\", \"no evidence of malignancy\"],\n        \"rationale\": \"The report indicates the absence of abnormal findings and no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no evidence of malignancy\", \"no abnormal findings\"],\n        \"rationale\": \"The report explicitly states there is no evidence of malignancy and no abnormal findings.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no evidence of malignancy\", \"no abnormal findings\"],\n        \"rationale\": \"The report indicates no evidence of malignancy and no abnormal findings.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no evidence of malignancy\", \"no abnormal findings\"],\n        \"rationale\": \"The report explicitly states there is no evidence of malignancy and no abnormal findings.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no evidence of malignancy\", \"no abnormal findings\"],\n        \"rationale\": \"The report indicates no evidence of malignancy and no abnormal findings.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no evidence of malignancy\", \"no abnormal findings\"],",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report describes a healing fracture with normal bone density and no pathological features. It explicitly states that no malignancy was identified.",
      "findings": [
        "healing fracture",
        "normal bone density",
        "no pathological features",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 93,
      "timestamp": "2026-01-09T15:19:56.112756"
    },
    {
      "sample_idx": 94,
      "input": "05/08/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Normal brain MRI for age. No mass lesion. No abnormal enhancement. Headaches attributed to migraine. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 05/08/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal brain MRI\", \"No mass lesion\", \"No abnormal enhancement\", \"Headaches attributed to migraine\", \"No malignancy identified\"],\n        \"rationale\": \"The report explicitly states that the brain MRI is normal, and no mass lesion or abnormal enhancement is present. The headaches are attributed to migraine, and no malignancy is identified. Therefore, no malignancy is present.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal brain MRI\", \"No mass lesion\", \"No abnormal enhancement\", \"Headaches attributed to migraine\", \"No malignancy identified\"],\n        \"rationale\": \"The report explicitly states that the brain MRI is normal, and no mass lesion or abnormal enhancement is present. The headaches are attributed to migraine, and no malignancy is identified. Therefore, no malignancy is present.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal brain MRI\", \"No mass lesion\", \"No abnormal enhancement\", \"Headaches attributed to migraine\", \"No malignancy identified\"],\n        \"rationale\": \"The report explicitly states that the brain MRI is normal, and no mass lesion or abnormal enhancement is present. The headaches are attributed to migraine, and no malignancy is identified. Therefore, no malignancy is present.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal brain MRI\", \"No mass lesion\", \"No abnormal enhancement\", \"Headaches attributed to migraine\", \"No malignancy identified\"],\n        \"rationale\": \"The report explicitly states that the brain MRI is normal, and no mass lesion or abnormal enhancement is present. The headaches are attributed to migraine, and no malignancy is identified. Therefore, no malignancy is present.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal brain MRI\",",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states that the brain MRI is normal, and no mass lesion or abnormal enhancement is present. The headaches are attributed to migraine, and no malignancy is identified. Therefore, no malignancy is present.",
      "findings": [
        "Normal brain MRI",
        "No mass lesion",
        "No abnormal enhancement",
        "Headaches attributed to migraine",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 94,
      "timestamp": "2026-01-09T15:19:56.112768"
    },
    {
      "sample_idx": 95,
      "input": "10/03/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Healing fracture - normal process. No pathological features. Bone density normal. Trauma history consistent. No malignancy identified. Reassurance provided.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 10/03/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"healing fracture\", \"normal bone density\", \"no pathological features\"],\n        \"rationale\": \"The report states that there is a healing fracture, normal bone density, and no pathological features. The report also explicitly states that no malignancy was identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no pathological features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that there are no pathological features and that no malignancy was identified. Therefore, there are no abnormal findings suggesting malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no pathological features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that there are no pathological features and that no malignancy was identified. Therefore, there are no abnormal findings suggesting malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no pathological features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that there are no pathological features and that no malignancy was identified. Therefore, there are no abnormal findings suggesting malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no pathological features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that there are no pathological features and that no malignancy was identified. Therefore, there are no abnormal findings suggesting malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no pathological features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that there are no pathological features and that no malignancy was identified. Therefore",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report states that there is a healing fracture, normal bone density, and no pathological features. The report also explicitly states that no malignancy was identified.",
      "findings": [
        "healing fracture",
        "normal bone density",
        "no pathological features"
      ],
      "fracture_mentioned": null,
      "idx": 95,
      "timestamp": "2026-01-09T15:19:56.112778"
    },
    {
      "sample_idx": 96,
      "input": "28/09/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Hodgkin Lymphoma.\n\nFrom clinical notes: Hodgkin Lymphoma. Paediatric oncology assessment.\n\nFindings: mediastinal lymphadenopathy with bulky anterior mediastinal mass. PET-CT showing FDG-avid nodes. Classical Hodgkin, nodular sclerosing type. Recommend MDT discussion and treatment planning.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 28/09/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"bulky anterior mediastinal mass\", \"FDG-avid nodes\", \"Classical Hodgkin, nodular sclerosing type\"],\n        \"rationale\": \"The report describes mediastinal lymphadenopathy, a bulky anterior mediastinal mass, FDG-avid nodes, and the diagnosis of Classical Hodgkin Lymphoma, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"Hodgkin Lymphoma\", \"nodular sclerosing type\"],\n        \"rationale\": \"The report explicitly states Hodgkin Lymphoma, and the specific subtype nodular sclerosing, confirming malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"FDG-avid nodes\"],\n        \"rationale\": \"The report mentions FDG-avid nodes, which are indicative of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"bulky anterior mediastinal mass\"],\n        \"rationale\": \"The report mentions a bulky anterior mediastinal mass, which is indicative of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\"],\n        \"rationale\": \"The report mentions mediastinal lymphadenopathy, which is indicative of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"Hodgkin Lymphoma\"],\n        \"rationale\": \"The report explicitly states Hodgkin Lymphoma, confirming malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\":",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes mediastinal lymphadenopathy, a bulky anterior mediastinal mass, FDG-avid nodes, and the diagnosis of Classical Hodgkin Lymphoma, indicating malignancy.",
      "findings": [
        "mediastinal lymphadenopathy",
        "bulky anterior mediastinal mass",
        "FDG-avid nodes",
        "Classical Hodgkin, nodular sclerosing type"
      ],
      "fracture_mentioned": null,
      "idx": 96,
      "timestamp": "2026-01-09T15:19:56.112790"
    },
    {
      "sample_idx": 97,
      "input": "02/01/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Bone pain. Suspected Brain Tumor - Glioma.\n\nFrom clinical notes: Brain Tumor - Glioma. Paediatric oncology assessment.\n\nFindings: left temporal lobe infiltrative mass with mass effect. FLAIR hyperintensity. Biopsy confirms diffuse astrocytoma WHO grade II. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 02/01/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"left temporal lobe infiltrative mass with mass effect\", \"FLAIR hyperintensity\", \"Biopsy confirms diffuse astrocytoma WHO grade II\"],\n        \"rationale\": \"The report describes a brain tumor, specifically a diffuse astrocytoma (WHO grade II), confirmed by biopsy. This indicates malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"left temporal lobe infiltrative mass with mass effect\", \"FLAIR hyperintensity\", \"Biopsy confirms diffuse astrocytoma WHO grade II\"],\n        \"rationale\": \"The report describes a brain tumor, specifically a diffuse astrocytoma (WHO grade II), confirmed by biopsy. This indicates malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"left temporal lobe infiltrative mass with mass effect\", \"FLAIR hyperintensity\", \"Biopsy confirms diffuse astrocytoma WHO grade II\"],\n        \"rationale\": \"The report describes a brain tumor, specifically a diffuse astrocytoma (WHO grade II), confirmed by biopsy. This indicates malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"left temporal lobe infiltrative mass with mass effect\", \"FLAIR hyperintensity\", \"Biopsy confirms diffuse astrocytoma WHO grade II\"],\n        \"rationale\": \"The report describes a brain tumor, specifically a diffuse astrocytoma (WHO grade II), confirmed by biopsy. This indicates malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"left temporal lobe infiltrative mass with mass effect\", \"FLAIR hyperintensity\", \"Biopsy confirms diffuse astrocytoma WHO grade II\"],\n        \"rationale\": \"The report describes a brain tumor, specifically a diffuse",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes a brain tumor, specifically a diffuse astrocytoma (WHO grade II), confirmed by biopsy. This indicates malignancy.",
      "findings": [
        "left temporal lobe infiltrative mass with mass effect",
        "FLAIR hyperintensity",
        "Biopsy confirms diffuse astrocytoma WHO grade II"
      ],
      "fracture_mentioned": null,
      "idx": 97,
      "timestamp": "2026-01-09T15:19:56.112800"
    },
    {
      "sample_idx": 98,
      "input": "29/06/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Follow-up post-treatment. No previous oncology history.\n\nFindings: Normal CBC with age-appropriate values. No blast cells. Platelets adequate. Hemoglobin within normal limits. No malignancy identified. Reassurance provided.\n\nDr James Chen, Consultant Paediatric Oncologist 29/06/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC\", \"no blast cells\", \"no malignancy identified\"],\n        \"rationale\": \"The report states that the CBC is normal, there are no blast cells, and no malignancy is identified. These findings indicate the absence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC\", \"no blast cells\", \"no malignancy identified\"],\n        \"rationale\": \"The report states that the CBC is normal, there are no blast cells, and no malignancy is identified. These findings indicate the absence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC\", \"no blast cells\", \"no malignancy identified\"],\n        \"rationale\": \"The report states that the CBC is normal, there are no blast cells, and no malignancy is identified. These findings indicate the absence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC\", \"no blast cells\", \"no malignancy identified\"],\n        \"rationale\": \"The report states that the CBC is normal, there are no blast cells, and no malignancy is identified. These findings indicate the absence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC\", \"no blast cells\", \"no malignancy identified\"],\n        \"rationale\": \"The report states that the CBC is normal, there are no blast cells, and no malignancy is identified. These findings indicate the absence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC\", \"no blast cells\", \"",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report states that the CBC is normal, there are no blast cells, and no malignancy is identified. These findings indicate the absence of malignancy.",
      "findings": [
        "normal CBC",
        "no blast cells",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 98,
      "timestamp": "2026-01-09T15:19:56.112810"
    },
    {
      "sample_idx": 99,
      "input": "21/03/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Hodgkin Lymphoma.\n\nFrom clinical notes: Hodgkin Lymphoma. Paediatric oncology assessment.\n\nFindings: mediastinal lymphadenopathy with bulky anterior mediastinal mass. PET-CT showing FDG-avid nodes. Classical Hodgkin, nodular sclerosing type. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 21/03/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"bulky anterior mediastinal mass\", \"FDG-avid nodes\", \"Classical Hodgkin, nodular sclerosing type\"],\n        \"rationale\": \"The report explicitly describes mediastinal lymphadenopathy, a bulky anterior mediastinal mass, FDG-avid nodes, and confirms the diagnosis of Classical Hodgkin Lymphoma with nodular sclerosing type, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"bulky anterior mediastinal mass\", \"FDG-avid nodes\", \"Classical Hodgkin, nodular sclerosing type\"],\n        \"rationale\": \"The report explicitly describes mediastinal lymphadenopathy, a bulky anterior mediastinal mass, FDG-avid nodes, and confirms the diagnosis of Classical Hodgkin Lymphoma with nodular sclerosing type, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"bulky anterior mediastinal mass\", \"FDG-avid nodes\", \"Classical Hodgkin, nodular sclerosing type\"],\n        \"rationale\": \"The report explicitly describes mediastinal lymphadenopathy, a bulky anterior mediastinal mass, FDG-avid nodes, and confirms the diagnosis of Classical Hodgkin Lymphoma with nodular sclerosing type, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"bulky anterior mediastinal mass\", \"FDG-avid nodes\", \"Classical Hodgkin, nodular sclerosing type\"],\n        \"rationale\": \"The report explicitly describes mediastinal lymphadenopathy, a bulky anterior mediastinal mass, FDG-avid nodes, and confirms the diagnosis of Classical Hodgkin Lymphoma with nodular sclerosing type, indicating malignancy.\"\n    }\n}\n```\n```json",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly describes mediastinal lymphadenopathy, a bulky anterior mediastinal mass, FDG-avid nodes, and confirms the diagnosis of Classical Hodgkin Lymphoma with nodular sclerosing type, indicating malignancy.",
      "findings": [
        "mediastinal lymphadenopathy",
        "bulky anterior mediastinal mass",
        "FDG-avid nodes",
        "Classical Hodgkin, nodular sclerosing type"
      ],
      "fracture_mentioned": null,
      "idx": 99,
      "timestamp": "2026-01-09T15:19:56.112822"
    }
  ],
  "num_samples": 100,
  "samples": [
    {
      "sample_idx": 0,
      "input": "02/01/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Resolved febrile illness. Blood counts normalized. No organomegaly. Clinical improvement noted. No malignancy identified. Reassurance provided.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 02/01/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"resolved febrile illness\", \"blood counts normalized\", \"no organomegaly\", \"no malignancy identified\"],\n        \"rationale\": \"The report indicates a resolved febrile illness, normalized blood counts, absence of organomegaly, and no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Resolved febrile illness\", \"Blood counts normalized\", \"No organomegaly\", \"No malignancy identified\"],\n        \"rationale\": \"The report mentions the resolution of a febrile illness, normalized blood counts, absence of organomegaly, and the absence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Resolved febrile illness\", \"Blood counts normalized\", \"No organomegaly\", \"No malignancy identified\"],\n        \"rationale\": \"The report shows a resolved febrile illness, normalized blood counts, no organomegaly, and no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Resolved febrile illness\", \"Blood counts normalized\", \"No organomegaly\", \"No malignancy identified\"],\n        \"rationale\": \"The report shows a resolved febrile illness, normalized blood counts, no organomegaly, and no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Resolved febrile illness\", \"Blood counts normalized\", \"No organomegaly\", \"No malignancy identified\"],\n        \"rationale\": \"The report shows a resolved febrile illness, normalized blood counts, no organomegaly, and no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report indicates a resolved febrile illness, normalized blood counts, absence of organomegaly, and no evidence of malignancy.",
      "findings": [
        "resolved febrile illness",
        "blood counts normalized",
        "no organomegaly",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 0,
      "timestamp": "2026-01-09T15:19:56.111645"
    },
    {
      "sample_idx": 1,
      "input": "26/10/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Brain Tumor - Medulloblastoma.\n\nFrom clinical notes: Brain Tumor - Medulloblastoma. Paediatric oncology assessment.\n\nFindings: posterior fossa mass with enhancement and hydrocephalus. Restricted diffusion. High-grade medulloblastoma on histology. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 26/10/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"posterior fossa mass with enhancement and hydrocephalus\", \"Restricted diffusion\", \"High-grade medulloblastoma on histology\"],\n        \"rationale\": \"The report mentions a posterior fossa mass with enhancement and hydrocephalus, along with restricted diffusion, which are indicative of a brain tumor. Histology confirms a high-grade medulloblastoma, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"posterior fossa mass with enhancement and hydrocephalus\", \"Restricted diffusion\", \"High-grade medulloblastoma on histology\"],\n        \"rationale\": \"The report mentions a posterior fossa mass with enhancement and hydrocephalus, along with restricted diffusion, which are indicative of a brain tumor. Histology confirms a high-grade medulloblastoma, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"posterior fossa mass with enhancement and hydrocephalus\", \"Restricted diffusion\", \"High-grade medulloblastoma on histology\"],\n        \"rationale\": \"The report mentions a posterior fossa mass with enhancement and hydrocephalus, along with restricted diffusion, which are indicative of a brain tumor. Histology confirms a high-grade medulloblastoma, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"posterior fossa mass with enhancement and hydrocephalus\", \"Restricted diffusion\", \"High-grade medulloblastoma on histology\"],\n        \"rationale\": \"The report mentions a posterior fossa mass with enhancement and hydrocephalus, along with restricted diffusion, which are indicative of a brain tumor. Histology confirms a high-grade medulloblastoma, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"posterior fossa mass with enhancement and hydrocephalus\", \"Restricted diffusion\",",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report mentions a posterior fossa mass with enhancement and hydrocephalus, along with restricted diffusion, which are indicative of a brain tumor. Histology confirms a high-grade medulloblastoma, indicating malignancy.",
      "findings": [
        "posterior fossa mass with enhancement and hydrocephalus",
        "Restricted diffusion",
        "High-grade medulloblastoma on histology"
      ],
      "fracture_mentioned": null,
      "idx": 1,
      "timestamp": "2026-01-09T15:19:56.111669"
    },
    {
      "sample_idx": 2,
      "input": "03/07/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Follow-up post-treatment. No previous oncology history.\n\nFindings: Reactive lymphadenopathy secondary to viral infection. Node size decreasing on follow-up. No atypical features. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 03/07/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report mentions reactive lymphadenopathy, which is a benign finding. The report explicitly states that no atypical features or malignancy were identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\"],\n        \"rationale\": \"The report explicitly states reactive lymphadenopathy, which is a benign finding.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly mentions reactive lymphadenopathy, which is a benign finding. The report also states that no atypical features or malignancy were identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\"],\n        \"rationale\": \"The report explicitly mentions reactive lymphadenopathy, which is a benign finding.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly mentions reactive lymphadenopathy, which is a benign finding. The report also states that no atypical features or malignancy were identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\"],\n        \"rationale\": \"The report explicitly mentions reactive lymphadenopathy, which is a benign finding.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malign",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report mentions reactive lymphadenopathy, which is a benign finding. The report explicitly states that no atypical features or malignancy were identified.",
      "findings": [
        "reactive lymphadenopathy",
        "no atypical features",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 2,
      "timestamp": "2026-01-09T15:19:56.111683"
    },
    {
      "sample_idx": 3,
      "input": "27/02/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Non-Hodgkin Lymphoma.\n\nFrom clinical notes: Non-Hodgkin Lymphoma. Paediatric oncology assessment.\n\nFindings: abdominal lymphadenopathy with mesenteric and retroperitoneal nodes. Burkitt lymphoma confirmed on biopsy. High LDH levels. Recommend MDT discussion and treatment planning.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 27/02/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"abdominal lymphadenopathy\", \"Burkitt lymphoma confirmed on biopsy\", \"high LDH levels\"],\n        \"rationale\": \"The report mentions abdominal lymphadenopathy, confirms Burkitt lymphoma on biopsy, and reports elevated LDH levels, all of which are indicative of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"abdominal lymphadenopathy\", \"Burkitt lymphoma confirmed on biopsy\", \"high LDH levels\"],\n        \"rationale\": \"The report mentions abdominal lymphadenopathy, confirms Burkitt lymphoma on biopsy, and reports elevated LDH levels, all of which are indicative of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"abdominal lymphadenopathy\", \"Burkitt lymphoma confirmed on biopsy\", \"high LDH levels\"],\n        \"rationale\": \"The report mentions abdominal lymphadenopathy, confirms Burkitt lymphoma on biopsy, and reports elevated LDH levels, all of which are indicative of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"abdominal lymphadenopathy\", \"Burkitt lymphoma confirmed on biopsy\", \"high LDH levels\"],\n        \"rationale\": \"The report mentions abdominal lymphadenopathy, confirms Burkitt lymphoma on biopsy, and reports elevated LDH levels, all of which are indicative of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"abdominal lymphadenopathy\", \"Burkitt lymphoma confirmed on biopsy\", \"high LDH levels\"],\n        \"rationale\": \"The report mentions abdominal lymphadenopathy, confirms Burkitt lymphoma on biopsy, and reports elevated LDH levels, all of which are indicative of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\":",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report mentions abdominal lymphadenopathy, confirms Burkitt lymphoma on biopsy, and reports elevated LDH levels, all of which are indicative of malignancy.",
      "findings": [
        "abdominal lymphadenopathy",
        "Burkitt lymphoma confirmed on biopsy",
        "high LDH levels"
      ],
      "fracture_mentioned": null,
      "idx": 3,
      "timestamp": "2026-01-09T15:19:56.111695"
    },
    {
      "sample_idx": 4,
      "input": "04/05/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Acute Lymphoblastic Leukemia.\n\nFrom clinical notes: Acute Lymphoblastic Leukemia. Paediatric oncology assessment.\n\nFindings: bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells. Immunophenotyping consistent with B-cell ALL. CNS involvement negative. Recommend MDT discussion and treatment planning.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 04/05/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells\", \"Immunophenotyping consistent with B-cell ALL\"],\n        \"rationale\": \"The report explicitly states bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells and immunophenotyping consistent with B-cell ALL, confirming malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells\", \"Immunophenotyping consistent with B-cell ALL\"],\n        \"rationale\": \"The report explicitly states bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells and immunophenotyping consistent with B-cell ALL, confirming malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells\", \"Immunophenotyping consistent with B-cell ALL\"],\n        \"rationale\": \"The report explicitly states bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells and immunophenotyping consistent with B-cell ALL, confirming malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells\", \"Immunophenotyping consistent with B-cell ALL\"],\n        \"rationale\": \"The report explicitly states bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells and immunophenotyping consistent with B-cell ALL, confirming malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells\", \"Immunophenotyping consistent with B-cell ALL\"],\n        \"",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly states bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells and immunophenotyping consistent with B-cell ALL, confirming malignancy.",
      "findings": [
        "bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells",
        "Immunophenotyping consistent with B-cell ALL"
      ],
      "fracture_mentioned": null,
      "idx": 4,
      "timestamp": "2026-01-09T15:19:56.111707"
    },
    {
      "sample_idx": 5,
      "input": "17/09/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Reactive lymphadenopathy secondary to viral infection. Node size decreasing on follow-up. No atypical features. No malignancy identified. Reassurance provided.\n\nDr James Chen, Consultant Paediatric Oncologist 17/09/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly mentions reactive lymphadenopathy, indicating a benign process, and confirms the absence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly mentions reactive lymphadenopathy, indicating a benign process, and confirms the absence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly mentions reactive lymphadenopathy, indicating a benign process, and confirms the absence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly mentions reactive lymphadenopathy, indicating a benign process, and confirms the absence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly mentions reactive lymphadenopathy, indicating a benign process, and confirms the absence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly mentions reactive lymphadenopathy, indicating a benign process, and confirms the absence of",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly mentions reactive lymphadenopathy, indicating a benign process, and confirms the absence of malignancy.",
      "findings": [
        "reactive lymphadenopathy",
        "no atypical features",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 5,
      "timestamp": "2026-01-09T15:19:56.111718"
    },
    {
      "sample_idx": 6,
      "input": "11/07/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Lymphadenopathy. Suspected Neuroblastoma.\n\nFrom clinical notes: Neuroblastoma. Paediatric oncology assessment.\n\nFindings: large heterogeneous suprarenal mass with calcifications. MIBG avidity present. Elevated urinary catecholamines. Stage III disease. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 11/07/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"elevated urinary catecholamines\", \"Stage III disease\"],\n        \"rationale\": \"The report describes a suprarenal mass with calcifications, MIBG avidity, and elevated urinary catecholamines, suggestive of neuroblastoma. The stage III diagnosis further supports the presence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"elevated urinary catecholamines\", \"Stage III disease\"],\n        \"rationale\": \"The report describes a suprarenal mass with calcifications, MIBG avidity, and elevated urinary catecholamines, suggestive of neuroblastoma. The stage III diagnosis further supports the presence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"elevated urinary catecholamines\", \"Stage III disease\"],\n        \"rationale\": \"The report describes a suprarenal mass with calcifications, MIBG avidity, and elevated urinary catecholamines, suggestive of neuroblastoma. The stage III diagnosis further supports the presence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"elevated urinary catecholamines\", \"Stage III disease\"],\n        \"rationale\": \"The report describes a suprarenal mass with calcifications, MIBG avidity, and elevated urinary catecholamines, suggestive of neuroblastoma. The stage III diagnosis further supports the presence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes a suprarenal mass with calcifications, MIBG avidity, and elevated urinary catecholamines, suggestive of neuroblastoma. The stage III diagnosis further supports the presence of malignancy.",
      "findings": [
        "large heterogeneous suprarenal mass with calcifications",
        "MIBG avidity present",
        "elevated urinary catecholamines",
        "Stage III disease"
      ],
      "fracture_mentioned": null,
      "idx": 6,
      "timestamp": "2026-01-09T15:19:56.111731"
    },
    {
      "sample_idx": 7,
      "input": "21/03/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Normal chest radiograph. Clear lung fields. No mediastinal mass. Heart size normal. No malignancy identified. Reassurance provided.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 21/03/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no malignancy was identified, and the chest radiograph, lung fields, mediastinum, and heart size are all normal. Therefore, no malignancy is present.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no malignancy was identified, and the chest radiograph, lung fields, mediastinum, and heart size are all normal. Therefore, no malignancy is present.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no malignancy was identified, and the chest radiograph, lung fields, mediastinum, and heart size are all normal. Therefore, no malignancy is present.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no malignancy was identified, and the chest radiograph, lung fields, mediastinum, and heart size are all normal. Therefore, no malignancy is present.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states that no malignancy was identified, and the chest radiograph, lung fields, mediastinum, and heart size are all normal. Therefore, no malignancy is present.",
      "findings": [
        "normal chest radiograph",
        "clear lung fields",
        "no mediastinal mass",
        "heart size normal",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 7,
      "timestamp": "2026-01-09T15:19:56.111752"
    },
    {
      "sample_idx": 8,
      "input": "08/02/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Normal CBC with age-appropriate values. No blast cells. Platelets adequate. Hemoglobin within normal limits. No malignancy identified. Reassurance provided.\n\nDr James Chen, Consultant Paediatric Oncologist 08/02/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC\", \"age-appropriate values\", \"no blast cells\", \"platelets adequate\", \"hemoglobin within normal limits\", \"no malignancy identified\", \"reassurance provided\"],\n        \"rationale\": \"The report indicates normal blood counts, no blast cells, and no malignancy identified. The physician provides reassurance.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC\", \"age-appropriate values\", \"no blast cells\", \"platelets adequate\", \"hemoglobin within normal limits\", \"no malignancy identified\", \"reassurance provided\"],\n        \"rationale\": \"The report indicates normal blood counts, no blast cells, and no malignancy identified. The physician provides reassurance.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC\", \"age-appropriate values\", \"no blast cells\", \"platelets adequate\", \"hemoglobin within normal limits\", \"no malignancy identified\", \"reassurance provided\"],\n        \"rationale\": \"The report indicates normal blood counts, no blast cells, and no malignancy identified. The physician provides reassurance.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC\", \"age-appropriate values\", \"no blast cells\", \"platelets adequate\", \"hemoglobin within normal limits\", \"no malignancy identified\", \"reassurance provided\"],\n        \"rationale\": \"The report indicates normal blood counts, no blast cells, and no malignancy identified. The physician provides reassurance.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC\", \"age-appropriate values\", \"no blast cells\", \"platelets adequate\", \"hemoglobin within normal limits\", \"no malignancy identified\", \"reassurance provided\"],\n        \"rationale\": \"The",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report indicates normal blood counts, no blast cells, and no malignancy identified. The physician provides reassurance.",
      "findings": [
        "normal CBC",
        "age-appropriate values",
        "no blast cells",
        "platelets adequate",
        "hemoglobin within normal limits",
        "no malignancy identified",
        "reassurance provided"
      ],
      "fracture_mentioned": null,
      "idx": 8,
      "timestamp": "2026-01-09T15:19:56.111765"
    },
    {
      "sample_idx": 9,
      "input": "25/04/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Wilms Tumor.\n\nFrom clinical notes: Wilms Tumor. Paediatric oncology assessment.\n\nFindings: large heterogeneous left renal mass with pseudocapsule. No vascular invasion. Favorable histology on biopsy. Stage II. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 25/04/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"no vascular invasion\", \"favorable histology on biopsy\", \"stage II\"],\n        \"rationale\": \"The report explicitly describes a large renal mass with a pseudocapsule, no vascular invasion, and favorable histology, indicating a Wilms tumor. The stage is also specified as Stage II.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"no vascular invasion\", \"favorable histology on biopsy\", \"stage II\"],\n        \"rationale\": \"The report explicitly describes a large renal mass with a pseudocapsule, no vascular invasion, and favorable histology, indicating a Wilms tumor. The stage is also specified as Stage II.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"no vascular invasion\", \"favorable histology on biopsy\", \"stage II\"],\n        \"rationale\": \"The report explicitly describes a large renal mass with a pseudocapsule, no vascular invasion, and favorable histology, indicating a Wilms tumor. The stage is also specified as Stage II.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"no vascular invasion\", \"favorable histology on biopsy\", \"stage II\"],\n        \"rationale\": \"The report explicitly describes a large renal mass with a pseudocapsule, no vascular invasion, and favorable histology, indicating a Wilms tumor. The stage is also specified as Stage II.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"no vascular invasion\", \"favorable",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly describes a large renal mass with a pseudocapsule, no vascular invasion, and favorable histology, indicating a Wilms tumor. The stage is also specified as Stage II.",
      "findings": [
        "large heterogeneous left renal mass with pseudocapsule",
        "no vascular invasion",
        "favorable histology on biopsy",
        "stage II"
      ],
      "fracture_mentioned": null,
      "idx": 9,
      "timestamp": "2026-01-09T15:19:56.111779"
    },
    {
      "sample_idx": 10,
      "input": "26/12/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Hodgkin Lymphoma.\n\nFrom clinical notes: Hodgkin Lymphoma. Paediatric oncology assessment.\n\nFindings: mediastinal lymphadenopathy with bulky anterior mediastinal mass. PET-CT showing FDG-avid nodes. Classical Hodgkin, nodular sclerosing type. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 26/12/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"bulky anterior mediastinal mass\", \"FDG-avid nodes\", \"Classical Hodgkin, nodular sclerosing type\"],\n        \"rationale\": \"The report explicitly mentions mediastinal lymphadenopathy, a bulky anterior mediastinal mass, FDG-avid nodes, and the diagnosis of Classical Hodgkin lymphoma, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"bulky anterior mediastinal mass\", \"FDG-avid nodes\", \"Classical Hodgkin, nodular sclerosing type\"],\n        \"rationale\": \"The report explicitly mentions mediastinal lymphadenopathy, a bulky anterior mediastinal mass, FDG-avid nodes, and the diagnosis of Classical Hodgkin lymphoma, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"bulky anterior mediastinal mass\", \"FDG-avid nodes\", \"Classical Hodgkin, nodular sclerosing type\"],\n        \"rationale\": \"The report explicitly mentions mediastinal lymphadenopathy, a bulky anterior mediastinal mass, FDG-avid nodes, and the diagnosis of Classical Hodgkin lymphoma, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"bulky anterior mediastinal mass\", \"FDG-avid nodes\", \"Classical Hodgkin, nodular sclerosing type\"],\n        \"rationale\": \"The report explicitly mentions mediastinal lymphadenopathy, a bulky anterior mediastinal mass, FDG-avid nodes, and the diagnosis of Classical Hodgkin lymphoma, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly mentions mediastinal lymphadenopathy, a bulky anterior mediastinal mass, FDG-avid nodes, and the diagnosis of Classical Hodgkin lymphoma, indicating malignancy.",
      "findings": [
        "mediastinal lymphadenopathy",
        "bulky anterior mediastinal mass",
        "FDG-avid nodes",
        "Classical Hodgkin, nodular sclerosing type"
      ],
      "fracture_mentioned": null,
      "idx": 10,
      "timestamp": "2026-01-09T15:19:56.111791"
    },
    {
      "sample_idx": 11,
      "input": "18/09/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Neuroblastoma.\n\nFrom clinical notes: Neuroblastoma. Paediatric oncology assessment.\n\nFindings: large heterogeneous suprarenal mass with calcifications. MIBG avidity present. Elevated urinary catecholamines. Stage III disease. Recommend MDT discussion and treatment planning.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 18/09/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"Elevated urinary catecholamines\", \"Stage III disease\"],\n        \"rationale\": \"The report describes a large suprarenal mass with calcifications, MIBG avidity, and elevated urinary catecholamines, which are consistent with neuroblastoma. Stage III disease is also reported.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"Elevated urinary catecholamines\", \"Stage III disease\"],\n        \"rationale\": \"The report describes a large suprarenal mass with calcifications, MIBG avidity, and elevated urinary catecholamines, which are consistent with neuroblastoma. Stage III disease is also reported.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"Elevated urinary catecholamines\", \"Stage III disease\"],\n        \"rationale\": \"The report describes a large suprarenal mass with calcifications, MIBG avidity, and elevated urinary catecholamines, which are consistent with neuroblastoma. Stage III disease is also reported.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"Elevated urinary catecholamines\", \"Stage III disease\"],\n        \"rationale\": \"The report describes a large suprarenal mass with calcifications, MIBG avidity, and elevated urinary catecholamines, which are consistent with neuroblastoma. Stage III disease is also reported.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes a large suprarenal mass with calcifications, MIBG avidity, and elevated urinary catecholamines, which are consistent with neuroblastoma. Stage III disease is also reported.",
      "findings": [
        "large heterogeneous suprarenal mass with calcifications",
        "MIBG avidity present",
        "Elevated urinary catecholamines",
        "Stage III disease"
      ],
      "fracture_mentioned": null,
      "idx": 11,
      "timestamp": "2026-01-09T15:19:56.111804"
    },
    {
      "sample_idx": 12,
      "input": "15/12/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Hepatoblastoma.\n\nFrom clinical notes: Hepatoblastoma. Paediatric oncology assessment.\n\nFindings: large heterogeneous hepatic mass with elevated AFP. Fetal histology subtype. PRETEXT stage II. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 15/12/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous hepatic mass\", \"elevated AFP\", \"Fetal histology subtype\", \"PRETEXT stage II\"],\n        \"rationale\": \"The report describes a large hepatic mass, elevated AFP, a specific histological subtype, and a stage indicating advanced disease. These findings are highly suggestive of malignancy, specifically Hepatoblastoma, which was already suspected based on the clinical notes.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous hepatic mass\", \"elevated AFP\", \"Fetal histology subtype\", \"PRETEXT stage II\"],\n        \"rationale\": \"The report describes a large hepatic mass, elevated AFP, a specific histological subtype, and a stage indicating advanced disease. These findings are highly suggestive of malignancy, specifically Hepatoblastoma, which was already suspected based on the clinical notes.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous hepatic mass\", \"elevated AFP\", \"Fetal histology subtype\", \"PRETEXT stage II\"],\n        \"rationale\": \"The report describes a large hepatic mass, elevated AFP, a specific histological subtype, and a stage indicating advanced disease. These findings are highly suggestive of malignancy, specifically Hepatoblastoma, which was already suspected based on the clinical notes.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous hepatic mass\", \"elevated AFP\", \"Fetal histology subtype\", \"PRETEXT stage II\"],\n        \"rationale\": \"The report describes a large hepatic mass, elevated AFP, a specific histological subtype, and a stage indicating advanced disease. These findings are highly suggestive of malignancy, specifically Hepatoblastoma, which was already suspected based on the clinical notes.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes a large hepatic mass, elevated AFP, a specific histological subtype, and a stage indicating advanced disease. These findings are highly suggestive of malignancy, specifically Hepatoblastoma, which was already suspected based on the clinical notes.",
      "findings": [
        "large heterogeneous hepatic mass",
        "elevated AFP",
        "Fetal histology subtype",
        "PRETEXT stage II"
      ],
      "fracture_mentioned": null,
      "idx": 12,
      "timestamp": "2026-01-09T15:19:56.111817"
    },
    {
      "sample_idx": 13,
      "input": "26/02/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Langerhans Cell Histiocytosis.\n\nFrom clinical notes: Langerhans Cell Histiocytosis. Paediatric oncology assessment.\n\nFindings: multiple lytic skull lesions with soft tissue component. CD1a and Langerin positive. Multisystem disease. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 26/02/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"multiple lytic skull lesions with soft tissue component\", \"CD1a and Langerin positive\", \"Multisystem disease\"],\n        \"rationale\": \"The report describes multiple lytic skull lesions with soft tissue component, which is suggestive of Langerhans Cell Histiocytosis. The positive CD1a and Langerin staining confirms the diagnosis, and the description of multisystem disease further supports the malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"multiple lytic skull lesions with soft tissue component\", \"CD1a and Langerin positive\", \"Multisystem disease\"],\n        \"rationale\": \"The report describes multiple lytic skull lesions with soft tissue component, which is suggestive of Langerhans Cell Histiocytosis. The positive CD1a and Langerin staining confirms the diagnosis, and the description of multisystem disease further supports the malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"multiple lytic skull lesions with soft tissue component\", \"CD1a and Langerin positive\", \"Multisystem disease\"],\n        \"rationale\": \"The report describes multiple lytic skull lesions with soft tissue component, which is suggestive of Langerhans Cell Histiocytosis. The positive CD1a and Langerin staining confirms the diagnosis, and the description of multisystem disease further supports the malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"multiple lytic skull lesions with soft tissue component\", \"CD1a and Langerin positive\", \"Multisystem disease\"],\n        \"rationale\": \"The report describes multiple lytic skull lesions with soft tissue component, which is suggestive of Langerhans Cell Histiocytosis. The positive CD1a and Langerin staining confirms the diagnosis, and the description of multisystem disease further supports the malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes multiple lytic skull lesions with soft tissue component, which is suggestive of Langerhans Cell Histiocytosis. The positive CD1a and Langerin staining confirms the diagnosis, and the description of multisystem disease further supports the malignancy.",
      "findings": [
        "multiple lytic skull lesions with soft tissue component",
        "CD1a and Langerin positive",
        "Multisystem disease"
      ],
      "fracture_mentioned": null,
      "idx": 13,
      "timestamp": "2026-01-09T15:19:56.111830"
    },
    {
      "sample_idx": 14,
      "input": "08/09/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Post-viral lymphocytosis. Atypical lymphocytes resolving. Monospot positive. EBV serology confirms. No malignancy identified. Reassurance provided.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 08/09/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"post-viral lymphocytosis\", \"atypical lymphocytes resolving\", \"monospot positive\", \"EBV serology confirms\"],\n        \"rationale\": \"The report identifies post-viral lymphocytosis, atypical lymphocytes resolving, and a positive monospot test, all consistent with a viral infection. EBV serology confirms the diagnosis. No malignancy is identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no malignancy is identified. This indicates the absence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"lymphoblasts 85% of marrow\", \"B-cell ALL immunophenotype\", \"bone marrow infiltration\"],\n        \"rationale\": \"The report explicitly identifies bone marrow infiltration with lymphoblasts and immunophenotyping consistent with acute lymphoblastic leukemia, confirming malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC\", \"age-appropriate values\", \"no blast cells\"],\n        \"rationale\": \"The report shows normal blood counts with no atypical or malignant cells. No evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"lymphoblasts 85% of marrow\", \"B-cell ALL immunophenotype\", \"bone marrow infiltration\"],\n        \"rationale\": \"The report explicitly identifies bone marrow infiltration with lymphoblasts and immunophenotyping consistent with acute lymphoblastic leukemia, confirming malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC\", \"age-appropriate",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report identifies post-viral lymphocytosis, atypical lymphocytes resolving, and a positive monospot test, all consistent with a viral infection. EBV serology confirms the diagnosis. No malignancy is identified.",
      "findings": [
        "post-viral lymphocytosis",
        "atypical lymphocytes resolving",
        "monospot positive",
        "EBV serology confirms"
      ],
      "fracture_mentioned": null,
      "idx": 14,
      "timestamp": "2026-01-09T15:19:56.111842"
    },
    {
      "sample_idx": 15,
      "input": "14/07/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Bone pain. Suspected Acute Myeloid Leukemia.\n\nFrom clinical notes: Acute Myeloid Leukemia. Paediatric oncology assessment.\n\nFindings: myeloblasts accounting for 70% of marrow cellularity. Cytogenetic analysis reveals t(8;21) translocation. Favorable risk category. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 14/07/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"myeloblasts accounting for 70% of marrow cellularity\", \"t(8;21) translocation\"],\n        \"rationale\": \"The report mentions myeloblasts accounting for 70% of marrow cellularity, which is consistent with Acute Myeloid Leukemia. The presence of t(8;21) translocation is also a characteristic feature of Acute Myeloid Leukemia.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"myeloblasts accounting for 70% of marrow cellularity\", \"t(8;21) translocation\"],\n        \"rationale\": \"The report indicates a high percentage of myeloblasts in the bone marrow (70%), which is a hallmark of Acute Myeloid Leukemia (AML). The presence of the t(8;21) translocation is a specific genetic abnormality associated with AML, further supporting the diagnosis.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"myeloblasts accounting for 70% of marrow cellularity\", \"t(8;21) translocation\"],\n        \"rationale\": \"The report indicates a high percentage of myeloblasts in the bone marrow (70%), which is a hallmark of Acute Myeloid Leukemia (AML). The presence of the t(8;21) translocation is a specific genetic abnormality associated with AML, further supporting the diagnosis.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"myeloblasts accounting for 70% of marrow cellularity\", \"t(8;21) translocation\"],\n        \"rationale\": \"The report indicates a high percentage of myeloblasts in the bone marrow (70%), which is a hallmark of Acute Myeloid Leukemia (AML). The presence of the t(8;21) translocation is a specific genetic abnormality associated with AML, further supporting the diagnosis.\"\n",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report mentions myeloblasts accounting for 70% of marrow cellularity, which is consistent with Acute Myeloid Leukemia. The presence of t(8;21) translocation is also a characteristic feature of Acute Myeloid Leukemia.",
      "findings": [
        "myeloblasts accounting for 70% of marrow cellularity",
        "t(8;21) translocation"
      ],
      "fracture_mentioned": null,
      "idx": 15,
      "timestamp": "2026-01-09T15:19:56.111854"
    },
    {
      "sample_idx": 16,
      "input": "07/10/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Unexplained fever and weight loss. Suspected Rhabdomyosarcoma.\n\nFrom clinical notes: Rhabdomyosarcoma. Paediatric oncology assessment.\n\nFindings: parameningeal mass with intracranial extension. Embryonal rhabdomyosarcoma on biopsy. PAX-FOXO1 fusion negative. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 07/10/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"embryonal rhabdomyosarcoma\", \"parameningeal mass with intracranial extension\"],\n        \"rationale\": \"The report explicitly identifies embryonal rhabdomyosarcoma, a type of cancer, and describes a parameningeal mass with intracranial extension, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"embryonal rhabdomyosarcoma\", \"parameningeal mass with intracranial extension\"],\n        \"rationale\": \"The report explicitly identifies embryonal rhabdomyosarcoma, a type of cancer, and describes a parameningeal mass with intracranial extension, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"embryonal rhabdomyosarcoma\", \"parameningeal mass with intracranial extension\"],\n        \"rationale\": \"The report explicitly identifies embryonal rhabdomyosarcoma, a type of cancer, and describes a parameningeal mass with intracranial extension, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"embryonal rhabdomyosarcoma\", \"parameningeal mass with intracranial extension\"],\n        \"rationale\": \"The report explicitly identifies embryonal rhabdomyosarcoma, a type of cancer, and describes a parameningeal mass with intracranial extension, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"embryonal rhabdomyosarcoma\", \"parameningeal mass with intracranial extension\"],\n        \"rationale\": \"The report explicitly identifies embryonal rhabdomyosarcoma, a type of cancer, and describes a parameningeal mass with intracranial extension, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly identifies embryonal rhabdomyosarcoma, a type of cancer, and describes a parameningeal mass with intracranial extension, indicating malignancy.",
      "findings": [
        "embryonal rhabdomyosarcoma",
        "parameningeal mass with intracranial extension"
      ],
      "fracture_mentioned": null,
      "idx": 16,
      "timestamp": "2026-01-09T15:19:56.111864"
    },
    {
      "sample_idx": 17,
      "input": "06/04/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Normal chest radiograph. Clear lung fields. No mediastinal mass. Heart size normal. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 06/04/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\", \"reassurance provided\"],\n        \"rationale\": \"The report explicitly states that the chest radiograph is normal, with no signs of malignancy. The physician provided reassurance. Therefore, there is no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\", \"reassurance provided\"],\n        \"rationale\": \"The report explicitly states that the chest radiograph is normal, with no signs of malignancy. The physician provided reassurance. Therefore, there is no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\", \"reassurance provided\"],\n        \"rationale\": \"The report explicitly states that the chest radiograph is normal, with no signs of malignancy. The physician provided reassurance. Therefore, there is no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\", \"reassurance provided\"],\n        \"rationale\": \"The report explicitly states that the chest radiograph is normal, with no signs of malignancy. The physician provided reassurance. Therefore, there is no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states that the chest radiograph is normal, with no signs of malignancy. The physician provided reassurance. Therefore, there is no evidence of malignancy.",
      "findings": [
        "normal chest radiograph",
        "clear lung fields",
        "no mediastinal mass",
        "heart size normal",
        "no malignancy identified",
        "reassurance provided"
      ],
      "fracture_mentioned": null,
      "idx": 17,
      "timestamp": "2026-01-09T15:19:56.111876"
    },
    {
      "sample_idx": 18,
      "input": "23/05/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Bone pain. Suspected Brain Tumor - Medulloblastoma.\n\nFrom clinical notes: Brain Tumor - Medulloblastoma. Paediatric oncology assessment.\n\nFindings: posterior fossa mass with enhancement and hydrocephalus. Restricted diffusion. High-grade medulloblastoma on histology. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 23/05/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"posterior fossa mass with enhancement and hydrocephalus\", \"Restricted diffusion\", \"High-grade medulloblastoma on histology\"],\n        \"rationale\": \"The report explicitly mentions a posterior fossa mass with enhancement and hydrocephalus, confirmed by restricted diffusion and identified as high-grade medulloblastoma on histology, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"posterior fossa mass with enhancement and hydrocephalus\", \"Restricted diffusion\", \"High-grade medulloblastoma on histology\"],\n        \"rationale\": \"The report explicitly mentions a posterior fossa mass with enhancement and hydrocephalus, confirmed by restricted diffusion and identified as high-grade medulloblastoma on histology, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"posterior fossa mass with enhancement and hydrocephalus\", \"Restricted diffusion\", \"High-grade medulloblastoma on histology\"],\n        \"rationale\": \"The report explicitly mentions a posterior fossa mass with enhancement and hydrocephalus, confirmed by restricted diffusion and identified as high-grade medulloblastoma on histology, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"posterior fossa mass with enhancement and hydrocephalus\", \"Restricted diffusion\", \"High-grade medulloblastoma on histology\"],\n        \"rationale\": \"The report explicitly mentions a posterior fossa mass with enhancement and hydrocephalus, confirmed by restricted diffusion and identified as high-grade medulloblastoma on histology, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"posterior fossa mass with enhancement and hydrocephalus\", \"Restricted diffusion\", \"High-grade medulloblastoma on histology\"],\n        \"rationale\": \"The report explicitly mentions a posterior fossa mass with enhancement and",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly mentions a posterior fossa mass with enhancement and hydrocephalus, confirmed by restricted diffusion and identified as high-grade medulloblastoma on histology, indicating malignancy.",
      "findings": [
        "posterior fossa mass with enhancement and hydrocephalus",
        "Restricted diffusion",
        "High-grade medulloblastoma on histology"
      ],
      "fracture_mentioned": null,
      "idx": 18,
      "timestamp": "2026-01-09T15:19:56.111889"
    },
    {
      "sample_idx": 19,
      "input": "09/07/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Abnormal imaging. Suspected Neuroblastoma.\n\nFrom clinical notes: Neuroblastoma. Paediatric oncology assessment.\n\nFindings: large heterogeneous suprarenal mass with calcifications. MIBG avidity present. Elevated urinary catecholamines. Stage III disease. Recommend MDT discussion and treatment planning.\n\nDr James Chen, Consultant Paediatric Oncologist 09/07/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"elevated urinary catecholamines\", \"Stage III disease\"],\n        \"rationale\": \"The report describes a suprarenal mass with calcifications, MIBG avidity, and elevated urinary catecholamines, suggestive of neuroblastoma. The stage is also specified as Stage III, further supporting the diagnosis of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"elevated urinary catecholamines\", \"Stage III disease\"],\n        \"rationale\": \"The report describes a suprarenal mass with calcifications, MIBG avidity, and elevated urinary catecholamines, suggestive of neuroblastoma. The stage is also specified as Stage III, further supporting the diagnosis of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"elevated urinary catecholamines\", \"Stage III disease\"],\n        \"rationale\": \"The report describes a suprarenal mass with calcifications, MIBG avidity, and elevated urinary catecholamines, suggestive of neuroblastoma. The stage is also specified as Stage III, further supporting the diagnosis of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"elevated urinary catecholamines\", \"Stage III disease\"],\n        \"rationale\": \"The report describes a suprarenal mass with calcifications, MIBG avidity, and elevated urinary catecholamines, suggestive of neuroblastoma. The stage is also specified as Stage III, further supporting the diagnosis of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malign",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes a suprarenal mass with calcifications, MIBG avidity, and elevated urinary catecholamines, suggestive of neuroblastoma. The stage is also specified as Stage III, further supporting the diagnosis of malignancy.",
      "findings": [
        "large heterogeneous suprarenal mass with calcifications",
        "MIBG avidity present",
        "elevated urinary catecholamines",
        "Stage III disease"
      ],
      "fracture_mentioned": null,
      "idx": 19,
      "timestamp": "2026-01-09T15:19:56.111902"
    },
    {
      "sample_idx": 20,
      "input": "18/08/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Wilms Tumor.\n\nFrom clinical notes: Wilms Tumor. Paediatric oncology assessment.\n\nFindings: large heterogeneous left renal mass with pseudocapsule. No vascular invasion. Favorable histology on biopsy. Stage II. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 18/08/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"no vascular invasion\", \"favorable histology on biopsy\", \"stage II\"],\n        \"rationale\": \"The report describes a renal mass with characteristics consistent with Wilms Tumor, confirmed by favorable histology and stage II. This indicates malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"no vascular invasion\", \"favorable histology on biopsy\", \"stage II\"],\n        \"rationale\": \"The report describes a renal mass with characteristics consistent with Wilms Tumor, confirmed by favorable histology and stage II. This indicates malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"no vascular invasion\", \"favorable histology on biopsy\", \"stage II\"],\n        \"rationale\": \"The report describes a renal mass with characteristics consistent with Wilms Tumor, confirmed by favorable histology and stage II. This indicates malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"no vascular invasion\", \"favorable histology on biopsy\", \"stage II\"],\n        \"rationale\": \"The report describes a renal mass with characteristics consistent with Wilms Tumor, confirmed by favorable histology and stage II. This indicates malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"no vascular invasion\", \"favorable histology on biopsy\", \"stage II\"],\n        \"rationale\": \"The report describes a renal mass with characteristics consistent with Wilms Tumor, confirmed by favorable histology and stage II. This indicates malignancy.\"\n    }",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes a renal mass with characteristics consistent with Wilms Tumor, confirmed by favorable histology and stage II. This indicates malignancy.",
      "findings": [
        "large heterogeneous left renal mass with pseudocapsule",
        "no vascular invasion",
        "favorable histology on biopsy",
        "stage II"
      ],
      "fracture_mentioned": null,
      "idx": 20,
      "timestamp": "2026-01-09T15:19:56.111913"
    },
    {
      "sample_idx": 21,
      "input": "13/03/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Normal brain MRI for age. No mass lesion. No abnormal enhancement. Headaches attributed to migraine. No malignancy identified. Reassurance provided.\n\nDr James Chen, Consultant Paediatric Oncologist 13/03/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\"],\n        \"rationale\": \"The report states that the brain MRI is normal, with no mass lesion, abnormal enhancement, or malignancy identified. This indicates that there is no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\"],\n        \"rationale\": \"The report states that the brain MRI is normal, with no mass lesion, abnormal enhancement, or malignancy identified. This indicates that there is no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\"],\n        \"rationale\": \"The report states that the brain MRI is normal, with no mass lesion, abnormal enhancement, or malignancy identified. This indicates that there is no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\"],\n        \"rationale\": \"The report states that the brain MRI is normal, with no mass lesion, abnormal enhancement, or malignancy identified. This indicates that there is no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\"],\n        \"rationale\": \"The report states that the brain MRI is normal, with no mass lesion, abnormal enhancement, or malignancy identified. This indicates that there is no evidence of malignancy.\"\n    }\n}\n```\n",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report states that the brain MRI is normal, with no mass lesion, abnormal enhancement, or malignancy identified. This indicates that there is no evidence of malignancy.",
      "findings": [
        "normal brain MRI",
        "no mass lesion",
        "no abnormal enhancement",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 21,
      "timestamp": "2026-01-09T15:19:56.111924"
    },
    {
      "sample_idx": 22,
      "input": "18/10/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Wilms Tumor.\n\nFrom clinical notes: Wilms Tumor. Paediatric oncology assessment.\n\nFindings: large heterogeneous left renal mass with pseudocapsule. No vascular invasion. Favorable histology on biopsy. Stage II. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 18/10/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"no vascular invasion\", \"favorable histology on biopsy\", \"stage II\"],\n        \"rationale\": \"The report describes a left renal mass with features suggestive of Wilms Tumor, including a pseudocapsule and favorable histology. The report also states that the stage is II. The presence of a renal mass, along with a favorable histology, indicates malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"no vascular invasion\", \"favorable histology on biopsy\", \"stage II\"],\n        \"rationale\": \"The report describes a left renal mass with features suggestive of Wilms Tumor, including a pseudocapsule and favorable histology. The report also states that the stage is II. The presence of a renal mass, along with a favorable histology, indicates malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"no vascular invasion\", \"favorable histology on biopsy\", \"stage II\"],\n        \"rationale\": \"The report describes a left renal mass with features suggestive of Wilms Tumor, including a pseudocapsule and favorable histology. The report also states that the stage is II. The presence of a renal mass, along with a favorable histology, indicates malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"no vascular invasion\", \"favorable histology on biopsy\", \"stage II\"],\n        \"rationale\": \"The report describes a left renal mass with features suggestive of Wilms Tumor, including a pseudocapsule and favorable histology. The report also states that the stage is II. The presence of a renal mass, along with a favorable histology, indicates malignancy.\"\n    }\n}\n```\n```json",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes a left renal mass with features suggestive of Wilms Tumor, including a pseudocapsule and favorable histology. The report also states that the stage is II. The presence of a renal mass, along with a favorable histology, indicates malignancy.",
      "findings": [
        "large heterogeneous left renal mass with pseudocapsule",
        "no vascular invasion",
        "favorable histology on biopsy",
        "stage II"
      ],
      "fracture_mentioned": null,
      "idx": 22,
      "timestamp": "2026-01-09T15:19:56.111938"
    },
    {
      "sample_idx": 23,
      "input": "02/05/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Normal brain MRI for age. No mass lesion. No abnormal enhancement. Headaches attributed to migraine. No malignancy identified. Reassurance provided.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 02/05/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no mass lesion, abnormal enhancement, or malignancy was identified. Therefore, there is no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no mass lesion, abnormal enhancement, or malignancy was identified. Therefore, there is no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no mass lesion, abnormal enhancement, or malignancy was identified. Therefore, there is no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no mass lesion, abnormal enhancement, or malignancy was identified. Therefore, there is no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no mass lesion, abnormal enhancement, or malignancy was identified. Therefore, there is no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        ",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states that no mass lesion, abnormal enhancement, or malignancy was identified. Therefore, there is no evidence of malignancy.",
      "findings": [
        "normal brain MRI",
        "no mass lesion",
        "no abnormal enhancement",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 23,
      "timestamp": "2026-01-09T15:19:56.111950"
    },
    {
      "sample_idx": 24,
      "input": "16/05/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Normal brain MRI for age. No mass lesion. No abnormal enhancement. Headaches attributed to migraine. No malignancy identified. Reassurance provided.\n\nDr James Chen, Consultant Paediatric Oncologist 16/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no malignancy was identified. The brain MRI is normal. The findings are reassuring and indicate no malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal\", \"no abnormal findings\"],\n        \"rationale\": \"The report indicates that there are no abnormal findings, and that the patient has no history of malignancy. Therefore, there is no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no findings suggestive of malignancy\", \"no evidence of cancer\"],\n        \"rationale\": \"The report explicitly states that there are no findings suggestive of malignancy, and no evidence of cancer. Therefore, there is no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no evidence of malignancy\", \"no abnormal findings\"],\n        \"rationale\": \"The report explicitly states that there is no evidence of malignancy and no abnormal findings. Therefore, there is no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no evidence of malignancy\", \"no abnormal findings\"],\n        \"rationale\": \"The report explicitly states that there is no evidence of malignancy and no abnormal findings. Therefore, there is no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no evidence of malignancy\", \"no abnormal findings\"],\n        \"rationale\": \"The report explicitly states that there is no evidence of malignancy and no abnormal",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states that no malignancy was identified. The brain MRI is normal. The findings are reassuring and indicate no malignancy.",
      "findings": [
        "normal brain MRI",
        "no mass lesion",
        "no abnormal enhancement",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 24,
      "timestamp": "2026-01-09T15:19:56.111960"
    },
    {
      "sample_idx": 25,
      "input": "16/05/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Unexplained fever and weight loss. Suspected Ewing Sarcoma.\n\nFrom clinical notes: Ewing Sarcoma. Paediatric oncology assessment.\n\nFindings: permeative bone destruction in left femoral diaphysis with large soft tissue mass. Onion-skin periosteal reaction. EWSR1 fusion positive. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 16/05/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"permeative bone destruction in left femoral diaphysis\", \"large soft tissue mass\", \"onion-skin periosteal reaction\", \"EWSR1 fusion positive\"],\n        \"rationale\": \"The report describes bone destruction, a soft tissue mass, periosteal reaction, and EWSR1 fusion positivity, all suggestive of Ewing Sarcoma, a malignant bone tumor.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"permeative bone destruction in left femoral diaphysis\", \"large soft tissue mass\", \"onion-skin periosteal reaction\", \"EWSR1 fusion positive\"],\n        \"rationale\": \"The report describes bone destruction, a soft tissue mass, periosteal reaction, and EWSR1 fusion positivity, all suggestive of Ewing Sarcoma, a malignant bone tumor.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"permeative bone destruction in left femoral diaphysis\", \"large soft tissue mass\", \"onion-skin periosteal reaction\", \"EWSR1 fusion positive\"],\n        \"rationale\": \"The report describes bone destruction, a soft tissue mass, periosteal reaction, and EWSR1 fusion positivity, all suggestive of Ewing Sarcoma, a malignant bone tumor.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"permeative bone destruction in left femoral diaphysis\", \"large soft tissue mass\", \"onion-skin periosteal reaction\", \"EWSR1 fusion positive\"],\n        \"rationale\": \"The report describes bone destruction, a soft tissue mass, periosteal reaction, and EWSR1 fusion positivity, all suggestive of Ewing Sarcoma, a malignant bone tumor.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes bone destruction, a soft tissue mass, periosteal reaction, and EWSR1 fusion positivity, all suggestive of Ewing Sarcoma, a malignant bone tumor.",
      "findings": [
        "permeative bone destruction in left femoral diaphysis",
        "large soft tissue mass",
        "onion-skin periosteal reaction",
        "EWSR1 fusion positive"
      ],
      "fracture_mentioned": null,
      "idx": 25,
      "timestamp": "2026-01-09T15:19:56.111972"
    },
    {
      "sample_idx": 26,
      "input": "13/08/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Non-Hodgkin Lymphoma.\n\nFrom clinical notes: Non-Hodgkin Lymphoma. Paediatric oncology assessment.\n\nFindings: abdominal lymphadenopathy with mesenteric and retroperitoneal nodes. Burkitt lymphoma confirmed on biopsy. High LDH levels. Recommend MDT discussion and treatment planning.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 13/08/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"abdominal lymphadenopathy\", \"mesenteric and retroperitoneal nodes\", \"Burkitt lymphoma confirmed on biopsy\", \"high LDH levels\"],\n        \"rationale\": \"The report explicitly mentions abdominal lymphadenopathy, mesenteric and retroperitoneal nodes, confirmed Burkitt lymphoma on biopsy, and elevated LDH levels, all of which are indicative of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"abdominal lymphadenopathy\", \"mesenteric and retroperitoneal nodes\", \"Burkitt lymphoma confirmed on biopsy\", \"high LDH levels\"],\n        \"rationale\": \"The report explicitly mentions abdominal lymphadenopathy, mesenteric and retroperitoneal nodes, confirmed Burkitt lymphoma on biopsy, and elevated LDH levels, all of which are indicative of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"abdominal lymphadenopathy\", \"mesenteric and retroperitoneal nodes\", \"Burkitt lymphoma confirmed on biopsy\", \"high LDH levels\"],\n        \"rationale\": \"The report explicitly mentions abdominal lymphadenopathy, mesenteric and retroperitoneal nodes, confirmed Burkitt lymphoma on biopsy, and elevated LDH levels, all of which are indicative of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"abdominal lymphadenopathy\", \"mesenteric and retroperitoneal nodes\", \"Burkitt lymphoma confirmed on biopsy\", \"high LDH levels\"],\n        \"rationale\": \"The report explicitly mentions abdominal lymphadenopathy, mesenteric and retroperitoneal nodes, confirmed Burkitt lymphoma on biopsy, and elevated LDH levels, all of which are indicative of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"abdominal lymphadenopathy\", \"mesenteric and retroperitoneal nodes\", \"Burkitt lymphoma",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly mentions abdominal lymphadenopathy, mesenteric and retroperitoneal nodes, confirmed Burkitt lymphoma on biopsy, and elevated LDH levels, all of which are indicative of malignancy.",
      "findings": [
        "abdominal lymphadenopathy",
        "mesenteric and retroperitoneal nodes",
        "Burkitt lymphoma confirmed on biopsy",
        "high LDH levels"
      ],
      "fracture_mentioned": null,
      "idx": 26,
      "timestamp": "2026-01-09T15:19:56.111984"
    },
    {
      "sample_idx": 27,
      "input": "25/06/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Healing fracture - normal process. No pathological features. Bone density normal. Trauma history consistent. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 25/06/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"healing fracture\", \"no pathological features\", \"no malignancy identified\"],\n        \"rationale\": \"The report describes a healing fracture with no pathological features and explicitly states that no malignancy was identified. Therefore, the findings are not indicative of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"healing fracture\", \"no pathological features\", \"no malignancy identified\"],\n        \"rationale\": \"The report describes a healing fracture with no pathological features and explicitly states that no malignancy was identified. Therefore, the findings are not indicative of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"healing fracture\", \"no pathological features\", \"no malignancy identified\"],\n        \"rationale\": \"The report describes a healing fracture with no pathological features and explicitly states that no malignancy was identified. Therefore, the findings are not indicative of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"healing fracture\", \"no pathological features\", \"no malignancy identified\"],\n        \"rationale\": \"The report describes a healing fracture with no pathological features and explicitly states that no malignancy was identified. Therefore, the findings are not indicative of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"healing fracture\", \"no pathological features\", \"no malignancy identified\"],\n        \"rationale\": \"The report describes a healing fracture with no pathological features and explicitly states that no malignancy was identified. Therefore, the findings are not indicative of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"healing fracture\", \"no pathological features\", \"no malignancy",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report describes a healing fracture with no pathological features and explicitly states that no malignancy was identified. Therefore, the findings are not indicative of malignancy.",
      "findings": [
        "healing fracture",
        "no pathological features",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 27,
      "timestamp": "2026-01-09T15:19:56.111995"
    },
    {
      "sample_idx": 28,
      "input": "01/07/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Benign bone cyst - resolved. No aggressive features. Normal bone density. No recurrence on imaging. No malignancy identified. Reassurance provided.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 01/07/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"benign bone cyst - resolved\", \"normal bone density\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that a benign bone cyst was resolved, bone density is normal, and no malignancy was identified. The report also reassures the patient.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal bone density\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that bone density is normal and no malignancy was identified. The report also reassures the patient.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no malignancy was identified. The report also reassures the patient.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no malignancy was identified. The report also reassures the patient.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no malignancy was identified. The report also reassures the patient.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no malignancy was identified. The report also reassures the patient.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no malignancy",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states that a benign bone cyst was resolved, bone density is normal, and no malignancy was identified. The report also reassures the patient.",
      "findings": [
        "benign bone cyst - resolved",
        "normal bone density",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 28,
      "timestamp": "2026-01-09T15:19:56.112006"
    },
    {
      "sample_idx": 29,
      "input": "04/12/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Neuroblastoma.\n\nFrom clinical notes: Neuroblastoma. Paediatric oncology assessment.\n\nFindings: large heterogeneous suprarenal mass with calcifications. MIBG avidity present. Elevated urinary catecholamines. Stage III disease. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 04/12/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"elevated urinary catecholamines\", \"Stage III disease\"],\n        \"rationale\": \"The report describes a suprarenal mass with calcifications, MIBG avidity, and elevated urinary catecholamines, consistent with Neuroblastoma. The stage III disease diagnosis confirms malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"elevated urinary catecholamines\", \"Stage III disease\"],\n        \"rationale\": \"The report describes a suprarenal mass with calcifications, MIBG avidity, and elevated urinary catecholamines, consistent with Neuroblastoma. The stage III disease diagnosis confirms malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"elevated urinary catecholamines\", \"Stage III disease\"],\n        \"rationale\": \"The report describes a suprarenal mass with calcifications, MIBG avidity, and elevated urinary catecholamines, consistent with Neuroblastoma. The stage III disease diagnosis confirms malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"elevated urinary catecholamines\", \"Stage III disease\"],\n        \"rationale\": \"The report describes a suprarenal mass with calcifications, MIBG avidity, and elevated urinary catecholamines, consistent with Neuroblastoma. The stage III disease diagnosis confirms malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes a suprarenal mass with calcifications, MIBG avidity, and elevated urinary catecholamines, consistent with Neuroblastoma. The stage III disease diagnosis confirms malignancy.",
      "findings": [
        "large heterogeneous suprarenal mass with calcifications",
        "MIBG avidity present",
        "elevated urinary catecholamines",
        "Stage III disease"
      ],
      "fracture_mentioned": null,
      "idx": 29,
      "timestamp": "2026-01-09T15:19:56.112018"
    },
    {
      "sample_idx": 30,
      "input": "15/07/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Lymphadenopathy. Suspected Brain Tumor - Medulloblastoma.\n\nFrom clinical notes: Brain Tumor - Medulloblastoma. Paediatric oncology assessment.\n\nFindings: posterior fossa mass with enhancement and hydrocephalus. Restricted diffusion. High-grade medulloblastoma on histology. Recommend MDT discussion and treatment planning.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 15/07/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"posterior fossa mass with enhancement and hydrocephalus\", \"restricted diffusion\", \"high-grade medulloblastoma on histology\"],\n        \"rationale\": \"The report describes a posterior fossa mass with enhancement and hydrocephalus, confirmed as high-grade medulloblastoma on histology. These findings indicate malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"posterior fossa mass with enhancement and hydrocephalus\", \"restricted diffusion\", \"high-grade medulloblastoma on histology\"],\n        \"rationale\": \"The report describes a posterior fossa mass with enhancement and hydrocephalus, confirmed as high-grade medulloblastoma on histology. These findings indicate malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"posterior fossa mass with enhancement and hydrocephalus\", \"restricted diffusion\", \"high-grade medulloblastoma on histology\"],\n        \"rationale\": \"The report describes a posterior fossa mass with enhancement and hydrocephalus, confirmed as high-grade medulloblastoma on histology. These findings indicate malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"posterior fossa mass with enhancement and hydrocephalus\", \"restricted diffusion\", \"high-grade medulloblastoma on histology\"],\n        \"rationale\": \"The report describes a posterior fossa mass with enhancement and hydrocephalus, confirmed as high-grade medulloblastoma on histology. These findings indicate malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"posterior fossa mass with enhancement and hydrocephalus\", \"restricted diffusion\", \"high-grade medulloblastoma on histology\"],\n        \"rationale\": \"The report describes a posterior fossa mass with enhancement and hydrocephalus, confirmed as high-grade medulloblastoma on histology. These findings indicate malignancy.\"\n    }",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes a posterior fossa mass with enhancement and hydrocephalus, confirmed as high-grade medulloblastoma on histology. These findings indicate malignancy.",
      "findings": [
        "posterior fossa mass with enhancement and hydrocephalus",
        "restricted diffusion",
        "high-grade medulloblastoma on histology"
      ],
      "fracture_mentioned": null,
      "idx": 30,
      "timestamp": "2026-01-09T15:19:56.112029"
    },
    {
      "sample_idx": 31,
      "input": "02/04/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Normal chest radiograph. Clear lung fields. No mediastinal mass. Heart size normal. No malignancy identified. Reassurance provided.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 02/04/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that the chest radiograph is normal and that no malignancy is identified. Therefore, there is no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that the chest radiograph is normal and that no malignancy is identified. Therefore, there is no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that the chest radiograph is normal and that no malignancy is identified. Therefore, there is no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that the chest radiograph is normal and that no malignancy is identified. Therefore, there is no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that the chest radiograph is normal and that no malignancy is identified. Therefore, there is no evidence of malignancy.\"",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states that the chest radiograph is normal and that no malignancy is identified. Therefore, there is no evidence of malignancy.",
      "findings": [
        "normal chest radiograph",
        "clear lung fields",
        "no mediastinal mass",
        "heart size normal",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 31,
      "timestamp": "2026-01-09T15:19:56.112040"
    },
    {
      "sample_idx": 32,
      "input": "04/10/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Germ Cell Tumor.\n\nFrom clinical notes: Germ Cell Tumor. Paediatric oncology assessment.\n\nFindings: sacrococcygeal mass with mixed solid and cystic components. Elevated AFP and beta-hCG. Yolk sac tumor elements present. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 04/10/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"sacrococcygeal mass with mixed solid and cystic components\", \"Elevated AFP and beta-hCG\", \"Yolk sac tumor elements present\"],\n        \"rationale\": \"The report describes a sacrococcygeal mass with mixed solid and cystic components, elevated AFP and beta-hCG, and the presence of yolk sac tumor elements. These findings are highly suggestive of a germ cell tumor, specifically a yolk sac tumor, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"sacrococcygeal mass with mixed solid and cystic components\", \"Elevated AFP and beta-hCG\", \"Yolk sac tumor elements present\"],\n        \"rationale\": \"The report describes a sacrococcygeal mass with mixed solid and cystic components, elevated AFP and beta-hCG, and the presence of yolk sac tumor elements. These findings are highly suggestive of a germ cell tumor, specifically a yolk sac tumor, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"sacrococcygeal mass with mixed solid and cystic components\", \"Elevated AFP and beta-hCG\", \"Yolk sac tumor elements present\"],\n        \"rationale\": \"The report describes a sacrococcygeal mass with mixed solid and cystic components, elevated AFP and beta-hCG, and the presence of yolk sac tumor elements. These findings are highly suggestive of a germ cell tumor, specifically a yolk sac tumor, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"sacrococcygeal mass with mixed solid and cystic components\", \"Elevated AFP and beta-hCG\", \"Yolk sac tumor elements present\"],\n        \"rationale\": \"The report describes a sacrococcygeal mass with mixed solid and cystic components, elevated AFP and",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes a sacrococcygeal mass with mixed solid and cystic components, elevated AFP and beta-hCG, and the presence of yolk sac tumor elements. These findings are highly suggestive of a germ cell tumor, specifically a yolk sac tumor, indicating malignancy.",
      "findings": [
        "sacrococcygeal mass with mixed solid and cystic components",
        "Elevated AFP and beta-hCG",
        "Yolk sac tumor elements present"
      ],
      "fracture_mentioned": null,
      "idx": 32,
      "timestamp": "2026-01-09T15:19:56.112054"
    },
    {
      "sample_idx": 33,
      "input": "24/11/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Hodgkin Lymphoma.\n\nFrom clinical notes: Hodgkin Lymphoma. Paediatric oncology assessment.\n\nFindings: mediastinal lymphadenopathy with bulky anterior mediastinal mass. PET-CT showing FDG-avid nodes. Classical Hodgkin, nodular sclerosing type. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 24/11/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"bulky anterior mediastinal mass\", \"FDG-avid nodes\", \"Classical Hodgkin, nodular sclerosing type\"],\n        \"rationale\": \"The report explicitly mentions mediastinal lymphadenopathy, a bulky anterior mediastinal mass, FDG-avid nodes, and the presence of Classical Hodgkin Lymphoma, nodular sclerosing type. These findings are indicative of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"bulky anterior mediastinal mass\", \"FDG-avid nodes\", \"Classical Hodgkin, nodular sclerosing type\"],\n        \"rationale\": \"The report explicitly mentions mediastinal lymphadenopathy, a bulky anterior mediastinal mass, FDG-avid nodes, and the presence of Classical Hodgkin Lymphoma, nodular sclerosing type. These findings are indicative of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"bulky anterior mediastinal mass\", \"FDG-avid nodes\", \"Classical Hodgkin, nodular sclerosing type\"],\n        \"rationale\": \"The report explicitly mentions mediastinal lymphadenopathy, a bulky anterior mediastinal mass, FDG-avid nodes, and the presence of Classical Hodgkin Lymphoma, nodular sclerosing type. These findings are indicative of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"bulky anterior mediastinal mass\", \"FDG-avid nodes\", \"Classical Hodgkin, nodular sclerosing type\"],\n        \"rationale\": \"The report explicitly mentions mediastinal lymphadenopathy, a bulky anterior mediastinal mass, FDG-avid nodes, and the presence of Classical Hodgkin Lymphoma, nodular sclerosing type. These findings are indicative of",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly mentions mediastinal lymphadenopathy, a bulky anterior mediastinal mass, FDG-avid nodes, and the presence of Classical Hodgkin Lymphoma, nodular sclerosing type. These findings are indicative of malignancy.",
      "findings": [
        "mediastinal lymphadenopathy",
        "bulky anterior mediastinal mass",
        "FDG-avid nodes",
        "Classical Hodgkin, nodular sclerosing type"
      ],
      "fracture_mentioned": null,
      "idx": 33,
      "timestamp": "2026-01-09T15:19:56.112067"
    },
    {
      "sample_idx": 34,
      "input": "07/03/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Normal CBC with age-appropriate values. No blast cells. Platelets adequate. Hemoglobin within normal limits. No malignancy identified. Reassurance provided.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 07/03/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal CBC with age-appropriate values\", \"No blast cells\", \"Platelets adequate\", \"Hemoglobin within normal limits\", \"No malignancy identified\"],\n        \"rationale\": \"The report explicitly states that the CBC is normal, no blast cells are present, and there is no malignancy identified. This indicates no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal CBC with age-appropriate values\", \"No blast cells\", \"Platelets adequate\", \"Hemoglobin within normal limits\", \"No malignancy identified\"],\n        \"rationale\": \"The report explicitly states that the CBC is normal, no blast cells are present, and there is no malignancy identified. This indicates no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal CBC with age-appropriate values\", \"No blast cells\", \"Platelets adequate\", \"Hemoglobin within normal limits\", \"No malignancy identified\"],\n        \"rationale\": \"The report explicitly states that the CBC is normal, no blast cells are present, and there is no malignancy identified. This indicates no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal CBC with age-appropriate values\", \"No blast cells\", \"Platelets adequate\", \"Hemoglobin within normal limits\", \"No malignancy identified\"],\n        \"rationale\": \"The report explicitly states that the CBC is normal, no blast cells are present, and there is no malignancy identified. This indicates no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal CBC with age-appropriate values\", \"No blast cells\", \"Platelets adequate\", \"Hemoglobin within normal limits\", \"No malignancy identified\"],\n        ",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states that the CBC is normal, no blast cells are present, and there is no malignancy identified. This indicates no evidence of malignancy.",
      "findings": [
        "Normal CBC with age-appropriate values",
        "No blast cells",
        "Platelets adequate",
        "Hemoglobin within normal limits",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 34,
      "timestamp": "2026-01-09T15:19:56.112096"
    },
    {
      "sample_idx": 35,
      "input": "04/10/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Benign soft tissue mass - lipoma confirmed. Well-circumscribed. No enhancement. No intervention required. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 04/10/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"lipoma confirmed\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that a lipoma was confirmed and that no malignancy was identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"well-circumscribed\", \"no enhancement\", \"no intervention required\"],\n        \"rationale\": \"The report describes the lipoma as well-circumscribed, with no enhancement and no intervention required, all of which are benign findings.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no previous oncology history\", \"reassurance provided\"],\n        \"rationale\": \"The report indicates that the patient has no previous oncology history and that reassurance was provided, which is consistent with a benign finding.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"lipoma confirmed\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that a lipoma was confirmed and that no malignancy was identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"well-circumscribed\", \"no enhancement\", \"no intervention required\"],\n        \"rationale\": \"The report describes the lipoma as well-circumscribed, with no enhancement and no intervention required, all of which are benign findings.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no previous oncology history\", \"reassurance provided\"],\n        \"rationale\": \"The report indicates that the patient has no previous oncology history and that reassurance was provided, which is consistent with a benign finding.\"\n    }\n}\n```\n",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states that a lipoma was confirmed and that no malignancy was identified.",
      "findings": [
        "lipoma confirmed",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 35,
      "timestamp": "2026-01-09T15:19:56.112106"
    },
    {
      "sample_idx": 36,
      "input": "04/01/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Normal chest radiograph. Clear lung fields. No mediastinal mass. Heart size normal. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 04/01/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that the chest radiograph and lung fields are clear, with no mediastinal mass or heart abnormalities. The final statement confirms that no malignancy is identified, thus there is no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that the chest radiograph and lung fields are clear, with no mediastinal mass or heart abnormalities. The final statement confirms that no malignancy is identified, thus there is no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that the chest radiograph and lung fields are clear, with no mediastinal mass or heart abnormalities. The final statement confirms that no malignancy is identified, thus there is no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that the chest radiograph and lung fields are clear, with no mediastinal mass or heart abnormalities. The final statement confirms that no malignancy is identified, thus there is no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states that the chest radiograph and lung fields are clear, with no mediastinal mass or heart abnormalities. The final statement confirms that no malignancy is identified, thus there is no evidence of malignancy.",
      "findings": [
        "normal chest radiograph",
        "clear lung fields",
        "no mediastinal mass",
        "heart size normal",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 36,
      "timestamp": "2026-01-09T15:19:56.112118"
    },
    {
      "sample_idx": 37,
      "input": "02/04/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Abnormal imaging. Suspected Osteosarcoma.\n\nFrom clinical notes: Osteosarcoma. Paediatric oncology assessment.\n\nFindings: destructive lesion in distal femur with soft tissue component. Sunburst periosteal reaction. Elevated alkaline phosphatase. Recommend MDT discussion and treatment planning.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 02/04/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"destructive lesion in distal femur with soft tissue component\", \"sunburst periosteal reaction\", \"elevated alkaline phosphatase\"],\n        \"rationale\": \"The report describes a destructive lesion in the distal femur with soft tissue involvement, sunburst periosteal reaction, and elevated alkaline phosphatase. These findings are highly suggestive of osteosarcoma, a malignant bone tumor.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"osteosarcoma\", \"destructive lesion in distal femur with soft tissue component\", \"sunburst periosteal reaction\", \"elevated alkaline phosphatase\"],\n        \"rationale\": \"The report explicitly states the presence of osteosarcoma. The description of the lesion and associated findings (sunburst periosteal reaction, elevated alkaline phosphatase) strongly support the diagnosis of osteosarcoma, which is a malignant bone tumor.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"osteosarcoma\", \"destructive lesion in distal femur with soft tissue component\", \"sunburst periosteal reaction\", \"elevated alkaline phosphatase\"],\n        \"rationale\": \"The report explicitly states the presence of osteosarcoma. The description of the lesion and associated findings (sunburst periosteal reaction, elevated alkaline phosphatase) strongly support the diagnosis of osteosarcoma, which is a malignant bone tumor.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"osteosarcoma\", \"destructive lesion in distal femur with soft tissue component\", \"sunburst periosteal reaction\", \"elevated alkaline phosphatase\"],\n        \"rationale\": \"The report explicitly states the presence of osteosarcoma. The description of the lesion and associated findings (sunburst periosteal reaction, elevated alkaline phosphatase) strongly support the diagnosis of osteosarcoma, which is a malignant bone tumor.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\":",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes a destructive lesion in the distal femur with soft tissue involvement, sunburst periosteal reaction, and elevated alkaline phosphatase. These findings are highly suggestive of osteosarcoma, a malignant bone tumor.",
      "findings": [
        "destructive lesion in distal femur with soft tissue component",
        "sunburst periosteal reaction",
        "elevated alkaline phosphatase"
      ],
      "fracture_mentioned": null,
      "idx": 37,
      "timestamp": "2026-01-09T15:19:56.112131"
    },
    {
      "sample_idx": 38,
      "input": "05/03/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Lymphadenopathy. Suspected Osteosarcoma.\n\nFrom clinical notes: Osteosarcoma. Paediatric oncology assessment.\n\nFindings: destructive lesion in distal femur with soft tissue component. Sunburst periosteal reaction. Elevated alkaline phosphatase. Recommend MDT discussion and treatment planning.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 05/03/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"destructive lesion in distal femur with soft tissue component\", \"sunburst periosteal reaction\", \"elevated alkaline phosphatase\"],\n        \"rationale\": \"The report describes a destructive lesion in the distal femur with soft tissue involvement, sunburst periosteal reaction, and elevated alkaline phosphatase, suggesting a possible osteosarcoma.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"osteosarcoma\", \"pediatric oncology assessment\"],\n        \"rationale\": \"The report explicitly mentions osteosarcoma, a type of bone cancer, and indicates a pediatric oncology assessment, strongly suggesting malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"destructive lesion in distal femur with soft tissue component\", \"sunburst periosteal reaction\", \"elevated alkaline phosphatase\"],\n        \"rationale\": \"The report describes a destructive lesion in the distal femur with soft tissue involvement, sunburst periosteal reaction, and elevated alkaline phosphatase, suggesting a possible osteosarcoma.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"osteosarcoma\", \"pediatric oncology assessment\"],\n        \"rationale\": \"The report explicitly mentions osteosarcoma, a type of bone cancer, and indicates a pediatric oncology assessment, strongly suggesting malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"destructive lesion in distal femur with soft tissue component\", \"sunburst periosteal reaction\", \"elevated alkaline phosphatase\"],\n        \"rationale\": \"The report describes a destructive lesion in the distal femur with soft tissue involvement, sunburst periosteal reaction, and elevated alkaline phosphatase, suggesting a possible osteosarcoma.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes a destructive lesion in the distal femur with soft tissue involvement, sunburst periosteal reaction, and elevated alkaline phosphatase, suggesting a possible osteosarcoma.",
      "findings": [
        "destructive lesion in distal femur with soft tissue component",
        "sunburst periosteal reaction",
        "elevated alkaline phosphatase"
      ],
      "fracture_mentioned": null,
      "idx": 38,
      "timestamp": "2026-01-09T15:19:56.112142"
    },
    {
      "sample_idx": 39,
      "input": "01/11/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Post-viral lymphocytosis. Atypical lymphocytes resolving. Monospot positive. EBV serology confirms. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 01/11/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"post-viral lymphocytosis\", \"atypical lymphocytes resolving\", \"monospot positive\", \"EBV serology confirms\"],\n        \"rationale\": \"The report describes post-viral lymphocytosis and resolving atypical lymphocytes, which are benign findings. No malignancy is identified. The report provides reassurance.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"post-viral lymphocytosis\", \"atypical lymphocytes resolving\", \"monospot positive\", \"EBV serology confirms\"],\n        \"rationale\": \"The report describes post-viral lymphocytosis and resolving atypical lymphocytes, which are benign findings. No malignancy is identified. The report provides reassurance.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"post-viral lymphocytosis\", \"atypical lymphocytes resolving\", \"monospot positive\", \"EBV serology confirms\"],\n        \"rationale\": \"The report describes post-viral lymphocytosis and resolving atypical lymphocytes, which are benign findings. No malignancy is identified. The report provides reassurance.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"post-viral lymphocytosis\", \"atypical lymphocytes resolving\", \"monospot positive\", \"EBV serology confirms\"],\n        \"rationale\": \"The report describes post-viral lymphocytosis and resolving atypical lymphocytes, which are benign findings. No malignancy is identified. The report provides reassurance.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"post-viral lymphocytosis\", \"atypical lymphocytes resolving\", \"monospot positive\", \"EBV serology confirms\"],\n        \"rationale\": \"The report describes post-viral lymphocytosis and resolving atypical lymphocytes, which are benign findings. No malignancy is",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report describes post-viral lymphocytosis and resolving atypical lymphocytes, which are benign findings. No malignancy is identified. The report provides reassurance.",
      "findings": [
        "post-viral lymphocytosis",
        "atypical lymphocytes resolving",
        "monospot positive",
        "EBV serology confirms"
      ],
      "fracture_mentioned": null,
      "idx": 39,
      "timestamp": "2026-01-09T15:19:56.112153"
    },
    {
      "sample_idx": 40,
      "input": "26/04/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Wilms Tumor.\n\nFrom clinical notes: Wilms Tumor. Paediatric oncology assessment.\n\nFindings: large heterogeneous left renal mass with pseudocapsule. No vascular invasion. Favorable histology on biopsy. Stage II. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 26/04/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"no vascular invasion\", \"favorable histology on biopsy\", \"Stage II\"],\n        \"rationale\": \"The report describes a left renal mass with features suggestive of Wilms Tumor, including the presence of a pseudocapsule and favorable histology. The report also states that the tumor is Stage II.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"no vascular invasion\", \"favorable histology on biopsy\", \"Stage II\"],\n        \"rationale\": \"The report describes a left renal mass with features suggestive of Wilms Tumor, including the presence of a pseudocapsule and favorable histology. The report also states that the tumor is Stage II.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"no vascular invasion\", \"favorable histology on biopsy\", \"Stage II\"],\n        \"rationale\": \"The report describes a left renal mass with features suggestive of Wilms Tumor, including the presence of a pseudocapsule and favorable histology. The report also states that the tumor is Stage II.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"no vascular invasion\", \"favorable histology on biopsy\", \"Stage II\"],\n        \"rationale\": \"The report describes a left renal mass with features suggestive of Wilms Tumor, including the presence of a pseudocapsule and favorable histology. The report also states that the tumor is Stage II.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"no vascular invasion",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes a left renal mass with features suggestive of Wilms Tumor, including the presence of a pseudocapsule and favorable histology. The report also states that the tumor is Stage II.",
      "findings": [
        "large heterogeneous left renal mass with pseudocapsule",
        "no vascular invasion",
        "favorable histology on biopsy",
        "Stage II"
      ],
      "fracture_mentioned": null,
      "idx": 40,
      "timestamp": "2026-01-09T15:19:56.112165"
    },
    {
      "sample_idx": 41,
      "input": "18/11/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Lymphadenopathy. Suspected Hodgkin Lymphoma.\n\nFrom clinical notes: Hodgkin Lymphoma. Paediatric oncology assessment.\n\nFindings: mediastinal lymphadenopathy with bulky anterior mediastinal mass. PET-CT showing FDG-avid nodes. Classical Hodgkin, nodular sclerosing type. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 18/11/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"bulky anterior mediastinal mass\", \"FDG-avid nodes\", \"Classical Hodgkin, nodular sclerosing type\"],\n        \"rationale\": \"The report explicitly mentions mediastinal lymphadenopathy, a bulky anterior mediastinal mass, FDG-avid nodes, and confirms Classical Hodgkin lymphoma with nodular sclerosing type. This indicates malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"bulky anterior mediastinal mass\", \"FDG-avid nodes\", \"Classical Hodgkin, nodular sclerosing type\"],\n        \"rationale\": \"The report explicitly mentions mediastinal lymphadenopathy, a bulky anterior mediastinal mass, FDG-avid nodes, and confirms Classical Hodgkin lymphoma with nodular sclerosing type. This indicates malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"bulky anterior mediastinal mass\", \"FDG-avid nodes\", \"Classical Hodgkin, nodular sclerosing type\"],\n        \"rationale\": \"The report explicitly mentions mediastinal lymphadenopathy, a bulky anterior mediastinal mass, FDG-avid nodes, and confirms Classical Hodgkin lymphoma with nodular sclerosing type. This indicates malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"bulky anterior mediastinal mass\", \"FDG-avid nodes\", \"Classical Hodgkin, nodular sclerosing type\"],\n        \"rationale\": \"The report explicitly mentions mediastinal lymphadenopathy, a bulky anterior mediastinal mass, FDG-avid nodes, and confirms Classical Hodgkin lymphoma with nodular sclerosing type. This indicates malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly mentions mediastinal lymphadenopathy, a bulky anterior mediastinal mass, FDG-avid nodes, and confirms Classical Hodgkin lymphoma with nodular sclerosing type. This indicates malignancy.",
      "findings": [
        "mediastinal lymphadenopathy",
        "bulky anterior mediastinal mass",
        "FDG-avid nodes",
        "Classical Hodgkin, nodular sclerosing type"
      ],
      "fracture_mentioned": null,
      "idx": 41,
      "timestamp": "2026-01-09T15:19:56.112176"
    },
    {
      "sample_idx": 42,
      "input": "20/04/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Follow-up post-treatment. No previous oncology history.\n\nFindings: Post-viral lymphocytosis. Atypical lymphocytes resolving. Monospot positive. EBV serology confirms. No malignancy identified. Reassurance provided.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 20/04/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"post-viral lymphocytosis\", \"atypical lymphocytes resolving\", \"monospot positive\", \"EBV serology confirms\"],\n        \"rationale\": \"The report mentions post-viral lymphocytosis, atypical lymphocytes resolving, monospot positivity, and EBV serology confirmation. While these findings indicate a viral infection, they do not represent malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"post-viral lymphocytosis\", \"atypical lymphocytes resolving\", \"monospot positive\", \"EBV serology confirms\"],\n        \"rationale\": \"The report mentions post-viral lymphocytosis, atypical lymphocytes resolving, monospot positivity, and EBV serology confirmation. While these findings indicate a viral infection, they do not represent malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"post-viral lymphocytosis\", \"atypical lymphocytes resolving\", \"monospot positive\", \"EBV serology confirms\"],\n        \"rationale\": \"The report mentions post-viral lymphocytosis, atypical lymphocytes resolving, monospot positivity, and EBV serology confirmation. While these findings indicate a viral infection, they do not represent malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"post-viral lymphocytosis\", \"atypical lymphocytes resolving\", \"monospot positive\", \"EBV serology confirms\"],\n        \"rationale\": \"The report mentions post-viral lymphocytosis, atypical lymphocytes resolving, monospot positivity, and EBV serology confirmation. While these findings indicate a viral infection, they do not represent malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"post-viral lymphocytosis\", \"atypical",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report mentions post-viral lymphocytosis, atypical lymphocytes resolving, monospot positivity, and EBV serology confirmation. While these findings indicate a viral infection, they do not represent malignancy.",
      "findings": [
        "post-viral lymphocytosis",
        "atypical lymphocytes resolving",
        "monospot positive",
        "EBV serology confirms"
      ],
      "fracture_mentioned": null,
      "idx": 42,
      "timestamp": "2026-01-09T15:19:56.112188"
    },
    {
      "sample_idx": 43,
      "input": "20/01/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Follow-up post-treatment. No previous oncology history.\n\nFindings: Normal brain MRI for age. No mass lesion. No abnormal enhancement. Headaches attributed to migraine. No malignancy identified. Reassurance provided.\n\nDr James Chen, Consultant Paediatric Oncologist 20/01/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that there are no mass lesions, abnormal enhancement, or malignancy identified on the brain MRI, and that the patient is reassured. Therefore, no malignancy is present.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that there are no mass lesions, abnormal enhancement, or malignancy identified on the brain MRI, and that the patient is reassured. Therefore, no malignancy is present.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that there are no mass lesions, abnormal enhancement, or malignancy identified on the brain MRI, and that the patient is reassured. Therefore, no malignancy is present.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that there are no mass lesions, abnormal enhancement, or malignancy identified on the brain MRI, and that the patient is reassured. Therefore, no malignancy is present.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that there are no mass lesions, abnormal enhancement, or malignancy identified on the brain MRI, and that the patient",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states that there are no mass lesions, abnormal enhancement, or malignancy identified on the brain MRI, and that the patient is reassured. Therefore, no malignancy is present.",
      "findings": [
        "normal brain MRI",
        "no mass lesion",
        "no abnormal enhancement",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 43,
      "timestamp": "2026-01-09T15:19:56.112199"
    },
    {
      "sample_idx": 44,
      "input": "22/11/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Abnormal imaging. Suspected Ewing Sarcoma.\n\nFrom clinical notes: Ewing Sarcoma. Paediatric oncology assessment.\n\nFindings: permeative bone destruction in left femoral diaphysis with large soft tissue mass. Onion-skin periosteal reaction. EWSR1 fusion positive. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 22/11/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"permeative bone destruction in left femoral diaphysis with large soft tissue mass\", \"onion-skin periosteal reaction\", \"EWSR1 fusion positive\"],\n        \"rationale\": \"The report describes a large soft tissue mass and bone destruction with onion-skin periosteal reaction, along with a positive EWSR1 fusion, which are all indicative of Ewing Sarcoma.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"permeative bone destruction in left femoral diaphysis with large soft tissue mass\", \"onion-skin periosteal reaction\", \"EWSR1 fusion positive\"],\n        \"rationale\": \"The report describes a large soft tissue mass and bone destruction with onion-skin periosteal reaction, along with a positive EWSR1 fusion, which are all indicative of Ewing Sarcoma.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"permeative bone destruction in left femoral diaphysis with large soft tissue mass\", \"onion-skin periosteal reaction\", \"EWSR1 fusion positive\"],\n        \"rationale\": \"The report describes a large soft tissue mass and bone destruction with onion-skin periosteal reaction, along with a positive EWSR1 fusion, which are all indicative of Ewing Sarcoma.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"permeative bone destruction in left femoral diaphysis with large soft tissue mass\", \"onion-skin periosteal reaction\", \"EWSR1 fusion positive\"],\n        \"rationale\": \"The report describes a large soft tissue mass and bone destruction with onion-skin periosteal reaction, along with a positive EWSR1 fusion, which are all indicative of Ewing Sarcoma.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes a large soft tissue mass and bone destruction with onion-skin periosteal reaction, along with a positive EWSR1 fusion, which are all indicative of Ewing Sarcoma.",
      "findings": [
        "permeative bone destruction in left femoral diaphysis with large soft tissue mass",
        "onion-skin periosteal reaction",
        "EWSR1 fusion positive"
      ],
      "fracture_mentioned": null,
      "idx": 44,
      "timestamp": "2026-01-09T15:19:56.112211"
    },
    {
      "sample_idx": 45,
      "input": "06/05/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Follow-up post-treatment. No previous oncology history.\n\nFindings: Normal brain MRI for age. No mass lesion. No abnormal enhancement. Headaches attributed to migraine. No malignancy identified. Reassurance provided.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 06/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that the brain MRI is normal, there is no mass lesion, no abnormal enhancement, and no malignancy is identified. Therefore, malignancy is ruled out.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC\", \"age-appropriate values\", \"no blast cells\"],\n        \"rationale\": \"The report shows normal blood counts with no atypical or malignant cells. No evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"lymphoblasts 85% of marrow\", \"B-cell ALL immunophenotype\", \"bone marrow infiltration\"],\n        \"rationale\": \"The report explicitly identifies bone marrow infiltration with lymphoblasts and immunophenotyping consistent with acute lymphoblastic leukemia, confirming malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that the brain MRI is normal, there is no mass lesion, no abnormal enhancement, and no malignancy is identified. Therefore, malignancy is ruled out.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC\", \"age-appropriate values\", \"no blast cells\"],\n        \"rationale\": \"The report shows normal blood counts with no atypical or malignant cells. No evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states that the brain MRI is normal, there is no mass lesion, no abnormal enhancement, and no malignancy is identified. Therefore, malignancy is ruled out.",
      "findings": [
        "normal brain MRI",
        "no mass lesion",
        "no abnormal enhancement",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 45,
      "timestamp": "2026-01-09T15:19:56.112222"
    },
    {
      "sample_idx": 46,
      "input": "24/10/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Physiological splenomegaly for age. No focal lesions. Normal echo texture. Benign finding. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 24/10/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"physiological splenomegaly\", \"no focal lesions\", \"normal echo texture\"],\n        \"rationale\": \"The report mentions physiological splenomegaly, absence of focal lesions, and normal echo texture, which are benign findings. No malignancy is identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"physiological splenomegaly\", \"no focal lesions\", \"normal echo texture\"],\n        \"rationale\": \"The report mentions physiological splenomegaly, absence of focal lesions, and normal echo texture, which are benign findings. No malignancy is identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"physiological splenomegaly\", \"no focal lesions\", \"normal echo texture\"],\n        \"rationale\": \"The report mentions physiological splenomegaly, absence of focal lesions, and normal echo texture, which are benign findings. No malignancy is identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"physiological splenomegaly\", \"no focal lesions\", \"normal echo texture\"],\n        \"rationale\": \"The report mentions physiological splenomegaly, absence of focal lesions, and normal echo texture, which are benign findings. No malignancy is identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"physiological splenomegaly\", \"no focal lesions\", \"normal echo texture\"],\n        \"rationale\": \"The report mentions physiological splenomegaly, absence of focal lesions, and normal echo texture, which are benign findings. No malignancy is identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"physiological splenomegaly\", \"",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report mentions physiological splenomegaly, absence of focal lesions, and normal echo texture, which are benign findings. No malignancy is identified.",
      "findings": [
        "physiological splenomegaly",
        "no focal lesions",
        "normal echo texture"
      ],
      "fracture_mentioned": null,
      "idx": 46,
      "timestamp": "2026-01-09T15:19:56.112232"
    },
    {
      "sample_idx": 47,
      "input": "01/02/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Reactive lymphadenopathy secondary to viral infection. Node size decreasing on follow-up. No atypical features. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 01/02/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report indicates reactive lymphadenopathy, meaning the lymph nodes are enlarged due to a benign process like a viral infection. The report explicitly states that no atypical features or malignancy were identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report indicates reactive lymphadenopathy, meaning the lymph nodes are enlarged due to a benign process like a viral infection. The report explicitly states that no atypical features or malignancy were identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report indicates reactive lymphadenopathy, meaning the lymph nodes are enlarged due to a benign process like a viral infection. The report explicitly states that no atypical features or malignancy were identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report indicates reactive lymphadenopathy, meaning the lymph nodes are enlarged due to a benign process like a viral infection. The report explicitly states that no atypical features or malignancy were identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report indicates reactive lymphadenopathy, meaning the lymph nodes are enlarged due to a benign process like a viral infection. The report explicitly states that no atypical features or malignancy were identified.\"\n    }\n}",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report indicates reactive lymphadenopathy, meaning the lymph nodes are enlarged due to a benign process like a viral infection. The report explicitly states that no atypical features or malignancy were identified.",
      "findings": [
        "reactive lymphadenopathy",
        "no atypical features",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 47,
      "timestamp": "2026-01-09T15:19:56.112243"
    },
    {
      "sample_idx": 48,
      "input": "03/10/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Lymphadenopathy. Suspected Osteosarcoma.\n\nFrom clinical notes: Osteosarcoma. Paediatric oncology assessment.\n\nFindings: destructive lesion in distal femur with soft tissue component. Sunburst periosteal reaction. Elevated alkaline phosphatase. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 03/10/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"destructive lesion in distal femur with soft tissue component\", \"sunburst periosteal reaction\", \"elevated alkaline phosphatase\"],\n        \"rationale\": \"The report describes a destructive lesion in the distal femur with soft tissue involvement, sunburst periosteal reaction, and elevated alkaline phosphatase. These findings are suggestive of osteosarcoma, a type of bone cancer.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"osteosarcoma\", \"distal femur\", \"sunburst periosteal reaction\"],\n        \"rationale\": \"The report explicitly mentions osteosarcoma, which is a malignant bone tumor.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"osteosarcoma\", \"distal femur\", \"sunburst periosteal reaction\"],\n        \"rationale\": \"The report explicitly mentions osteosarcoma, which is a malignant bone tumor.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"osteosarcoma\", \"distal femur\", \"sunburst periosteal reaction\"],\n        \"rationale\": \"The report explicitly mentions osteosarcoma, which is a malignant bone tumor.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"osteosarcoma\", \"distal femur\", \"sunburst periosteal reaction\"],\n        \"rationale\": \"The report explicitly mentions osteosarcoma, which is a malignant bone tumor.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"osteosarcoma\", \"distal femur\", \"sunburst periosteal reaction\"],\n        \"rationale\": \"The",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes a destructive lesion in the distal femur with soft tissue involvement, sunburst periosteal reaction, and elevated alkaline phosphatase. These findings are suggestive of osteosarcoma, a type of bone cancer.",
      "findings": [
        "destructive lesion in distal femur with soft tissue component",
        "sunburst periosteal reaction",
        "elevated alkaline phosphatase"
      ],
      "fracture_mentioned": null,
      "idx": 48,
      "timestamp": "2026-01-09T15:19:56.112255"
    },
    {
      "sample_idx": 49,
      "input": "05/08/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Reactive lymphadenopathy secondary to viral infection. Node size decreasing on follow-up. No atypical features. No malignancy identified. Reassurance provided.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 05/08/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report indicates reactive lymphadenopathy, which is a benign finding. It explicitly states that no atypical features or malignancy were identified, thus ruling out malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report indicates lymphadenopathy. It explicitly states that no atypical features or malignancy were identified, thus ruling out malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report indicates lymphadenopathy. It explicitly states that no atypical features or malignancy were identified, thus ruling out malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report indicates lymphadenopathy. It explicitly states that no atypical features or malignancy were identified, thus ruling out malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report indicates lymphadenopathy. It explicitly states that no atypical features or malignancy were identified, thus ruling out malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report indicates reactive lymphadenopathy, which is a benign finding. It explicitly states that no atypical features or malignancy were identified, thus ruling out malignancy.",
      "findings": [
        "reactive lymphadenopathy",
        "no atypical features",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 49,
      "timestamp": "2026-01-09T15:19:56.112266"
    },
    {
      "sample_idx": 50,
      "input": "02/05/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Normal chest radiograph. Clear lung fields. No mediastinal mass. Heart size normal. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 02/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no malignancy was identified on the chest radiograph, and that the findings are reassuring.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no malignancy was identified on the chest radiograph, and that the findings are reassuring.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no malignancy was identified on the chest radiograph, and that the findings are reassuring.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no malignancy was identified on the chest radiograph, and that the findings are reassuring.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no malignancy was identified on the chest radiograph, and that the findings are reassuring.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states that no malignancy was identified on the chest radiograph, and that the findings are reassuring.",
      "findings": [
        "normal chest radiograph",
        "clear lung fields",
        "no mediastinal mass",
        "heart size normal",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 50,
      "timestamp": "2026-01-09T15:19:56.112277"
    },
    {
      "sample_idx": 51,
      "input": "26/07/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Follow-up post-treatment. No previous oncology history.\n\nFindings: Benign soft tissue mass - lipoma confirmed. Well-circumscribed. No enhancement. No intervention required. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 26/07/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"benign soft tissue mass - lipoma\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that a benign lipoma was identified and that no malignancy was present.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no abnormality identified\"],\n        \"rationale\": \"The report states that no abnormality was identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no findings\"],\n        \"rationale\": \"The report indicates that no findings were present.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no evidence of malignancy\"],\n        \"rationale\": \"The report explicitly states that there is no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no malignancy was identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no malignancy\"],\n        \"rationale\": \"The report explicitly states that no malignancy is present.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no evidence of malignancy\"],\n        \"rationale\": \"The report indicates that no evidence of malignancy was found.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states that a benign lipoma was identified and that no malignancy was present.",
      "findings": [
        "benign soft tissue mass - lipoma",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 51,
      "timestamp": "2026-01-09T15:19:56.112285"
    },
    {
      "sample_idx": 52,
      "input": "25/03/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Bone pain. Suspected Wilms Tumor.\n\nFrom clinical notes: Wilms Tumor. Paediatric oncology assessment.\n\nFindings: large heterogeneous left renal mass with pseudocapsule. No vascular invasion. Favorable histology on biopsy. Stage II. Recommend MDT discussion and treatment planning.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 25/03/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"No vascular invasion\", \"Favorable histology on biopsy\", \"Stage II\"],\n        \"rationale\": \"The report describes a large heterogeneous renal mass, no vascular invasion, favorable histology, and Stage II, which are all indicative of a malignancy, specifically Wilms Tumor.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"No vascular invasion\", \"Favorable histology on biopsy\", \"Stage II\"],\n        \"rationale\": \"The report describes a large heterogeneous renal mass, no vascular invasion, favorable histology, and Stage II, which are all indicative of a malignancy, specifically Wilms Tumor.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"No vascular invasion\", \"Favorable histology on biopsy\", \"Stage II\"],\n        \"rationale\": \"The report describes a large heterogeneous renal mass, no vascular invasion, favorable histology, and Stage II, which are all indicative of a malignancy, specifically Wilms Tumor.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"No vascular invasion\", \"Favorable histology on biopsy\", \"Stage II\"],\n        \"rationale\": \"The report describes a large heterogeneous renal mass, no vascular invasion, favorable histology, and Stage II, which are all indicative of a malignancy, specifically Wilms Tumor.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"No vascular invasion\", \"Favorable histology on biopsy\", \"Stage II\"],\n        \"rationale\": \"The",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes a large heterogeneous renal mass, no vascular invasion, favorable histology, and Stage II, which are all indicative of a malignancy, specifically Wilms Tumor.",
      "findings": [
        "large heterogeneous left renal mass with pseudocapsule",
        "No vascular invasion",
        "Favorable histology on biopsy",
        "Stage II"
      ],
      "fracture_mentioned": null,
      "idx": 52,
      "timestamp": "2026-01-09T15:19:56.112297"
    },
    {
      "sample_idx": 53,
      "input": "05/01/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Reactive lymphadenopathy secondary to viral infection. Node size decreasing on follow-up. No atypical features. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 05/01/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report identifies reactive lymphadenopathy, which is a benign finding. The report explicitly states that no atypical features or malignancy are present, and reassurance was provided.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"lymphadenopathy\", \"no malignancy identified\"],\n        \"rationale\": \"The report mentions lymphadenopathy, which can be a normal finding, and explicitly states no malignancy is present.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report indicates lymphadenopathy, but specifies no atypical features and no malignancy. The report concludes with reassurance.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report mentions lymphadenopathy and states that no atypical features or malignancy are present.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report indicates lymphadenopathy, and confirms that no atypical features or malignancy are present.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report describes lymphadenopathy and states that no atypical features or malignancy are present. The report provides reassurance.\"\n",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report identifies reactive lymphadenopathy, which is a benign finding. The report explicitly states that no atypical features or malignancy are present, and reassurance was provided.",
      "findings": [
        "reactive lymphadenopathy",
        "no atypical features",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 53,
      "timestamp": "2026-01-09T15:19:56.112307"
    },
    {
      "sample_idx": 54,
      "input": "23/03/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Bone pain. Suspected Hepatoblastoma.\n\nFrom clinical notes: Hepatoblastoma. Paediatric oncology assessment.\n\nFindings: large heterogeneous hepatic mass with elevated AFP. Fetal histology subtype. PRETEXT stage II. Recommend MDT discussion and treatment planning.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 23/03/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous hepatic mass\", \"elevated AFP\", \"Fetal histology subtype\", \"PRETEXT stage II\"],\n        \"rationale\": \"The report describes a large heterogeneous hepatic mass with elevated AFP, which is indicative of Hepatoblastoma. The report also mentions Fetal histology subtype and PRETEXT stage II, further supporting the diagnosis of Hepatoblastoma.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous hepatic mass\", \"elevated AFP\", \"Fetal histology subtype\", \"PRETEXT stage II\"],\n        \"rationale\": \"The report describes a large heterogeneous hepatic mass with elevated AFP, which is indicative of Hepatoblastoma. The report also mentions Fetal histology subtype and PRETEXT stage II, further supporting the diagnosis of Hepatoblastoma.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous hepatic mass\", \"elevated AFP\", \"Fetal histology subtype\", \"PRETEXT stage II\"],\n        \"rationale\": \"The report describes a large heterogeneous hepatic mass with elevated AFP, which is indicative of Hepatoblastoma. The report also mentions Fetal histology subtype and PRETEXT stage II, further supporting the diagnosis of Hepatoblastoma.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous hepatic mass\", \"elevated AFP\", \"Fetal histology subtype\", \"PRETEXT stage II\"],\n        \"rationale\": \"The report describes a large heterogeneous hepatic mass with elevated AFP, which is indicative of Hepatoblastoma. The report also mentions Fetal histology subtype and PRETEXT stage II, further supporting the diagnosis of Hepatoblastoma.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous hepatic mass\", \"elevated AFP\",",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes a large heterogeneous hepatic mass with elevated AFP, which is indicative of Hepatoblastoma. The report also mentions Fetal histology subtype and PRETEXT stage II, further supporting the diagnosis of Hepatoblastoma.",
      "findings": [
        "large heterogeneous hepatic mass",
        "elevated AFP",
        "Fetal histology subtype",
        "PRETEXT stage II"
      ],
      "fracture_mentioned": null,
      "idx": 54,
      "timestamp": "2026-01-09T15:19:56.112319"
    },
    {
      "sample_idx": 55,
      "input": "31/08/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Normal chest radiograph. Clear lung fields. No mediastinal mass. Heart size normal. No malignancy identified. Reassurance provided.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 31/08/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that the chest radiograph is normal, with no evidence of malignancy. The report provides reassurance.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that the chest radiograph is normal, with no evidence of malignancy. The report provides reassurance.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that the chest radiograph is normal, with no evidence of malignancy. The report provides reassurance.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that the chest radiograph is normal, with no evidence of malignancy. The report provides reassurance.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that the chest radiograph is normal, with no evidence of malignancy. The report provides reassurance.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states that the chest radiograph is normal, with no evidence of malignancy. The report provides reassurance.",
      "findings": [
        "normal chest radiograph",
        "clear lung fields",
        "no mediastinal mass",
        "heart size normal",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 55,
      "timestamp": "2026-01-09T15:19:56.112330"
    },
    {
      "sample_idx": 56,
      "input": "26/01/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Reactive lymphadenopathy secondary to viral infection. Node size decreasing on follow-up. No atypical features. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 26/01/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states reactive lymphadenopathy, no atypical features, and no malignancy identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states lymphadenopathy, no atypical features, and no malignancy identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states reactive lymphadenopathy, no atypical features, and no malignancy identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states reactive lymphadenopathy, no atypical features, and no malignancy identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states reactive lymphadenopathy, no atypical features, and no malignancy identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states reactive lymphadenopathy, no atypical features, and no malignancy identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states reactive lymphadenopathy, no atypical features, and no malignancy identified.",
      "findings": [
        "reactive lymphadenopathy",
        "no atypical features",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 56,
      "timestamp": "2026-01-09T15:19:56.112339"
    },
    {
      "sample_idx": 57,
      "input": "24/11/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Germ Cell Tumor.\n\nFrom clinical notes: Germ Cell Tumor. Paediatric oncology assessment.\n\nFindings: sacrococcygeal mass with mixed solid and cystic components. Elevated AFP and beta-hCG. Yolk sac tumor elements present. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 24/11/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"sacrococcygeal mass with mixed solid and cystic components\", \"elevated AFP and beta-hCG\", \"yolk sac tumor elements present\"],\n        \"rationale\": \"The report describes a sacrococcygeal mass with mixed solid and cystic components, elevated AFP and beta-hCG, and the presence of yolk sac tumor elements, all of which are indicative of a germ cell tumor, a type of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"sacrococcygeal mass with mixed solid and cystic components\", \"elevated AFP and beta-hCG\", \"yolk sac tumor elements present\"],\n        \"rationale\": \"The report describes a sacrococcygeal mass with mixed solid and cystic components, elevated AFP and beta-hCG, and the presence of yolk sac tumor elements, all of which are indicative of a germ cell tumor, a type of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"sacrococcygeal mass with mixed solid and cystic components\", \"elevated AFP and beta-hCG\", \"yolk sac tumor elements present\"],\n        \"rationale\": \"The report describes a sacrococcygeal mass with mixed solid and cystic components, elevated AFP and beta-hCG, and the presence of yolk sac tumor elements, all of which are indicative of a germ cell tumor, a type of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"sacrococcygeal mass with mixed solid and cystic components\", \"elevated AFP and beta-hCG\", \"yolk sac tumor elements present\"],\n        \"rationale\": \"The report describes a sacrococcygeal mass with mixed solid and cystic components, elevated AFP and beta-hCG, and the presence of yolk sac tumor",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes a sacrococcygeal mass with mixed solid and cystic components, elevated AFP and beta-hCG, and the presence of yolk sac tumor elements, all of which are indicative of a germ cell tumor, a type of malignancy.",
      "findings": [
        "sacrococcygeal mass with mixed solid and cystic components",
        "elevated AFP and beta-hCG",
        "yolk sac tumor elements present"
      ],
      "fracture_mentioned": null,
      "idx": 57,
      "timestamp": "2026-01-09T15:19:56.112351"
    },
    {
      "sample_idx": 58,
      "input": "01/01/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Unexplained fever and weight loss. Suspected Germ Cell Tumor.\n\nFrom clinical notes: Germ Cell Tumor. Paediatric oncology assessment.\n\nFindings: sacrococcygeal mass with mixed solid and cystic components. Elevated AFP and beta-hCG. Yolk sac tumor elements present. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 01/01/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"sacrococcygeal mass\", \"mixed solid and cystic components\", \"elevated AFP and beta-hCG\", \"yolk sac tumor elements\"],\n        \"rationale\": \"The report describes a sacrococcygeal mass with mixed solid and cystic components, elevated AFP and beta-hCG, and the presence of yolk sac tumor elements, indicating a germ cell tumor.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"sacrococcygeal mass\", \"mixed solid and cystic components\", \"elevated AFP and beta-hCG\", \"yolk sac tumor elements\"],\n        \"rationale\": \"The report describes a sacrococcygeal mass with mixed solid and cystic components, elevated AFP and beta-hCG, and the presence of yolk sac tumor elements, indicating a germ cell tumor.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"sacrococcygeal mass\", \"mixed solid and cystic components\", \"elevated AFP and beta-hCG\", \"yolk sac tumor elements\"],\n        \"rationale\": \"The report describes a sacrococcygeal mass with mixed solid and cystic components, elevated AFP and beta-hCG, and the presence of yolk sac tumor elements, indicating a germ cell tumor.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"sacrococcygeal mass\", \"mixed solid and cystic components\", \"elevated AFP and beta-hCG\", \"yolk sac tumor elements\"],\n        \"rationale\": \"The report describes a sacrococcygeal mass with mixed solid and cystic components, elevated AFP and beta-hCG, and the presence of yolk sac tumor elements, indicating a germ cell tumor.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes a sacrococcygeal mass with mixed solid and cystic components, elevated AFP and beta-hCG, and the presence of yolk sac tumor elements, indicating a germ cell tumor.",
      "findings": [
        "sacrococcygeal mass",
        "mixed solid and cystic components",
        "elevated AFP and beta-hCG",
        "yolk sac tumor elements"
      ],
      "fracture_mentioned": null,
      "idx": 58,
      "timestamp": "2026-01-09T15:19:56.112362"
    },
    {
      "sample_idx": 59,
      "input": "16/06/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Rhabdomyosarcoma.\n\nFrom clinical notes: Rhabdomyosarcoma. Paediatric oncology assessment.\n\nFindings: parameningeal mass with intracranial extension. Embryonal rhabdomyosarcoma on biopsy. PAX-FOXO1 fusion negative. Recommend MDT discussion and treatment planning.\n\nDr James Chen, Consultant Paediatric Oncologist 16/06/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"parameningeal mass with intracranial extension\", \"embryonal rhabdomyosarcoma on biopsy\", \"PAX-FOXO1 fusion negative\"],\n        \"rationale\": \"The report explicitly mentions a parameningeal mass with intracranial extension, confirming a diagnosis of embryonal rhabdomyosarcoma. The PAX-FOXO1 fusion status is also provided, which helps to classify the subtype of rhabdomyosarcoma. The presence of a mass and a confirmed diagnosis of rhabdomyosarcoma indicate malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"embryonal rhabdomyosarcoma on biopsy\"],\n        \"rationale\": \"The report explicitly mentions embryonal rhabdomyosarcoma on biopsy, indicating the presence of a malignant tumor.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"embryonal rhabdomyosarcoma on biopsy\"],\n        \"rationale\": \"The report explicitly mentions embryonal rhabdomyosarcoma on biopsy, indicating the presence of a malignant tumor.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"embryonal rhabdomyosarcoma on biopsy\"],\n        \"rationale\": \"The report explicitly mentions embryonal rhabdomyosarcoma on biopsy, indicating the presence of a malignant tumor.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"embryonal rhabdomyosarcoma on biopsy\"],\n        \"rationale\": \"The report explicitly mentions embryonal rhabdomyosarcoma on biopsy, indicating the presence of a malignant tumor.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malign",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly mentions a parameningeal mass with intracranial extension, confirming a diagnosis of embryonal rhabdomyosarcoma. The PAX-FOXO1 fusion status is also provided, which helps to classify the subtype of rhabdomyosarcoma. The presence of a mass and a confirmed diagnosis of rhabdomyosarcoma indicate malignancy.",
      "findings": [
        "parameningeal mass with intracranial extension",
        "embryonal rhabdomyosarcoma on biopsy",
        "PAX-FOXO1 fusion negative"
      ],
      "fracture_mentioned": null,
      "idx": 59,
      "timestamp": "2026-01-09T15:19:56.112376"
    },
    {
      "sample_idx": 60,
      "input": "08/05/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Normal brain MRI for age. No mass lesion. No abnormal enhancement. Headaches attributed to migraine. No malignancy identified. Reassurance provided.\n\nDr James Chen, Consultant Paediatric Oncologist 08/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\"],\n        \"rationale\": \"The report confirms the absence of malignancy and other concerning findings.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no evidence of malignancy\", \"normal findings\"],\n        \"rationale\": \"The report explicitly states that no evidence of malignancy was found, and that the findings were normal.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no evidence of malignancy\", \"normal findings\"],\n        \"rationale\": \"The report explicitly states that no evidence of malignancy was found, and that the findings were normal.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no evidence of malignancy\", \"normal findings\"],\n        \"rationale\": \"The report explicitly states that no evidence of malignancy was found, and that the findings were normal.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no evidence of malignancy\", \"normal findings\"],\n        \"rationale\": \"The report explicitly states that no evidence of malignancy was found, and that the findings were normal.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no evidence of malignancy\", \"normal findings\"],\n        \"rationale\": \"The report explicitly states that no evidence of malignancy was found, and that the findings were normal.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\":",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report confirms the absence of malignancy and other concerning findings.",
      "findings": [
        "normal brain MRI",
        "no mass lesion",
        "no abnormal enhancement",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 60,
      "timestamp": "2026-01-09T15:19:56.112385"
    },
    {
      "sample_idx": 61,
      "input": "09/07/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Follow-up post-treatment. No previous oncology history.\n\nFindings: Post-viral lymphocytosis. Atypical lymphocytes resolving. Monospot positive. EBV serology confirms. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 09/07/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"post-viral lymphocytosis\", \"atypical lymphocytes resolving\", \"monospot positive\", \"EBV serology confirms\", \"no malignancy identified\"],\n        \"rationale\": \"The report notes post-viral lymphocytosis, resolving atypical lymphocytes, and confirms EBV infection. It explicitly states that no malignancy is identified. Therefore, there is no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"post-viral lymphocytosis\", \"atypical lymphocytes resolving\", \"monospot positive\", \"EBV serology confirms\", \"no malignancy identified\"],\n        \"rationale\": \"The report notes post-viral lymphocytosis, resolving atypical lymphocytes, and confirms EBV infection. It explicitly states that no malignancy is identified. Therefore, there is no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"post-viral lymphocytosis\", \"atypical lymphocytes resolving\", \"monospot positive\", \"EBV serology confirms\", \"no malignancy identified\"],\n        \"rationale\": \"The report notes post-viral lymphocytosis, resolving atypical lymphocytes, and confirms EBV infection. It explicitly states that no malignancy is identified. Therefore, there is no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"post-viral lymphocytosis\", \"atypical lymphocytes resolving\", \"monospot positive\", \"EBV serology confirms\", \"no malignancy identified\"],\n        \"rationale\": \"The report notes post-viral lymphocytosis, resolving atypical lymphocytes, and confirms EBV infection. It explicitly states that no malignancy is identified. Therefore, there is no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report notes post-viral lymphocytosis, resolving atypical lymphocytes, and confirms EBV infection. It explicitly states that no malignancy is identified. Therefore, there is no evidence of malignancy.",
      "findings": [
        "post-viral lymphocytosis",
        "atypical lymphocytes resolving",
        "monospot positive",
        "EBV serology confirms",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 61,
      "timestamp": "2026-01-09T15:19:56.112397"
    },
    {
      "sample_idx": 62,
      "input": "08/05/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Reactive lymphadenopathy secondary to viral infection. Node size decreasing on follow-up. No atypical features. No malignancy identified. Reassurance provided.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 08/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report mentions reactive lymphadenopathy and specifically states that no malignancy is identified. Therefore, the finding is not indicative of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report mentions reactive lymphadenopathy and specifically states that no malignancy is identified. Therefore, the finding is not indicative of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report mentions reactive lymphadenopathy and specifically states that no malignancy is identified. Therefore, the finding is not indicative of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report mentions reactive lymphadenopathy and specifically states that no malignancy is identified. Therefore, the finding is not indicative of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report mentions reactive lymphadenopathy and specifically states that no malignancy is identified. Therefore, the finding is not indicative of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report mentions reactive lymphadenopathy and specifically states that no malignancy is identified. Therefore, the finding is not indicative of malignancy.",
      "findings": [
        "reactive lymphadenopathy",
        "no atypical features",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 62,
      "timestamp": "2026-01-09T15:19:56.112407"
    },
    {
      "sample_idx": 63,
      "input": "04/12/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Resolved febrile illness. Blood counts normalized. No organomegaly. Clinical improvement noted. No malignancy identified. Reassurance provided.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 04/12/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"resolved febrile illness\", \"normalized blood counts\", \"no organomegaly\", \"no malignancy identified\"],\n        \"rationale\": \"The report states that the patient had a resolved febrile illness and that blood counts normalized, which are not malignant findings. It also explicitly states that no malignancy was identified. The report provides reassurance.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"resolved febrile illness\", \"normalized blood counts\", \"no organomegaly\", \"no malignancy identified\"],\n        \"rationale\": \"The report states that the patient had a resolved febrile illness and that blood counts normalized, which are not malignant findings. It also explicitly states that no malignancy was identified. The report provides reassurance.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"resolved febrile illness\", \"normalized blood counts\", \"no organomegaly\", \"no malignancy identified\"],\n        \"rationale\": \"The report states that the patient had a resolved febrile illness and that blood counts normalized, which are not malignant findings. It also explicitly states that no malignancy was identified. The report provides reassurance.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"resolved febrile illness\", \"normalized blood counts\", \"no organomegaly\", \"no malignancy identified\"],\n        \"rationale\": \"The report states that the patient had a resolved febrile illness and that blood counts normalized, which are not malignant findings. It also explicitly states that no malignancy was identified. The report provides reassurance.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"resolved febrile illness\", \"normalized blood counts\", \"no organomegaly\", \"no malignancy identified\"],\n        \"rationale\": \"The report states that",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report states that the patient had a resolved febrile illness and that blood counts normalized, which are not malignant findings. It also explicitly states that no malignancy was identified. The report provides reassurance.",
      "findings": [
        "resolved febrile illness",
        "normalized blood counts",
        "no organomegaly",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 63,
      "timestamp": "2026-01-09T15:19:56.112419"
    },
    {
      "sample_idx": 64,
      "input": "29/09/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Reactive lymphadenopathy secondary to viral infection. Node size decreasing on follow-up. No atypical features. No malignancy identified. Reassurance provided.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 29/09/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report describes reactive lymphadenopathy, which is a benign finding. The report explicitly states that no atypical features or malignancy are present. The report concludes with reassurance that no malignancy was identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report describes reactive lymphadenopathy, which is a benign finding. The report explicitly states that no atypical features or malignancy are present. The report concludes with reassurance that no malignancy was identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report describes reactive lymphadenopathy, which is a benign finding. The report explicitly states that no atypical features or malignancy are present. The report concludes with reassurance that no malignancy was identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report describes reactive lymphadenopathy, which is a benign finding. The report explicitly states that no atypical features or malignancy are present. The report concludes with reassurance that no malignancy was identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report describes reactive lymphadenopathy, which is a benign finding. The report explicitly states that no atypical features or malignancy are present. The report concludes with reassurance that no malignancy was",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report describes reactive lymphadenopathy, which is a benign finding. The report explicitly states that no atypical features or malignancy are present. The report concludes with reassurance that no malignancy was identified.",
      "findings": [
        "reactive lymphadenopathy",
        "no atypical features",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 64,
      "timestamp": "2026-01-09T15:19:56.112430"
    },
    {
      "sample_idx": 65,
      "input": "09/06/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Abnormal imaging. Suspected Retinoblastoma.\n\nFrom clinical notes: Retinoblastoma. Paediatric oncology assessment.\n\nFindings: intraocular mass with calcifications. Bilateral disease. Family history positive. RB1 germline mutation detected. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 09/06/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"intraocular mass with calcifications\", \"Bilateral disease\", \"Family history positive\", \"RB1 germline mutation detected\"],\n        \"rationale\": \"The report mentions intraocular masses with calcifications, bilateral disease, a positive family history, and the detection of an RB1 germline mutation, which are all consistent with retinoblastoma, a type of cancer.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"intraocular mass with calcifications\", \"Bilateral disease\", \"Family history positive\", \"RB1 germline mutation detected\"],\n        \"rationale\": \"The report mentions intraocular masses with calcifications, bilateral disease, a positive family history, and the detection of an RB1 germline mutation, which are all consistent with retinoblastoma, a type of cancer.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"intraocular mass with calcifications\", \"Bilateral disease\", \"Family history positive\", \"RB1 germline mutation detected\"],\n        \"rationale\": \"The report mentions intraocular masses with calcifications, bilateral disease, a positive family history, and the detection of an RB1 germline mutation, which are all consistent with retinoblastoma, a type of cancer.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"intraocular mass with calcifications\", \"Bilateral disease\", \"Family history positive\", \"RB1 germline mutation detected\"],\n        \"rationale\": \"The report mentions intraocular masses with calcifications, bilateral disease, a positive family history, and the detection of an RB1 germline mutation, which are all consistent with retinoblastoma, a type of cancer.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report mentions intraocular masses with calcifications, bilateral disease, a positive family history, and the detection of an RB1 germline mutation, which are all consistent with retinoblastoma, a type of cancer.",
      "findings": [
        "intraocular mass with calcifications",
        "Bilateral disease",
        "Family history positive",
        "RB1 germline mutation detected"
      ],
      "fracture_mentioned": null,
      "idx": 65,
      "timestamp": "2026-01-09T15:19:56.112443"
    },
    {
      "sample_idx": 66,
      "input": "16/05/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Abnormal imaging. Suspected Neuroblastoma.\n\nFrom clinical notes: Neuroblastoma. Paediatric oncology assessment.\n\nFindings: large heterogeneous suprarenal mass with calcifications. MIBG avidity present. Elevated urinary catecholamines. Stage III disease. Recommend MDT discussion and treatment planning.\n\nDr James Chen, Consultant Paediatric Oncologist 16/05/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"elevated urinary catecholamines\", \"Stage III disease\"],\n        \"rationale\": \"The report describes a suprarenal mass with calcifications, MIBG avidity, and elevated urinary catecholamines, which are suggestive of neuroblastoma. The report also indicates stage III disease, confirming malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"elevated urinary catecholamines\", \"Stage III disease\"],\n        \"rationale\": \"The report describes a suprarenal mass with calcifications, MIBG avidity, and elevated urinary catecholamines, which are suggestive of neuroblastoma. The report also indicates stage III disease, confirming malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"elevated urinary catecholamines\", \"Stage III disease\"],\n        \"rationale\": \"The report describes a suprarenal mass with calcifications, MIBG avidity, and elevated urinary catecholamines, which are suggestive of neuroblastoma. The report also indicates stage III disease, confirming malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"elevated urinary catecholamines\", \"Stage III disease\"],\n        \"rationale\": \"The report describes a suprarenal mass with calcifications, MIBG avidity, and elevated urinary catecholamines, which are suggestive of neuroblastoma. The report also indicates stage III disease, confirming malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        ",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes a suprarenal mass with calcifications, MIBG avidity, and elevated urinary catecholamines, which are suggestive of neuroblastoma. The report also indicates stage III disease, confirming malignancy.",
      "findings": [
        "large heterogeneous suprarenal mass with calcifications",
        "MIBG avidity present",
        "elevated urinary catecholamines",
        "Stage III disease"
      ],
      "fracture_mentioned": null,
      "idx": 66,
      "timestamp": "2026-01-09T15:19:56.112455"
    },
    {
      "sample_idx": 67,
      "input": "21/03/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Follow-up post-treatment. No previous oncology history.\n\nFindings: Normal CBC with age-appropriate values. No blast cells. Platelets adequate. Hemoglobin within normal limits. No malignancy identified. Reassurance provided.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 21/03/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC\", \"age-appropriate values\", \"no blast cells\"],\n        \"rationale\": \"The report shows normal blood counts with no atypical or malignant cells. No evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no blast cells\", \"platelets adequate\", \"hemoglobin within normal limits\"],\n        \"rationale\": \"The report indicates the absence of blast cells, adequate platelets, and normal hemoglobin levels, which are all reassuring findings and do not suggest malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC\", \"no malignancy identified\"],\n        \"rationale\": \"The report confirms a normal complete blood count (CBC) and explicitly states that no malignancy was identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC\", \"no blast cells\"],\n        \"rationale\": \"The report shows a normal complete blood count and the absence of blast cells, indicating no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no blast cells\", \"normal CBC\"],\n        \"rationale\": \"The report states that no blast cells were found and that the complete blood count (CBC) was normal, which does not indicate malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC\", \"no blast cells\"],\n        \"rationale\": \"The report shows a normal CBC and the absence of blast cells, which is reassuring and does not suggest malignancy.\"\n    }\n}\n```\n```json\n{\n    ",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report shows normal blood counts with no atypical or malignant cells. No evidence of malignancy.",
      "findings": [
        "normal CBC",
        "age-appropriate values",
        "no blast cells"
      ],
      "fracture_mentioned": null,
      "idx": 67,
      "timestamp": "2026-01-09T15:19:56.112464"
    },
    {
      "sample_idx": 68,
      "input": "27/02/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Bone pain. Suspected Rhabdomyosarcoma.\n\nFrom clinical notes: Rhabdomyosarcoma. Paediatric oncology assessment.\n\nFindings: parameningeal mass with intracranial extension. Embryonal rhabdomyosarcoma on biopsy. PAX-FOXO1 fusion negative. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 27/02/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"embryonal rhabdomyosarcoma on biopsy\"],\n        \"rationale\": \"The report explicitly identifies embryonal rhabdomyosarcoma on biopsy, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"parameningeal mass with intracranial extension\", \"embryonal rhabdomyosarcoma on biopsy\"],\n        \"rationale\": \"The report explicitly mentions a parameningeal mass with intracranial extension and confirms embryonal rhabdomyosarcoma on biopsy, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"embryonal rhabdomyosarcoma on biopsy\"],\n        \"rationale\": \"The report explicitly identifies embryonal rhabdomyosarcoma on biopsy, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"embryonal rhabdomyosarcoma on biopsy\"],\n        \"rationale\": \"The report explicitly identifies embryonal rhabdomyosarcoma on biopsy, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"embryonal rhabdomyosarcoma on biopsy\"],\n        \"rationale\": \"The report explicitly identifies embryonal rhabdomyosarcoma on biopsy, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"embryonal rhabdomyosarcoma on biopsy\"],\n        \"rationale\": \"The report explicitly identifies embryonal rhabdomyosarcoma on biopsy, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly identifies embryonal rhabdomyosarcoma on biopsy, indicating malignancy.",
      "findings": [
        "embryonal rhabdomyosarcoma on biopsy"
      ],
      "fracture_mentioned": null,
      "idx": 68,
      "timestamp": "2026-01-09T15:19:56.112472"
    },
    {
      "sample_idx": 69,
      "input": "16/10/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Normal chest radiograph. Clear lung fields. No mediastinal mass. Heart size normal. No malignancy identified. Reassurance provided.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 16/10/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal chest radiograph\", \"Clear lung fields\", \"No mediastinal mass\", \"Heart size normal\", \"No malignancy identified\", \"Reassurance provided\"],\n        \"rationale\": \"The report states that a chest radiograph was performed and found to be normal, with no mediastinal mass, heart size normal, and no malignancy identified. Reassurance was provided.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal chest radiograph\", \"Clear lung fields\", \"No mediastinal mass\", \"Heart size normal\", \"No malignancy identified\", \"Reassurance provided\"],\n        \"rationale\": \"The report indicates that a chest radiograph was performed and found to be normal, with no mediastinal mass, heart size normal, and no malignancy identified. Reassurance was provided.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal chest radiograph\", \"Clear lung fields\", \"No mediastinal mass\", \"Heart size normal\", \"No malignancy identified\", \"Reassurance provided\"],\n        \"rationale\": \"The report indicates that a chest radiograph was performed and found to be normal, with no mediastinal mass, heart size normal, and no malignancy identified. Reassurance was provided.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal chest radiograph\", \"Clear lung fields\", \"No mediastinal mass\", \"Heart size normal\", \"No malignancy identified\", \"Reassurance provided\"],\n        \"rationale\": \"The report indicates that a chest radiograph was performed and found to be normal, with no mediastinal mass, heart size normal, and no malignancy identified. Reassurance was provided.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal chest radiograph",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report states that a chest radiograph was performed and found to be normal, with no mediastinal mass, heart size normal, and no malignancy identified. Reassurance was provided.",
      "findings": [
        "Normal chest radiograph",
        "Clear lung fields",
        "No mediastinal mass",
        "Heart size normal",
        "No malignancy identified",
        "Reassurance provided"
      ],
      "fracture_mentioned": null,
      "idx": 69,
      "timestamp": "2026-01-09T15:19:56.112484"
    },
    {
      "sample_idx": 70,
      "input": "29/11/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Unexplained fever and weight loss. Suspected Retinoblastoma.\n\nFrom clinical notes: Retinoblastoma. Paediatric oncology assessment.\n\nFindings: intraocular mass with calcifications. Bilateral disease. Family history positive. RB1 germline mutation detected. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 29/11/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"intraocular mass with calcifications\", \"bilateral disease\", \"family history positive\", \"RB1 germline mutation detected\"],\n        \"rationale\": \"The report explicitly mentions an intraocular mass with calcifications, bilateral disease, a positive family history, and the detection of an RB1 germline mutation, all of which are consistent with retinoblastoma, a type of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"intraocular mass with calcifications\", \"bilateral disease\", \"family history positive\", \"RB1 germline mutation detected\"],\n        \"rationale\": \"The report explicitly mentions an intraocular mass with calcifications, bilateral disease, a positive family history, and the detection of an RB1 germline mutation, all of which are consistent with retinoblastoma, a type of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"intraocular mass with calcifications\", \"bilateral disease\", \"family history positive\", \"RB1 germline mutation detected\"],\n        \"rationale\": \"The report explicitly mentions an intraocular mass with calcifications, bilateral disease, a positive family history, and the detection of an RB1 germline mutation, all of which are consistent with retinoblastoma, a type of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"intraocular mass with calcifications\", \"bilateral disease\", \"family history positive\", \"RB1 germline mutation detected\"],\n        \"rationale\": \"The report explicitly mentions an intraocular mass with calcifications, bilateral disease, a positive family history, and the detection of an RB1 germline mutation, all of which are consistent with retinoblastoma, a type of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly mentions an intraocular mass with calcifications, bilateral disease, a positive family history, and the detection of an RB1 germline mutation, all of which are consistent with retinoblastoma, a type of malignancy.",
      "findings": [
        "intraocular mass with calcifications",
        "bilateral disease",
        "family history positive",
        "RB1 germline mutation detected"
      ],
      "fracture_mentioned": null,
      "idx": 70,
      "timestamp": "2026-01-09T15:19:56.112496"
    },
    {
      "sample_idx": 71,
      "input": "11/10/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Abnormal imaging. Suspected Hodgkin Lymphoma.\n\nFrom clinical notes: Hodgkin Lymphoma. Paediatric oncology assessment.\n\nFindings: mediastinal lymphadenopathy with bulky anterior mediastinal mass. PET-CT showing FDG-avid nodes. Classical Hodgkin, nodular sclerosing type. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 11/10/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"bulky anterior mediastinal mass\", \"FDG-avid nodes\", \"Classical Hodgkin, nodular sclerosing type\"],\n        \"rationale\": \"The report explicitly mentions mediastinal lymphadenopathy, a bulky anterior mediastinal mass, FDG-avid nodes, and the diagnosis of Classical Hodgkin Lymphoma, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"bulky anterior mediastinal mass\", \"FDG-avid nodes\", \"Classical Hodgkin, nodular sclerosing type\"],\n        \"rationale\": \"The report explicitly mentions mediastinal lymphadenopathy, a bulky anterior mediastinal mass, FDG-avid nodes, and the diagnosis of Classical Hodgkin Lymphoma, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"bulky anterior mediastinal mass\", \"FDG-avid nodes\", \"Classical Hodgkin, nodular sclerosing type\"],\n        \"rationale\": \"The report explicitly mentions mediastinal lymphadenopathy, a bulky anterior mediastinal mass, FDG-avid nodes, and the diagnosis of Classical Hodgkin Lymphoma, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"bulky anterior mediastinal mass\", \"FDG-avid nodes\", \"Classical Hodgkin, nodular sclerosing type\"],\n        \"rationale\": \"The report explicitly mentions mediastinal lymphadenopathy, a bulky anterior mediastinal mass, FDG-avid nodes, and the diagnosis of Classical Hodgkin Lymphoma, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        ",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly mentions mediastinal lymphadenopathy, a bulky anterior mediastinal mass, FDG-avid nodes, and the diagnosis of Classical Hodgkin Lymphoma, indicating malignancy.",
      "findings": [
        "mediastinal lymphadenopathy",
        "bulky anterior mediastinal mass",
        "FDG-avid nodes",
        "Classical Hodgkin, nodular sclerosing type"
      ],
      "fracture_mentioned": null,
      "idx": 71,
      "timestamp": "2026-01-09T15:19:56.112508"
    },
    {
      "sample_idx": 72,
      "input": "13/09/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Unexplained fever and weight loss. Suspected Rhabdomyosarcoma.\n\nFrom clinical notes: Rhabdomyosarcoma. Paediatric oncology assessment.\n\nFindings: parameningeal mass with intracranial extension. Embryonal rhabdomyosarcoma on biopsy. PAX-FOXO1 fusion negative. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 13/09/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"parameningeal mass with intracranial extension\", \"embryonal rhabdomyosarcoma on biopsy\", \"PAX-FOXO1 fusion negative\"],\n        \"rationale\": \"The report identifies a parameningeal mass with intracranial extension, which is consistent with rhabdomyosarcoma. The biopsy confirms embryonal rhabdomyosarcoma, and the PAX-FOXO1 fusion status is reported, which is relevant for treatment planning. The report indicates a need for MDT discussion and treatment planning, suggesting a diagnosis of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"parameningeal mass with intracranial extension\", \"embryonal rhabdomyosarcoma on biopsy\", \"PAX-FOXO1 fusion negative\"],\n        \"rationale\": \"The report identifies a parameningeal mass with intracranial extension, which is consistent with rhabdomyosarcoma. The biopsy confirms embryonal rhabdomyosarcoma, and the PAX-FOXO1 fusion status is reported, which is relevant for treatment planning. The report indicates a need for MDT discussion and treatment planning, suggesting a diagnosis of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"parameningeal mass with intracranial extension\", \"embryonal rhabdomyosarcoma on biopsy\", \"PAX-FOXO1 fusion negative\"],\n        \"rationale\": \"The report identifies a parameningeal mass with intracranial extension, which is consistent with rhabdomyosarcoma. The biopsy confirms embryonal rhabdomyosarcoma, and the PAX-FOXO1 fusion status is reported, which is relevant for treatment planning. The report indicates a need for MDT discussion and treatment planning, suggesting a diagnosis of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"parameningeal mass with intracranial extension\", \"embryonal r",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report identifies a parameningeal mass with intracranial extension, which is consistent with rhabdomyosarcoma. The biopsy confirms embryonal rhabdomyosarcoma, and the PAX-FOXO1 fusion status is reported, which is relevant for treatment planning. The report indicates a need for MDT discussion and treatment planning, suggesting a diagnosis of malignancy.",
      "findings": [
        "parameningeal mass with intracranial extension",
        "embryonal rhabdomyosarcoma on biopsy",
        "PAX-FOXO1 fusion negative"
      ],
      "fracture_mentioned": null,
      "idx": 72,
      "timestamp": "2026-01-09T15:19:56.112522"
    },
    {
      "sample_idx": 73,
      "input": "03/12/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Physiological splenomegaly for age. No focal lesions. Normal echo texture. Benign finding. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 03/12/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"physiological splenomegaly\", \"no focal lesions\", \"normal echo texture\"],\n        \"rationale\": \"The report explicitly states that physiological splenomegaly is present, with no focal lesions and normal echo texture. The report concludes that no malignancy is identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"physiological splenomegaly\", \"no focal lesions\", \"normal echo texture\"],\n        \"rationale\": \"The report explicitly states that physiological splenomegaly is present, with no focal lesions and normal echo texture. The report concludes that no malignancy is identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"physiological splenomegaly\", \"no focal lesions\", \"normal echo texture\"],\n        \"rationale\": \"The report explicitly states that physiological splenomegaly is present, with no focal lesions and normal echo texture. The report concludes that no malignancy is identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"physiological splenomegaly\", \"no focal lesions\", \"normal echo texture\"],\n        \"rationale\": \"The report explicitly states that physiological splenomegaly is present, with no focal lesions and normal echo texture. The report concludes that no malignancy is identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"physiological splenomegaly\", \"no focal lesions\", \"normal echo texture\"],\n        \"rationale\": \"The report explicitly states that physiological splenomegaly is present, with no focal lesions and normal echo texture. The report concludes that no malignancy is identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states that physiological splenomegaly is present, with no focal lesions and normal echo texture. The report concludes that no malignancy is identified.",
      "findings": [
        "physiological splenomegaly",
        "no focal lesions",
        "normal echo texture"
      ],
      "fracture_mentioned": null,
      "idx": 73,
      "timestamp": "2026-01-09T15:19:56.112532"
    },
    {
      "sample_idx": 74,
      "input": "11/10/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Ewing Sarcoma.\n\nFrom clinical notes: Ewing Sarcoma. Paediatric oncology assessment.\n\nFindings: permeative bone destruction in left femoral diaphysis with large soft tissue mass. Onion-skin periosteal reaction. EWSR1 fusion positive. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 11/10/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"permeative bone destruction in left femoral diaphysis with large soft tissue mass\", \"onion-skin periosteal reaction\", \"EWSR1 fusion positive\"],\n        \"rationale\": \"The report explicitly mentions bone destruction, a soft tissue mass, and a positive EWSR1 fusion, all of which are indicative of Ewing Sarcoma, a malignant bone tumor.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"permeative bone destruction in left femoral diaphysis with large soft tissue mass\", \"onion-skin periosteal reaction\", \"EWSR1 fusion positive\"],\n        \"rationale\": \"The report explicitly mentions bone destruction, a soft tissue mass, and a positive EWSR1 fusion, all of which are indicative of Ewing Sarcoma, a malignant bone tumor.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"permeative bone destruction in left femoral diaphysis with large soft tissue mass\", \"onion-skin periosteal reaction\", \"EWSR1 fusion positive\"],\n        \"rationale\": \"The report explicitly mentions bone destruction, a soft tissue mass, and a positive EWSR1 fusion, all of which are indicative of Ewing Sarcoma, a malignant bone tumor.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"permeative bone destruction in left femoral diaphysis with large soft tissue mass\", \"onion-skin periosteal reaction\", \"EWSR1 fusion positive\"],\n        \"rationale\": \"The report explicitly mentions bone destruction, a soft tissue mass, and a positive EWSR1 fusion, all of which are indicative of Ewing Sarcoma, a malignant bone tumor.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"permeative",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly mentions bone destruction, a soft tissue mass, and a positive EWSR1 fusion, all of which are indicative of Ewing Sarcoma, a malignant bone tumor.",
      "findings": [
        "permeative bone destruction in left femoral diaphysis with large soft tissue mass",
        "onion-skin periosteal reaction",
        "EWSR1 fusion positive"
      ],
      "fracture_mentioned": null,
      "idx": 74,
      "timestamp": "2026-01-09T15:19:56.112543"
    },
    {
      "sample_idx": 75,
      "input": "28/12/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Reactive lymphadenopathy secondary to viral infection. Node size decreasing on follow-up. No atypical features. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 28/12/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy secondary to viral infection\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly mentions reactive lymphadenopathy likely due to a viral infection and confirms that no atypical features or malignancy were found.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy secondary to viral infection\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly mentions reactive lymphadenopathy likely due to a viral infection and confirms that no atypical features or malignancy were found.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy secondary to viral infection\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly mentions reactive lymphadenopathy likely due to a viral infection and confirms that no atypical features or malignancy were found.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy secondary to viral infection\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly mentions reactive lymphadenopathy likely due to a viral infection and confirms that no atypical features or malignancy were found.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy secondary to viral infection\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly mentions reactive lymphadenopathy likely due to a viral infection and confirms that no atypical features or malignancy were found.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly mentions reactive lymphadenopathy likely due to a viral infection and confirms that no atypical features or malignancy were found.",
      "findings": [
        "reactive lymphadenopathy secondary to viral infection",
        "no atypical features",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 75,
      "timestamp": "2026-01-09T15:19:56.112554"
    },
    {
      "sample_idx": 76,
      "input": "02/05/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Normal CBC with age-appropriate values. No blast cells. Platelets adequate. Hemoglobin within normal limits. No malignancy identified. Reassurance provided.\n\nDr James Chen, Consultant Paediatric Oncologist 02/05/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC with age-appropriate values\", \"no blast cells\", \"platelets adequate\", \"hemoglobin within normal limits\", \"no malignancy identified\", \"reassurance provided\"],\n        \"rationale\": \"The report describes a normal complete blood count (CBC) with no abnormal cells, including blast cells, and confirms the absence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC with age-appropriate values\", \"no blast cells\", \"platelets adequate\", \"hemoglobin within normal limits\", \"no malignancy identified\", \"reassurance provided\"],\n        \"rationale\": \"The report describes a normal complete blood count (CBC) with no abnormal cells, including blast cells, and confirms the absence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC with age-appropriate values\", \"no blast cells\", \"platelets adequate\", \"hemoglobin within normal limits\", \"no malignancy identified\", \"reassurance provided\"],\n        \"rationale\": \"The report describes a normal complete blood count (CBC) with no abnormal cells, including blast cells, and confirms the absence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC with age-appropriate values\", \"no blast cells\", \"platelets adequate\", \"hemoglobin within normal limits\", \"no malignancy identified\", \"reassurance provided\"],\n        \"rationale\": \"The report describes a normal complete blood count (CBC) with no abnormal cells, including blast cells, and confirms the absence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC with age-appropriate values\", \"no blast cells\", \"platelets adequate\", \"hemoglobin within",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report describes a normal complete blood count (CBC) with no abnormal cells, including blast cells, and confirms the absence of malignancy.",
      "findings": [
        "normal CBC with age-appropriate values",
        "no blast cells",
        "platelets adequate",
        "hemoglobin within normal limits",
        "no malignancy identified",
        "reassurance provided"
      ],
      "fracture_mentioned": null,
      "idx": 76,
      "timestamp": "2026-01-09T15:19:56.112566"
    },
    {
      "sample_idx": 77,
      "input": "06/10/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Healing fracture - normal process. No pathological features. Bone density normal. Trauma history consistent. No malignancy identified. Reassurance provided.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 06/10/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"healing fracture\", \"normal bone density\", \"no pathological features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that there are no pathological features, no malignancy identified, and the fracture is healing normally. This indicates that malignancy is not present.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no findings of malignancy\"],\n        \"rationale\": \"The report explicitly states that there are no findings of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no findings of malignancy\"],\n        \"rationale\": \"The report explicitly states that there are no findings of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no findings of malignancy\"],\n        \"rationale\": \"The report explicitly states that there are no findings of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no findings of malignancy\"],\n        \"rationale\": \"The report explicitly states that there are no findings of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no findings of malignancy\"],\n        \"rationale\": \"The report explicitly states that there are no findings of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no findings of malignancy\"],\n        \"rationale\": \"The report explicitly states that there are no findings of malignancy.\"\n    }\n}\n```\n```json\n{\n",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states that there are no pathological features, no malignancy identified, and the fracture is healing normally. This indicates that malignancy is not present.",
      "findings": [
        "healing fracture",
        "normal bone density",
        "no pathological features",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 77,
      "timestamp": "2026-01-09T15:19:56.112577"
    },
    {
      "sample_idx": 78,
      "input": "27/02/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Acute Lymphoblastic Leukemia.\n\nFrom clinical notes: Acute Lymphoblastic Leukemia. Paediatric oncology assessment.\n\nFindings: bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells. Immunophenotyping consistent with B-cell ALL. CNS involvement negative. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 27/02/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells\", \"Immunophenotyping consistent with B-cell ALL\", \"CNS involvement negative\"],\n        \"rationale\": \"The report explicitly mentions bone marrow infiltration with a high percentage of lymphoblasts and immunophenotyping consistent with B-cell ALL. CNS involvement is negative. These findings strongly indicate malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells\", \"Immunophenotyping consistent with B-cell ALL\", \"CNS involvement negative\"],\n        \"rationale\": \"The report explicitly mentions bone marrow infiltration with a high percentage of lymphoblasts and immunophenotyping consistent with B-cell ALL. CNS involvement is negative. These findings strongly indicate malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells\", \"Immunophenotyping consistent with B-cell ALL\", \"CNS involvement negative\"],\n        \"rationale\": \"The report explicitly mentions bone marrow infiltration with a high percentage of lymphoblasts and immunophenotyping consistent with B-cell ALL. CNS involvement is negative. These findings strongly indicate malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells\", \"Immunophenotyping consistent with B-cell ALL\", \"CNS involvement negative\"],\n        \"rationale\": \"The report explicitly mentions bone marrow infiltration with a high percentage of lymphoblasts and immunophenotyping consistent with B-cell ALL. CNS involvement is negative. These findings strongly indicate malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly mentions bone marrow infiltration with a high percentage of lymphoblasts and immunophenotyping consistent with B-cell ALL. CNS involvement is negative. These findings strongly indicate malignancy.",
      "findings": [
        "bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells",
        "Immunophenotyping consistent with B-cell ALL",
        "CNS involvement negative"
      ],
      "fracture_mentioned": null,
      "idx": 78,
      "timestamp": "2026-01-09T15:19:56.112590"
    },
    {
      "sample_idx": 79,
      "input": "17/05/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Post-viral lymphocytosis. Atypical lymphocytes resolving. Monospot positive. EBV serology confirms. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 17/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Post-viral lymphocytosis\", \"Atypical lymphocytes resolving\", \"Monospot positive\", \"EBV serology confirms\"],\n        \"rationale\": \"The report identifies post-viral lymphocytosis, atypical lymphocytes resolving, a positive Monospot test, and EBV serology confirmation, indicating a viral infection. No malignancy is identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Atypical lymphocytes resolving\", \"Monospot positive\", \"EBV serology confirms\"],\n        \"rationale\": \"The report identifies atypical lymphocytes resolving, a positive Monospot test, and EBV serology confirmation, indicating a viral infection. No malignancy is identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Atypical lymphocytes resolving\", \"Monospot positive\", \"EBV serology confirms\"],\n        \"rationale\": \"The report identifies atypical lymphocytes resolving, a positive Monospot test, and EBV serology confirmation, indicating a viral infection. No malignancy is identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Atypical lymphocytes resolving\", \"Monospot positive\", \"EBV serology confirms\"],\n        \"rationale\": \"The report identifies atypical lymphocytes resolving, a positive Monospot test, and EBV serology confirmation, indicating a viral infection. No malignancy is identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Atypical lymphocytes resolving\", \"Monospot positive\", \"EBV serology confirms\"],\n        \"rationale\": \"The report identifies atypical lymphocytes resolving, a positive Monospot test, and EBV serology confirmation, indicating a viral infection. No malignancy is identified.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report identifies post-viral lymphocytosis, atypical lymphocytes resolving, a positive Monospot test, and EBV serology confirmation, indicating a viral infection. No malignancy is identified.",
      "findings": [
        "Post-viral lymphocytosis",
        "Atypical lymphocytes resolving",
        "Monospot positive",
        "EBV serology confirms"
      ],
      "fracture_mentioned": null,
      "idx": 79,
      "timestamp": "2026-01-09T15:19:56.112601"
    },
    {
      "sample_idx": 80,
      "input": "18/02/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Physiological splenomegaly for age. No focal lesions. Normal echo texture. Benign finding. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 18/02/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"physiological splenomegaly for age\", \"no focal lesions\", \"normal echo texture\", \"benign finding\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that there are no focal lesions and no malignancy identified. The presence of physiological splenomegaly is noted, but not considered a malignancy. The report concludes with reassurance.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"physiological splenomegaly for age\", \"no focal lesions\", \"normal echo texture\", \"benign finding\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that there are no focal lesions and no malignancy identified. The presence of physiological splenomegaly is noted, but not considered a malignancy. The report concludes with reassurance.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"physiological splenomegaly for age\", \"no focal lesions\", \"normal echo texture\", \"benign finding\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that there are no focal lesions and no malignancy identified. The presence of physiological splenomegaly is noted, but not considered a malignancy. The report concludes with reassurance.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"physiological splenomegaly for age\", \"no focal lesions\", \"normal echo texture\", \"benign finding\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that there are no focal lesions and no malignancy identified. The presence of physiological splenomegaly is noted, but not considered a malignancy. The report concludes with reassurance.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"physiological splenomegaly for age\", \"no focal lesions\", \"normal echo texture",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states that there are no focal lesions and no malignancy identified. The presence of physiological splenomegaly is noted, but not considered a malignancy. The report concludes with reassurance.",
      "findings": [
        "physiological splenomegaly for age",
        "no focal lesions",
        "normal echo texture",
        "benign finding",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 80,
      "timestamp": "2026-01-09T15:19:56.112613"
    },
    {
      "sample_idx": 81,
      "input": "11/06/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Benign soft tissue mass - lipoma confirmed. Well-circumscribed. No enhancement. No intervention required. No malignancy identified. Reassurance provided.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 11/06/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"benign soft tissue mass - lipoma confirmed\", \"No malignancy identified\"],\n        \"rationale\": \"The report states the finding is a benign lipoma, and explicitly denies the presence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"No previous oncology history\", \"Reassurance provided\"],\n        \"rationale\": \"The patient has no prior history of cancer, and the report provides reassurance, indicating no suspicion of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC\", \"age-appropriate values\", \"no blast cells\"],\n        \"rationale\": \"The report shows normal blood counts with no atypical or malignant cells. No evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC\", \"age-appropriate values\", \"no blast cells\"],\n        \"rationale\": \"The report shows normal blood counts with no atypical or malignant cells. No evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC\", \"age-appropriate values\", \"no blast cells\"],\n        \"rationale\": \"The report shows normal blood counts with no atypical or malignant cells. No evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC\", \"age-appropriate values\", \"no blast cells\"],\n        \"rationale\": \"The report shows normal blood counts with no atypical or malignant cells. No evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report states the finding is a benign lipoma, and explicitly denies the presence of malignancy.",
      "findings": [
        "benign soft tissue mass - lipoma confirmed",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 81,
      "timestamp": "2026-01-09T15:19:56.112622"
    },
    {
      "sample_idx": 82,
      "input": "27/12/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Abnormal imaging. Suspected Wilms Tumor.\n\nFrom clinical notes: Wilms Tumor. Paediatric oncology assessment.\n\nFindings: large heterogeneous left renal mass with pseudocapsule. No vascular invasion. Favorable histology on biopsy. Stage II. Recommend MDT discussion and treatment planning.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 27/12/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"Wilms Tumor\"],\n        \"rationale\": \"The report describes a left renal mass and diagnoses it as Wilms Tumor, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"Wilms Tumor\"],\n        \"rationale\": \"The report describes a left renal mass and diagnoses it as Wilms Tumor, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"Wilms Tumor\"],\n        \"rationale\": \"The report describes a left renal mass and diagnoses it as Wilms Tumor, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"Wilms Tumor\"],\n        \"rationale\": \"The report describes a left renal mass and diagnoses it as Wilms Tumor, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"Wilms Tumor\"],\n        \"rationale\": \"The report describes a left renal mass and diagnoses it as Wilms Tumor, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"Wilms Tumor\"],\n        \"rationale\": \"The report describes a left renal mass and diagnoses it as Wilms Tumor, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    ",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes a left renal mass and diagnoses it as Wilms Tumor, indicating malignancy.",
      "findings": [
        "large heterogeneous left renal mass with pseudocapsule",
        "Wilms Tumor"
      ],
      "fracture_mentioned": null,
      "idx": 82,
      "timestamp": "2026-01-09T15:19:56.112631"
    },
    {
      "sample_idx": 83,
      "input": "05/11/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Osteosarcoma.\n\nFrom clinical notes: Osteosarcoma. Paediatric oncology assessment.\n\nFindings: destructive lesion in distal femur with soft tissue component. Sunburst periosteal reaction. Elevated alkaline phosphatase. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 05/11/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"destructive lesion in distal femur with soft tissue component\", \"sunburst periosteal reaction\", \"elevated alkaline phosphatase\"],\n        \"rationale\": \"The report describes a destructive lesion in the distal femur with soft tissue involvement, sunburst periosteal reaction, and elevated alkaline phosphatase. These findings are highly suggestive of osteosarcoma, a type of bone cancer.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"destructive lesion in distal femur with soft tissue component\", \"sunburst periosteal reaction\", \"elevated alkaline phosphatase\"],\n        \"rationale\": \"The report describes a destructive lesion in the distal femur with soft tissue involvement, sunburst periosteal reaction, and elevated alkaline phosphatase. These findings are highly suggestive of osteosarcoma, a type of bone cancer.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"destructive lesion in distal femur with soft tissue component\", \"sunburst periosteal reaction\", \"elevated alkaline phosphatase\"],\n        \"rationale\": \"The report describes a destructive lesion in the distal femur with soft tissue involvement, sunburst periosteal reaction, and elevated alkaline phosphatase. These findings are highly suggestive of osteosarcoma, a type of bone cancer.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"destructive lesion in distal femur with soft tissue component\", \"sunburst periosteal reaction\", \"elevated alkaline phosphatase\"],\n        \"rationale\": \"The report describes a destructive lesion in the distal femur with soft tissue involvement, sunburst periosteal reaction, and elevated alkaline phosphatase. These findings are highly suggestive of osteosarcoma, a type of bone cancer.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"destructive lesion",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes a destructive lesion in the distal femur with soft tissue involvement, sunburst periosteal reaction, and elevated alkaline phosphatase. These findings are highly suggestive of osteosarcoma, a type of bone cancer.",
      "findings": [
        "destructive lesion in distal femur with soft tissue component",
        "sunburst periosteal reaction",
        "elevated alkaline phosphatase"
      ],
      "fracture_mentioned": null,
      "idx": 83,
      "timestamp": "2026-01-09T15:19:56.112643"
    },
    {
      "sample_idx": 84,
      "input": "23/11/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Healing fracture - normal process. No pathological features. Bone density normal. Trauma history consistent. No malignancy identified. Reassurance provided.\n\nDr James Chen, Consultant Paediatric Oncologist 23/11/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"healing fracture\", \"no pathological features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that the healing fracture is normal and that no pathological features or malignancy are identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"healing fracture\", \"no pathological features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that the healing fracture is normal and that no pathological features or malignancy are identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"healing fracture\", \"no pathological features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that the healing fracture is normal and that no pathological features or malignancy are identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"healing fracture\", \"no pathological features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that the healing fracture is normal and that no pathological features or malignancy are identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"healing fracture\", \"no pathological features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that the healing fracture is normal and that no pathological features or malignancy are identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"healing fracture\", \"no pathological features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that the healing fracture is normal and that no pathological features or malignancy are identified.\"\n    }\n}\n```\n```json\n{\n    \"ab",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states that the healing fracture is normal and that no pathological features or malignancy are identified.",
      "findings": [
        "healing fracture",
        "no pathological features",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 84,
      "timestamp": "2026-01-09T15:19:56.112652"
    },
    {
      "sample_idx": 85,
      "input": "14/05/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Normal chest radiograph. Clear lung fields. No mediastinal mass. Heart size normal. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 14/05/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\"],\n        \"rationale\": \"The report states that the chest radiograph is normal and there is no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\"],\n        \"rationale\": \"The report indicates normal chest imaging with no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\"],\n        \"rationale\": \"The report states that there is no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no malignancy is identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\"],\n        \"rationale\": \"The report confirms the absence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\"],\n        \"ration",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report states that the chest radiograph is normal and there is no evidence of malignancy.",
      "findings": [
        "normal chest radiograph",
        "clear lung fields",
        "no mediastinal mass",
        "heart size normal",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 85,
      "timestamp": "2026-01-09T15:19:56.112662"
    },
    {
      "sample_idx": 86,
      "input": "11/06/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Hepatoblastoma.\n\nFrom clinical notes: Hepatoblastoma. Paediatric oncology assessment.\n\nFindings: large heterogeneous hepatic mass with elevated AFP. Fetal histology subtype. PRETEXT stage II. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 11/06/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous hepatic mass\", \"elevated AFP\", \"Fetal histology subtype\", \"PRETEXT stage II\"],\n        \"rationale\": \"The report describes a large heterogeneous hepatic mass, elevated AFP, and a fetal histology subtype, all suggestive of hepatoblastoma. The PRETEXT stage also indicates a certain stage of the cancer. The report concludes with a recommendation for MDT discussion and treatment planning, further supporting the suspicion of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous hepatic mass\", \"elevated AFP\", \"Fetal histology subtype\", \"PRETEXT stage II\"],\n        \"rationale\": \"The report describes a large heterogeneous hepatic mass, elevated AFP, and a fetal histology subtype, all suggestive of hepatoblastoma. The PRETEXT stage also indicates a certain stage of the cancer. The report concludes with a recommendation for MDT discussion and treatment planning, further supporting the suspicion of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous hepatic mass\", \"elevated AFP\", \"Fetal histology subtype\", \"PRETEXT stage II\"],\n        \"rationale\": \"The report describes a large heterogeneous hepatic mass, elevated AFP, and a fetal histology subtype, all suggestive of hepatoblastoma. The PRETEXT stage also indicates a certain stage of the cancer. The report concludes with a recommendation for MDT discussion and treatment planning, further supporting the suspicion of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous hepatic mass\", \"elevated AFP\", \"Fetal histology subtype\", \"PRETEXT stage II\"],\n        \"rationale\": \"The report describes a large heterogeneous hepatic mass, elevated AFP, and a fetal histology subtype, all suggestive of hepatoblastoma. The PRETEXT stage also indicates a certain stage of the cancer. The report concludes with a recommendation for MDT discussion and",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes a large heterogeneous hepatic mass, elevated AFP, and a fetal histology subtype, all suggestive of hepatoblastoma. The PRETEXT stage also indicates a certain stage of the cancer. The report concludes with a recommendation for MDT discussion and treatment planning, further supporting the suspicion of malignancy.",
      "findings": [
        "large heterogeneous hepatic mass",
        "elevated AFP",
        "Fetal histology subtype",
        "PRETEXT stage II"
      ],
      "fracture_mentioned": null,
      "idx": 86,
      "timestamp": "2026-01-09T15:19:56.112676"
    },
    {
      "sample_idx": 87,
      "input": "16/12/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Abnormal imaging. Suspected Acute Myeloid Leukemia.\n\nFrom clinical notes: Acute Myeloid Leukemia. Paediatric oncology assessment.\n\nFindings: myeloblasts accounting for 70% of marrow cellularity. Cytogenetic analysis reveals t(8;21) translocation. Favorable risk category. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 16/12/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"myeloblasts accounting for 70% of marrow cellularity\", \"t(8;21) translocation\"],\n        \"rationale\": \"The report states that myeloblasts account for 70% of marrow cellularity, indicating a diagnosis of acute myeloid leukemia. The presence of t(8;21) translocation is also consistent with AML. Therefore, malignancy is confirmed.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"myeloblasts accounting for 70% of marrow cellularity\", \"t(8;21) translocation\"],\n        \"rationale\": \"The report indicates a high percentage of myeloblasts in the bone marrow (70%), which is a hallmark of acute myeloid leukemia (AML). The presence of t(8;21) translocation is a specific cytogenetic abnormality commonly associated with AML. Therefore, the findings strongly suggest malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"myeloblasts accounting for 70% of marrow cellularity\", \"t(8;21) translocation\"],\n        \"rationale\": \"The report details a high percentage of myeloblasts in the bone marrow (70%), which is indicative of acute myeloid leukemia (AML). The presence of the t(8;21) translocation is a specific genetic abnormality strongly associated with AML. These findings together confirm the presence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"myeloblasts accounting for 70% of marrow cellularity\", \"t(8;21) translocation\"],\n        \"rationale\": \"The report states that myeloblasts account for 70% of marrow cellularity, which is diagnostic for acute myeloid leukemia (AML). The t(8;21) translocation is a specific genetic abnormality commonly found in AML. The presence of both findings indicates malignancy.\"",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report states that myeloblasts account for 70% of marrow cellularity, indicating a diagnosis of acute myeloid leukemia. The presence of t(8;21) translocation is also consistent with AML. Therefore, malignancy is confirmed.",
      "findings": [
        "myeloblasts accounting for 70% of marrow cellularity",
        "t(8;21) translocation"
      ],
      "fracture_mentioned": null,
      "idx": 87,
      "timestamp": "2026-01-09T15:19:56.112687"
    },
    {
      "sample_idx": 88,
      "input": "29/05/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Wilms Tumor.\n\nFrom clinical notes: Wilms Tumor. Paediatric oncology assessment.\n\nFindings: large heterogeneous left renal mass with pseudocapsule. No vascular invasion. Favorable histology on biopsy. Stage II. Recommend MDT discussion and treatment planning.\n\nDr James Chen, Consultant Paediatric Oncologist 29/05/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"no vascular invasion\", \"favorable histology on biopsy\", \"stage II\"],\n        \"rationale\": \"The report describes a left renal mass with a pseudocapsule, no vascular invasion, favorable histology, and stage II. This indicates the presence of a renal tumor, likely Wilms Tumor, which is a type of kidney cancer. The presence of a renal mass with the described characteristics is considered malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal renal function\", \"no evidence of metastatic disease\", \"normal blood counts\"],\n        \"rationale\": \"The report shows normal renal function, no evidence of metastatic disease, and normal blood counts. This indicates that there is no malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"lymphoblasts 85% of marrow\", \"B-cell ALL immunophenotype\", \"bone marrow infiltration\"],\n        \"rationale\": \"The report explicitly identifies bone marrow infiltration with lymphoblasts and immunophenotyping consistent with acute lymphoblastic leukemia, confirming malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC\", \"age-appropriate values\", \"no blast cells\"],\n        \"rationale\": \"The report shows normal blood counts with no atypical or malignant cells. No evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"no vascular invasion\", \"favorable histology on biopsy\", \"stage II\"],\n        \"rationale\": \"The report describes a left renal mass with a pseudocapsule, no vascular invasion, favorable histology, and stage II. This indicates the presence of a renal",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes a left renal mass with a pseudocapsule, no vascular invasion, favorable histology, and stage II. This indicates the presence of a renal tumor, likely Wilms Tumor, which is a type of kidney cancer. The presence of a renal mass with the described characteristics is considered malignancy.",
      "findings": [
        "large heterogeneous left renal mass with pseudocapsule",
        "no vascular invasion",
        "favorable histology on biopsy",
        "stage II"
      ],
      "fracture_mentioned": null,
      "idx": 88,
      "timestamp": "2026-01-09T15:19:56.112700"
    },
    {
      "sample_idx": 89,
      "input": "16/01/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Acute Lymphoblastic Leukemia.\n\nFrom clinical notes: Acute Lymphoblastic Leukemia. Paediatric oncology assessment.\n\nFindings: bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells. Immunophenotyping consistent with B-cell ALL. CNS involvement negative. Recommend MDT discussion and treatment planning.\n\nDr James Chen, Consultant Paediatric Oncologist 16/01/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells\", \"Immunophenotyping consistent with B-cell ALL\"],\n        \"rationale\": \"The report explicitly states bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells and confirms the presence of B-cell ALL based on immunophenotyping, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells\", \"Immunophenotyping consistent with B-cell ALL\"],\n        \"rationale\": \"The report explicitly states bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells and confirms the presence of B-cell ALL based on immunophenotyping, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells\", \"Immunophenotyping consistent with B-cell ALL\"],\n        \"rationale\": \"The report explicitly states bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells and confirms the presence of B-cell ALL based on immunophenotyping, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells\", \"Immunophenotyping consistent with B-cell ALL\"],\n        \"rationale\": \"The report explicitly states bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells and confirms the presence of B-cell ALL based on immunophenotyping, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"bone marrow infiltration with lymphoblasts comprising 85% of nucleated",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly states bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells and confirms the presence of B-cell ALL based on immunophenotyping, indicating malignancy.",
      "findings": [
        "bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells",
        "Immunophenotyping consistent with B-cell ALL"
      ],
      "fracture_mentioned": null,
      "idx": 89,
      "timestamp": "2026-01-09T15:19:56.112712"
    },
    {
      "sample_idx": 90,
      "input": "06/09/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Retinoblastoma.\n\nFrom clinical notes: Retinoblastoma. Paediatric oncology assessment.\n\nFindings: intraocular mass with calcifications. Bilateral disease. Family history positive. RB1 germline mutation detected. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 06/09/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"intraocular mass with calcifications\", \"bilateral disease\", \"family history positive\", \"RB1 germline mutation detected\"],\n        \"rationale\": \"The report describes an intraocular mass with calcifications, bilateral disease, a positive family history, and the detection of an RB1 germline mutation, all strongly suggestive of retinoblastoma, a malignant tumor.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"intraocular mass with calcifications\", \"bilateral disease\", \"family history positive\", \"RB1 germline mutation detected\"],\n        \"rationale\": \"The report describes an intraocular mass with calcifications, bilateral disease, a positive family history, and the detection of an RB1 germline mutation, all strongly suggestive of retinoblastoma, a malignant tumor.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"intraocular mass with calcifications\", \"bilateral disease\", \"family history positive\", \"RB1 germline mutation detected\"],\n        \"rationale\": \"The report describes an intraocular mass with calcifications, bilateral disease, a positive family history, and the detection of an RB1 germline mutation, all strongly suggestive of retinoblastoma, a malignant tumor.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"intraocular mass with calcifications\", \"bilateral disease\", \"family history positive\", \"RB1 germline mutation detected\"],\n        \"rationale\": \"The report describes an intraocular mass with calcifications, bilateral disease, a positive family history, and the detection of an RB1 germline mutation, all strongly suggestive of retinoblastoma, a malignant tumor.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"intraocular",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes an intraocular mass with calcifications, bilateral disease, a positive family history, and the detection of an RB1 germline mutation, all strongly suggestive of retinoblastoma, a malignant tumor.",
      "findings": [
        "intraocular mass with calcifications",
        "bilateral disease",
        "family history positive",
        "RB1 germline mutation detected"
      ],
      "fracture_mentioned": null,
      "idx": 90,
      "timestamp": "2026-01-09T15:19:56.112723"
    },
    {
      "sample_idx": 91,
      "input": "30/01/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Healing fracture - normal process. No pathological features. Bone density normal. Trauma history consistent. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 30/01/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"healing fracture\", \"normal bone density\", \"no pathological features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no pathological features or malignancy were identified. The healing fracture and normal bone density further support this conclusion.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"healing fracture\", \"normal bone density\", \"no pathological features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no pathological features or malignancy were identified. The healing fracture and normal bone density further support this conclusion.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"healing fracture\", \"normal bone density\", \"no pathological features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no pathological features or malignancy were identified. The healing fracture and normal bone density further support this conclusion.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"healing fracture\", \"normal bone density\", \"no pathological features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no pathological features or malignancy were identified. The healing fracture and normal bone density further support this conclusion.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"healing fracture\", \"normal bone density\", \"no pathological features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no pathological features or malignancy were identified. The healing fracture and normal bone density further support this conclusion.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"healing fracture\", \"normal bone",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states that no pathological features or malignancy were identified. The healing fracture and normal bone density further support this conclusion.",
      "findings": [
        "healing fracture",
        "normal bone density",
        "no pathological features",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 91,
      "timestamp": "2026-01-09T15:19:56.112734"
    },
    {
      "sample_idx": 92,
      "input": "22/05/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Benign bone cyst - resolved. No aggressive features. Normal bone density. No recurrence on imaging. No malignancy identified. Reassurance provided.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 22/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Benign bone cyst - resolved\", \"No aggressive features\", \"Normal bone density\", \"No recurrence on imaging\", \"No malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no malignancy is identified and that the bone cyst has resolved. This indicates no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Benign bone cyst - resolved\", \"No aggressive features\", \"Normal bone density\", \"No recurrence on imaging\", \"No malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no malignancy is identified and that the bone cyst has resolved. This indicates no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Benign bone cyst - resolved\", \"No aggressive features\", \"Normal bone density\", \"No recurrence on imaging\", \"No malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no malignancy is identified and that the bone cyst has resolved. This indicates no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Benign bone cyst - resolved\", \"No aggressive features\", \"Normal bone density\", \"No recurrence on imaging\", \"No malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no malignancy is identified and that the bone cyst has resolved. This indicates no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Benign bone cyst - resolved\", \"No aggressive features\", \"Normal bone density\", \"No recurrence on imaging\", \"No malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no malignancy is identified and that the bone cyst has resolved. This indicates no evidence of malignancy.\"\n    }\n}",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states that no malignancy is identified and that the bone cyst has resolved. This indicates no evidence of malignancy.",
      "findings": [
        "Benign bone cyst - resolved",
        "No aggressive features",
        "Normal bone density",
        "No recurrence on imaging",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 92,
      "timestamp": "2026-01-09T15:19:56.112745"
    },
    {
      "sample_idx": 93,
      "input": "04/02/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Healing fracture - normal process. No pathological features. Bone density normal. Trauma history consistent. No malignancy identified. Reassurance provided.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 04/02/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"healing fracture\", \"normal bone density\", \"no pathological features\", \"no malignancy identified\"],\n        \"rationale\": \"The report describes a healing fracture with normal bone density and no pathological features. It explicitly states that no malignancy was identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no abnormal findings\", \"no evidence of malignancy\"],\n        \"rationale\": \"The report indicates the absence of abnormal findings and no evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no evidence of malignancy\", \"no abnormal findings\"],\n        \"rationale\": \"The report explicitly states there is no evidence of malignancy and no abnormal findings.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no evidence of malignancy\", \"no abnormal findings\"],\n        \"rationale\": \"The report indicates no evidence of malignancy and no abnormal findings.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no evidence of malignancy\", \"no abnormal findings\"],\n        \"rationale\": \"The report explicitly states there is no evidence of malignancy and no abnormal findings.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no evidence of malignancy\", \"no abnormal findings\"],\n        \"rationale\": \"The report indicates no evidence of malignancy and no abnormal findings.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no evidence of malignancy\", \"no abnormal findings\"],",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report describes a healing fracture with normal bone density and no pathological features. It explicitly states that no malignancy was identified.",
      "findings": [
        "healing fracture",
        "normal bone density",
        "no pathological features",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 93,
      "timestamp": "2026-01-09T15:19:56.112756"
    },
    {
      "sample_idx": 94,
      "input": "05/08/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Normal brain MRI for age. No mass lesion. No abnormal enhancement. Headaches attributed to migraine. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 05/08/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal brain MRI\", \"No mass lesion\", \"No abnormal enhancement\", \"Headaches attributed to migraine\", \"No malignancy identified\"],\n        \"rationale\": \"The report explicitly states that the brain MRI is normal, and no mass lesion or abnormal enhancement is present. The headaches are attributed to migraine, and no malignancy is identified. Therefore, no malignancy is present.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal brain MRI\", \"No mass lesion\", \"No abnormal enhancement\", \"Headaches attributed to migraine\", \"No malignancy identified\"],\n        \"rationale\": \"The report explicitly states that the brain MRI is normal, and no mass lesion or abnormal enhancement is present. The headaches are attributed to migraine, and no malignancy is identified. Therefore, no malignancy is present.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal brain MRI\", \"No mass lesion\", \"No abnormal enhancement\", \"Headaches attributed to migraine\", \"No malignancy identified\"],\n        \"rationale\": \"The report explicitly states that the brain MRI is normal, and no mass lesion or abnormal enhancement is present. The headaches are attributed to migraine, and no malignancy is identified. Therefore, no malignancy is present.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal brain MRI\", \"No mass lesion\", \"No abnormal enhancement\", \"Headaches attributed to migraine\", \"No malignancy identified\"],\n        \"rationale\": \"The report explicitly states that the brain MRI is normal, and no mass lesion or abnormal enhancement is present. The headaches are attributed to migraine, and no malignancy is identified. Therefore, no malignancy is present.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal brain MRI\",",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states that the brain MRI is normal, and no mass lesion or abnormal enhancement is present. The headaches are attributed to migraine, and no malignancy is identified. Therefore, no malignancy is present.",
      "findings": [
        "Normal brain MRI",
        "No mass lesion",
        "No abnormal enhancement",
        "Headaches attributed to migraine",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 94,
      "timestamp": "2026-01-09T15:19:56.112768"
    },
    {
      "sample_idx": 95,
      "input": "10/03/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Healing fracture - normal process. No pathological features. Bone density normal. Trauma history consistent. No malignancy identified. Reassurance provided.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 10/03/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"healing fracture\", \"normal bone density\", \"no pathological features\"],\n        \"rationale\": \"The report states that there is a healing fracture, normal bone density, and no pathological features. The report also explicitly states that no malignancy was identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no pathological features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that there are no pathological features and that no malignancy was identified. Therefore, there are no abnormal findings suggesting malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no pathological features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that there are no pathological features and that no malignancy was identified. Therefore, there are no abnormal findings suggesting malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no pathological features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that there are no pathological features and that no malignancy was identified. Therefore, there are no abnormal findings suggesting malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no pathological features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that there are no pathological features and that no malignancy was identified. Therefore, there are no abnormal findings suggesting malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no pathological features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that there are no pathological features and that no malignancy was identified. Therefore",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report states that there is a healing fracture, normal bone density, and no pathological features. The report also explicitly states that no malignancy was identified.",
      "findings": [
        "healing fracture",
        "normal bone density",
        "no pathological features"
      ],
      "fracture_mentioned": null,
      "idx": 95,
      "timestamp": "2026-01-09T15:19:56.112778"
    },
    {
      "sample_idx": 96,
      "input": "28/09/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Hodgkin Lymphoma.\n\nFrom clinical notes: Hodgkin Lymphoma. Paediatric oncology assessment.\n\nFindings: mediastinal lymphadenopathy with bulky anterior mediastinal mass. PET-CT showing FDG-avid nodes. Classical Hodgkin, nodular sclerosing type. Recommend MDT discussion and treatment planning.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 28/09/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"bulky anterior mediastinal mass\", \"FDG-avid nodes\", \"Classical Hodgkin, nodular sclerosing type\"],\n        \"rationale\": \"The report describes mediastinal lymphadenopathy, a bulky anterior mediastinal mass, FDG-avid nodes, and the diagnosis of Classical Hodgkin Lymphoma, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"Hodgkin Lymphoma\", \"nodular sclerosing type\"],\n        \"rationale\": \"The report explicitly states Hodgkin Lymphoma, and the specific subtype nodular sclerosing, confirming malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"FDG-avid nodes\"],\n        \"rationale\": \"The report mentions FDG-avid nodes, which are indicative of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"bulky anterior mediastinal mass\"],\n        \"rationale\": \"The report mentions a bulky anterior mediastinal mass, which is indicative of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\"],\n        \"rationale\": \"The report mentions mediastinal lymphadenopathy, which is indicative of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"Hodgkin Lymphoma\"],\n        \"rationale\": \"The report explicitly states Hodgkin Lymphoma, confirming malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\":",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes mediastinal lymphadenopathy, a bulky anterior mediastinal mass, FDG-avid nodes, and the diagnosis of Classical Hodgkin Lymphoma, indicating malignancy.",
      "findings": [
        "mediastinal lymphadenopathy",
        "bulky anterior mediastinal mass",
        "FDG-avid nodes",
        "Classical Hodgkin, nodular sclerosing type"
      ],
      "fracture_mentioned": null,
      "idx": 96,
      "timestamp": "2026-01-09T15:19:56.112790"
    },
    {
      "sample_idx": 97,
      "input": "02/01/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Bone pain. Suspected Brain Tumor - Glioma.\n\nFrom clinical notes: Brain Tumor - Glioma. Paediatric oncology assessment.\n\nFindings: left temporal lobe infiltrative mass with mass effect. FLAIR hyperintensity. Biopsy confirms diffuse astrocytoma WHO grade II. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 02/01/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"left temporal lobe infiltrative mass with mass effect\", \"FLAIR hyperintensity\", \"Biopsy confirms diffuse astrocytoma WHO grade II\"],\n        \"rationale\": \"The report describes a brain tumor, specifically a diffuse astrocytoma (WHO grade II), confirmed by biopsy. This indicates malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"left temporal lobe infiltrative mass with mass effect\", \"FLAIR hyperintensity\", \"Biopsy confirms diffuse astrocytoma WHO grade II\"],\n        \"rationale\": \"The report describes a brain tumor, specifically a diffuse astrocytoma (WHO grade II), confirmed by biopsy. This indicates malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"left temporal lobe infiltrative mass with mass effect\", \"FLAIR hyperintensity\", \"Biopsy confirms diffuse astrocytoma WHO grade II\"],\n        \"rationale\": \"The report describes a brain tumor, specifically a diffuse astrocytoma (WHO grade II), confirmed by biopsy. This indicates malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"left temporal lobe infiltrative mass with mass effect\", \"FLAIR hyperintensity\", \"Biopsy confirms diffuse astrocytoma WHO grade II\"],\n        \"rationale\": \"The report describes a brain tumor, specifically a diffuse astrocytoma (WHO grade II), confirmed by biopsy. This indicates malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"left temporal lobe infiltrative mass with mass effect\", \"FLAIR hyperintensity\", \"Biopsy confirms diffuse astrocytoma WHO grade II\"],\n        \"rationale\": \"The report describes a brain tumor, specifically a diffuse",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes a brain tumor, specifically a diffuse astrocytoma (WHO grade II), confirmed by biopsy. This indicates malignancy.",
      "findings": [
        "left temporal lobe infiltrative mass with mass effect",
        "FLAIR hyperintensity",
        "Biopsy confirms diffuse astrocytoma WHO grade II"
      ],
      "fracture_mentioned": null,
      "idx": 97,
      "timestamp": "2026-01-09T15:19:56.112800"
    },
    {
      "sample_idx": 98,
      "input": "29/06/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Follow-up post-treatment. No previous oncology history.\n\nFindings: Normal CBC with age-appropriate values. No blast cells. Platelets adequate. Hemoglobin within normal limits. No malignancy identified. Reassurance provided.\n\nDr James Chen, Consultant Paediatric Oncologist 29/06/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC\", \"no blast cells\", \"no malignancy identified\"],\n        \"rationale\": \"The report states that the CBC is normal, there are no blast cells, and no malignancy is identified. These findings indicate the absence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC\", \"no blast cells\", \"no malignancy identified\"],\n        \"rationale\": \"The report states that the CBC is normal, there are no blast cells, and no malignancy is identified. These findings indicate the absence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC\", \"no blast cells\", \"no malignancy identified\"],\n        \"rationale\": \"The report states that the CBC is normal, there are no blast cells, and no malignancy is identified. These findings indicate the absence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC\", \"no blast cells\", \"no malignancy identified\"],\n        \"rationale\": \"The report states that the CBC is normal, there are no blast cells, and no malignancy is identified. These findings indicate the absence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC\", \"no blast cells\", \"no malignancy identified\"],\n        \"rationale\": \"The report states that the CBC is normal, there are no blast cells, and no malignancy is identified. These findings indicate the absence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC\", \"no blast cells\", \"",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report states that the CBC is normal, there are no blast cells, and no malignancy is identified. These findings indicate the absence of malignancy.",
      "findings": [
        "normal CBC",
        "no blast cells",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 98,
      "timestamp": "2026-01-09T15:19:56.112810"
    },
    {
      "sample_idx": 99,
      "input": "21/03/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Hodgkin Lymphoma.\n\nFrom clinical notes: Hodgkin Lymphoma. Paediatric oncology assessment.\n\nFindings: mediastinal lymphadenopathy with bulky anterior mediastinal mass. PET-CT showing FDG-avid nodes. Classical Hodgkin, nodular sclerosing type. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 21/03/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"bulky anterior mediastinal mass\", \"FDG-avid nodes\", \"Classical Hodgkin, nodular sclerosing type\"],\n        \"rationale\": \"The report explicitly describes mediastinal lymphadenopathy, a bulky anterior mediastinal mass, FDG-avid nodes, and confirms the diagnosis of Classical Hodgkin Lymphoma with nodular sclerosing type, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"bulky anterior mediastinal mass\", \"FDG-avid nodes\", \"Classical Hodgkin, nodular sclerosing type\"],\n        \"rationale\": \"The report explicitly describes mediastinal lymphadenopathy, a bulky anterior mediastinal mass, FDG-avid nodes, and confirms the diagnosis of Classical Hodgkin Lymphoma with nodular sclerosing type, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"bulky anterior mediastinal mass\", \"FDG-avid nodes\", \"Classical Hodgkin, nodular sclerosing type\"],\n        \"rationale\": \"The report explicitly describes mediastinal lymphadenopathy, a bulky anterior mediastinal mass, FDG-avid nodes, and confirms the diagnosis of Classical Hodgkin Lymphoma with nodular sclerosing type, indicating malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"bulky anterior mediastinal mass\", \"FDG-avid nodes\", \"Classical Hodgkin, nodular sclerosing type\"],\n        \"rationale\": \"The report explicitly describes mediastinal lymphadenopathy, a bulky anterior mediastinal mass, FDG-avid nodes, and confirms the diagnosis of Classical Hodgkin Lymphoma with nodular sclerosing type, indicating malignancy.\"\n    }\n}\n```\n```json",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly describes mediastinal lymphadenopathy, a bulky anterior mediastinal mass, FDG-avid nodes, and confirms the diagnosis of Classical Hodgkin Lymphoma with nodular sclerosing type, indicating malignancy.",
      "findings": [
        "mediastinal lymphadenopathy",
        "bulky anterior mediastinal mass",
        "FDG-avid nodes",
        "Classical Hodgkin, nodular sclerosing type"
      ],
      "fracture_mentioned": null,
      "idx": 99,
      "timestamp": "2026-01-09T15:19:56.112822"
    }
  ],
  "end_time": "2026-01-09T15:19:56.113242",
  "duration_seconds": 68.99375
}